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ABSTRACT
Fatigue in Patients w ith  Cancer - Analysis and Assessment
Although fatigue is the most frequent complaint in cancer patients, there is no 
universally accepted definition. This thesis presents a series of studies whose 
aims were definition of cancer-specific fatigue and the developm ent of an 
instrument which had the capacity to discriminate levels of fatigue in different 
groups of cancer patients.
The first study explored the concept of fatigue by com paring the personal 
experiences of cancer patients (n=20) w ith those of healthy individuals (n=20). 
Using grounded theory, themes emerged which classified fatigue into physical, 
affective and cognitive components. Differences were found in the expressions 
used by the two cohorts, particularly in relation to the physical sensations 
experienced. The descriptors generated by cancer patients were com pared with 
those used in the currently  available fatigue instrum ents and illustra ted  
considerable differences in content. They were therefore used to develop a new 
fatigue instrument - the Fatigue Assessment Questionnaire (FAQ).
The second study tested the reliability and feasibility of the FAQ in a non­
random ised, prospective, cross-sectional study of cancer patients (n=77) and 
healthy individuals (n=77). It was found to discrim inate betw een fatigue 
experienced by cancer patients and that experienced by healthy individuals. A 
tentative step-like theoretical explanation for the production, perception and 
expression of fatigue proposed at the end of study one was supported by factor 
analysis. It led to minor adaptations of the instrument.
The third study subjected the FAQ to further validity testing. Four hundred  and 
ninety-nine cancer patients w ith a variety of tum our types and stages were 
included in a prospective, non-randomised, cross-sectional study. Factor analysis 
supported the theoretical framework and led to modifications which resulted in 
a m ulti-dimensional, 20-item instrument. The FAQ discrim inated significantly 
different levels of fatigue and the distress that it caused in patien ts w ith  
metastatic cancer, patients with localised cancer and patients whose disease was
in remission. High levels of fatigue were mainly associated w ith advanced stages 
of cancer, in combination with high levels of depression.
The closing chapter discussed issues for further research and implications for 
practice.
INTRODUCTION
Even though fatigue has already been discussed and described in the previous 
century, it rem ained a sym ptom  which received only little atten tion  until 
recently. Patients did seem to find it unworthy or even felt embarrassed to speak 
about it w ith nurses and physicians, who showed a prevailing nihilistic attitude 
towards this symptom. Loss of strength, vitality or energy seemed to be silent, 
inevitable companions of patients with progressing cancer.
It was during the first course work in the context of M aster's studies at the 
University of Guildford in 1991, when fatigue started to emerge as a real problem 
in cancer patients. Whilst "problems" were defined as quality of life disruptive 
events, patients were asked to identify their deficiencies. Fatigue turned out to be 
the most frequent problem in 50 cancer patients within an oncology ward. This 
surprising result prom pted new interest in this newly detected quality of life 
domain. Once sensitised for this symptom, fatigue awareness increased. W hen 
listening to patients speaking about their well-being or suffering, caregivers ears 
and eyes could easily hear and see this omnipresent symptom of fatigue. In turn, 
once caregivers recognised and verbalised feelings of fatigue, patients spoke easily 
about it and they seemed to be thankful for the fact that somebody showed an 
interest in their fatigue problem.
When reviewing the literature concerned, fatigue indeed appeared to be a concept 
w ith which oncology nurses, mainly from the United States, had dealt before. 
During the eighties, assessment issues had been raised and some fatigue research 
in the context of cancer was published. In the early nineties, sum m arising key 
publication m ade it easier to grasp the current knowledge (Piper and Lindsey 
1989, W inningham and Nail 1994). However, the analysis of available literature 
and research showed that there still existed large gaps of know ledge in the 
definition of this im portant clinical problem and especially in the assessment and 
measurement of fatigue. A better understanding of the concept of fatigue was 
needed in order to develop new ways of assessment and m easures of relief. 
Reliable and valid measurement instruments, including the patient's experience 
and perspective and not only the scientists professional view, should form the 
baseline for supportive care. It was on these grounds that the decision was taken 
to tackle the concept of fatigue in cancer patients and to develop a scientifically 
and clinically useful, cancer specific m easurement instrument.
CHAPTER 1
REVIEW OF THE CONCEPT FATIGUE AND TIREDNESS 
IN HEALTH AND DISEASE, ESPECIALLY IN CANCER
1.1. AN INTRODUCTION TO FATIGUE IN GENERAL
In the English and French language, the word fatigue is being used to express 
feelings of extreme, unusual tiredness. In contrast to that, Italian speaking 
individuals use the w ord "stanchezza" (tiredness) and the Germ an speaking 
population also simply uses the word "Miidigkeit" (tiredness). The Latin word 
"fatigatio" is being translated in German with "general exhaustion" (allgemeine 
Erschopfung) (Duden 1985). In countries where the word fatigue does not exist, 
fatigue seems to be replaced by the words "extreme tiredness" and by "general 
exhaustion".
These linguistic differences reveal the complexity of the w ord, w hich not only 
represents a semantic problem in different languages and cultures bu t also raises 
questions of understanding and interpretation of the phenomenon. Fatigue is a 
word which is not only used in the context of medicine or psychology, it is also 
widely used in the technical area of engineering. Material can become fatigued 
and eventually break down. A similar technical use can be observed in medicine, 
where one speaks about a fatigue-fracture (Reuter 1995), a breakdow n of bone- 
tissue after exertion.
In Stedman's medical dictionary, fatigue in hum ans is "that state following a 
period of mental or bodily activity characterised by a lessened capacity for work" 
(Stedman 1973). Even though this definition is of a physiological nature and does 
not describe how the capacity of work is affected by fatigue, it does point to a 
m ultidim ensional concept by its origin. A ttem pts to define fatigue from  a 
psychological view point require the distinction between fatigue as an objective 
decrease in performance and general feelings of fatigue which "are not a simple 
act, but a psychological state made out of a num ber of simpler elements which 
include changes in affect or sentiments corresponding to obscure and sometimes 
subconscious tactile and muscular sensations" (Berrios 1990). It seems that the 
word "fatigue" could be used as an um brella- term  to describe a variety  of 
sensations or feelings and expressions of decreased capacity at physical, mental,
psychological or social levels. However, no universal definition of fa tigue/ 
tiredness in the context of health and disease is available yet. It is the aim of this 
chapter to identify fatigue from the viewpoint of health, disease and especially 
from the perspective of cancer.
Fatigue: New wine in old hoses ?
Fatigue was already a subject for research in the 19th and in the early 20th 
century. Some topics of interest from those periods are the following (Berrios 
1990): Fatiguability of muscles (Kronecker 1871), The mental symptoms of fatigue 
(Cowles 1893), Questions of "over-burdening" (Ueberbiirdungsfrage) (Kraepelin, 
1898), Fatigue from the psychological viewpoint (MacDougall, 1899), Fatigue- 
m easurem ent in education (Kensies 1898), Fatigue, intellectuel et physique 
(Mosso 1903, in French), A neglected measure of fatigue (Wells 1908), La Fatigue 
(Ioteyko 1920), Is a fatigue test possible? (Muscio 1921), Fatigue im pairm ent in 
men (Bartley 1947) and many more. The difficulty of scientific research related to 
fatigue was expressed by Muscio in 1921 when he stated "that the term fatigue be 
absolutely banished from scientific discussion and consequently that attem pts to 
obtain a fatigue test be abandoned" (Muscio 1921). The first scale to m easure 
tiredness was developed during the 1920s (Poffenberger 1928). During the 1960s 
the first international fatigue conference was organised by Grandjean, a noted 
fatigue theorist who reviewed neurophysiological experiments to underp in  a 
psycho physiological fatigue theory (Grandjean 1968), together w ith members of 
the Japanese Industrial Research Committee on Fatigue, such as Yoshitake, who 
conducted several studies using his Fatigue Symptom Checklist (Yoshitake 1971). 
In the 1970s and 1980s this Yoshitake symptom checklist and other scales were 
used in several nursing studies (Freel and H art 1977, Haylock and H art 1979, 
Davis 1984, Piper 1987). In the meantime, the num ber of nursing  studies of 
fatigue has increased dramatically. Key publications, sum m arising the fatigue 
literature, especially related to cancer, have made it easier for nurses to capture 
the body of present knowledge (Morris 1982, Hart and Freel 1982, Piper 1987, Piper 
1993, Irvine 1991, Nail and Winningham 1993).
Even though the am ount of research and literature has increased dram atically in 
the last decade, some fundamental questions still prevail. Is tiredness, fatigue or 
fatiguability more than a single entity, rather a variety of related phenomena? Is 
fatigue a problem  associated w ith physical processes in the m uscles, is it
associated with neuro physiological or psycho physiological processes in the brain 
or is it both? What are the causes of unusual tiredness in healthy and in diseased 
persons?
Fatigue: Physiological or neuro-physiological origin ?
Fatigue has been described w idely in the context of perform ance of healthy 
persons at w ork and in relation to working conditions. The fatigue theorist 
Grandjean defined it as a pleasant sensation after work, perceived by people as 
physiological induction of the sleeping period. He argued, that if the body was 
forced to continue at that point, the sensation w ould become unpleasant and 
distressing (Grandjean 1968). Grandjean therefore stressed the biological meaning 
and aim of tiredness: nature conducts the behaviour of hum ans and animals 
through feelings of fatigue to help the body to find its balance between rest and 
activity. Fatigue in his sense is a life sustaining state, sim ilar to other 
physiological needs, such as thirst, hunger, anxiety. However, the expert agrees 
that there is a need for delineation between different w ords in the attem pt to 
define fatigue. Physiology distinguishes between m uscle-fatigue and general 
fatigue. Muscle-fatigue is described as local, acute fatigue induced by exertion. 
General fatigue is seen as a state in which hum ans perceive tiredness as reduced 
performance and Grandjean defined this state also as general, mental or nervous 
fatiguability. He attem pted to identify the causes of fatiguability in healthy 
persons from the physiologist's viewpoint; these causes are illustrated in Figure
1.1. (translated from German): The diverse, daily sensations of fatigue accumulate 
until the body stops functioning and recovery allows draining of these sensations 
to take place (Grandjean 1961).
Grandjean interprets physiological fatigue as a decrease in physical performance 
but also as a consequence of neuro physiological processes. Experiments in cats 
w ith electrical, continuous stim ulation of the m id brain , especially in the 
thalamus, resulted in sedation with reduced reaction and tendency to sleep (Hess 
1948, Akert 1952). From these findings Grandjean suggested, that structures in the 
mid brain may represent an active inhibitory system. Cortical inhibition m ay 
result from two different causes: cortical activity may be reduced by increased 
activity of the inhibitory system, which appears to be regulated through hum oral 
factors. Secondly, the Reticular Activating System (RAS) in the m idline of the 
brain stem, which is known to be responsible for maintaining wakefulness and
7Figure 1.1: Sum-effect of daily causes of fatigue
Environment: Climate■
In tensity and duration  o f  
physical an d  m en ta l w ork
Psychological causes: 
responsibility worries, conflicts
Illness an d  pain,M on o ton y nutrition
Sensations o f  fa tig u e
Rest, recovery
Based on work from: Grandjean, E, 1961, Die zentrale Ermudung.
In: Handbuch der gesamten Arbeitsmedizin, Bd 1, 442-470. Berlin, Urban und Schwarzenberg.
alerting the cortex, appears to affect feelings of fatigue through secretion and 
accumulation of serotonin. Grandjean labels this process the active inhibitory 
system. When the RAS is inhibited, the organism is in a state of fatigue; if the 
activating system prevails, the organism is ready to increase perform ance and 
feels fresh and full of initiative. In the light of present neuro physiological 
knowledge, generalised fatigue could be considered a central nervous system state 
controlled by antagonistic activity of inhibitory and activating system s of the 
brain stem (Hart and Freel 1982).
Fatigue: Hum an response to m aintain health ?
In general, fatigue is frequently regarded as something to be avoided. Avoidance 
of fatigue may not be entirely desirable if it is viewed in relation to the process of 
adaptation in order to m aintain health. Fatigue sensations m ay be essential 
indicators that the physiological equilibrium somewhere in the body is breaking 
down (Dill 1967). It can be an index of stress on adaptive mechanisms. Therefore, 
fatigue could be defined as a defence mechanism, a protective phenomenon, that 
helps to maintain the physiological equilibrium by stimulating a desire for work 
decrements or stress avoidance w hen the response to stress reaches a level of 
discomfort (Bartley 1967). It could be argued, however, that the w ish to do work 
or to avoid stress may have other roots than fatigue.
Deviations from "normal" tiredness are not always easy to recognise. The activity 
of the hum an organism is rhythmical and geared toward the m aintenance of a 
dynamic, healthy equilibrium. Well known processes, such as circadian rhythm s, 
cardiac w ork-rest cycles, hum oral and neural balances and com pensatory 
mechanisms contribute to maintaining this dynamic equilibrium. In health, the 
body is not only rhythm ical in function bu t also m aintained in a state of 
watchfulness. The state of slight muscle contraction, the ease w ith which flight- 
fight forces are initiated and the so-called conservation-w ithdraw al process, 
which warns of impending energy depletion, are normal reactions that enable the 
organism to m aintain a balanced state in spite of constant bom bardm ent from 
internal and external stim uli (Morris 1982). This ability to adap t has been 
described as "hum an adaptation capacity", the individuals ability to cope 
successfully w ith  the stresses of life - a capacity tha t encom passes the 
morphological, biological, chemical, physiological and psychological processes 
that bring about coping responses ( Bafitis and Sargent 1977). Tiredness, which is
seen as a regulative, protective mechanism, could be called healthy tiredness. 
"Acceptable" fatigue includes recognition of tiredness and steps taken to 
overcome it as soon as possible, enabling the person to sustain performance. 
Persons, able to sustain performance perceive themselves as healthily tired, their 
tiredness does not make them anxious (Nixon 1976).
This definition of healthy tiredness has a similarity with the general definition of 
health given by Dubos (1959), who defines health  as the ability to adapt. 
Adaptation in his sense does not necessarily mean living w ithout disease but 
rather being able to live w ith disease. It has been postulated, that in  healthy 
persons increasing arousal results in increasing performance and that persisting 
arousal w ithout performance w ould lead to deterioration, breakdow n and ill 
health (Nixon 1976). This would mean that fatigue can be seen as a protective 
mechanism to m aintain health and to prevent illness. On the other side, fatigue 
or unusual tiredness can mean to have successfully fought off critical situations 
or conditions, or to be on the road to recovery. Clinical experience shows, that 
patients after serious illness or after major surgery experience extreme feelings of 
tiredness. This could be interpreted as fatigue or tiredness in order to regain 
health. W hether this kind of fatigue represents again a protective m echanism 
and w hether it is of physiological or psychological nature, is difficult to 
distinguish. It could how ever be concluded that people need tiredness to 
maintain health in order to prevent illness a n d / or to regain health. The degree 
to which a person should respond to that tiredness m ust be seen as a m atter of 
individual needs and resources because health, defined as the ability to adapt, 
represents a level of individual challenge.
Fatigue: Are there vulnerable populations ?
People generally believe that age plays a role in relation to fatigue, attributing 
higher levels of fatigue to the older population. Data from a large survey of 
American adults betw een 25 and 74 years of age were used to explore the 
relationship of self-perceived fatigue and age, gender, body m ass, nutritional 
intake, activity and emotional distress (Chen 1986). Chen concluded from his 
study, that there was no association between age and fatigue. A new er study, 
examining fatigue in general practice attendees concluded, that there was no 
correlation betw een age and the total of fatigue scores for m en and wom en 
(David 1990). A further study, comparing fatigue betw een 104 breast cancer
patients and 93 healthy women did not describe differences in age in the control 
group (Irvine 1994). Only a few fatigue-studies include a control group w ith 
healthy individuals. Methodological problems in defining and m easuring fatigue 
make it difficult to interpret and compare results.
Gender has been defined by Chen (1986) as a risk factor. He concluded that 
wom en had 1.5 times the risk of males of being fatigued. David found no 
difference between men and women in his study (David 1990) and Glaus (1993) 
found higher mean levels of fatigue in women than in men.
Chen found no difference for any nutrient in the diet between non-fatigued and 
fatigued women. The only significant difference betw een fatigued and non­
fatigued men was a higher calcium intake in non-fatigued men. Difficulties 
through potentially confounding variables have been discussed. Body mass was 
not found to be a significant predictor of fatigue. Chen's study supports the 
influence of activity on fatigue. Inactive subjects had more than twice the risk of 
those who were active of being afflicted w ith fatigue. He also reported  a 
significant association of self-perceived fatigue with psychological factors, such as 
depression, emotional stress and anxiety (Chen 1986).
Fatigue: Response to disease ?
Fatigue has been described as a warning signal of an approaching health disaster 
(Morris 1982). As an example, excessive tiredness may precede 30 to 55 % of 
myocardial infarctions or sudden cardiac deaths (Appels 1988). General fatigue in 
patients with cardiac disease might be due to failure of circulatory and metabolic 
adaptations, such as increased cardiac output or decreased efficiency of oxygen 
transport (Hart and Freel 1982). The same can be said for patients w ith  lung 
disease or persisting anaemia. This kind of fatigue might be classified as "caused 
by circulatory and metabolic adaptation failure".
Fatigue had also been identified among the top three stressors experienced by 
haem odialysis and peritoneal dialysis patients (Eichel 1986). Srivastava (1989) 
studied characteristics of the fatigue experience in end stage renal disease patients. 
A lthough haem odialysis im proved their well-being trem endously  once the 
trea tm en t w as in itia ted , com plaints about fatigue generally  con tinued . 
Srivastrava concluded, that even though the toxic effect of uraem ia w ith  low
levels of haem oglobin could be responsible for fatigue in these patients, the 
com ponents of the sym ptom  rem ained unknow n and seem ed to be rather 
physiological and non-specific. Fatigue associated w ith renal disease could be 
classified as fatigue caused by metabolic disorders. However, other researchers 
have shown that depression can go hand in hand with chronic disease such as 
chronic renal disease and that psychological as well as physiological components 
of fatigue should be assessed (Cardenas & Kutner 1982).
Patients suffering from m ultiple sclerosis identified fatigue as their m ost 
troublesom e sym ptom  (Krupp 1988). A study of patients w ith  rheum atoid 
arthritis highlighted the prevalence of fatigue: 52% of 101 patients stated that 
they constantly lacked energy (Crosby 1991). W hether fatigue in these conditions 
could be classified as primarily caused by immunological processes remains to be 
substantiated. Fatigue and muscular weakness are also prevalent sym ptoms in 
patients w ith prim ary hyperparathyroidism us. The im provem ent in muscle 
strength could be documented in a controlled study, where patients were treated 
w ith  su rg ical pa ra thy ro idectom y  (w ith correction  of hypercalcaem ia) 
(Kristoffersson 1992). Addison's disease is known to be accompanied by weakness 
and easy fatiguability. These two conditions m ight represent two examples of 
diseases which are "caused by endocrine disturbances". However, in all these 
severe disease-states, influences of physical and psychological effects from chronic 
illness, such as changes in activity, sleep-disturbance, pain, emotional distress, 
cannot be excluded.
It has been suggested that fatigue in patients w ith AIDS was more severe than in 
patients w ith bone m arrow  transplantation or m alignant m elanom a (Fawzy 
1990). Clinical experience shows that fatigue in AIDS is a universal complaint. 
W hether th is kind of fatigue can be classified as p rim arily  caused  by 
immunological or neurological processes has not been defined yet.
The Chronic Fatigue Syndrome (CSF) has recently received m uch attention from 
the media and health care professionals alike. It has also been labelled a post viral 
syndrome because the sym ptoms often followed an illness suggestive of viral 
infection (Behan 1985) or Myalgic Encephalomyelitis (ME). It has been argued that 
these last two names for the syndrome were inappropriate because first a defined 
initiating infection was not always documented and because patients w ith  CFS 
reported an insidious onset and second because m yalgia w as not universal
among patients and no laboratory tests show ed evidence of encephalitis or 
myelitis. The diagnosis today is defined by the following criteria: 1) generalised, 
chronic fatigue over six m onths duration, 2) neuro psychiatric dysfunction 
(impairment of concentration, short-term memory impairment) and 3) abnormal 
cell-mediated im m unity by reduction of lymphocyte subsets (T8 and or T4). 
Further supporting findings are m yalgia, arthralgia, headaches, depression, 
tinnitus, paraesthesiae and sleep disturbance, persistent over six months w ith no 
other cause and lym phadenopathy, localised muscle tenderness and pharyngitis 
(on two or m ore occasions after the illness) (LLoyd 1988). The exclusion of 
another clinical disease is part of the diagnosis. Today it is not clear, whether CFS 
is prim arily caused by viral infections, disorders of the im m unsystem  and 
whether endocrine and psychological causes play a role (Siegl 1994). Because CFS 
was seen as an organic diagnosis that included psychiatric features, it rem ained 
unclear what diagnosis would be assigned to patients known to have psychiatric 
syndrom es identified in the Diagnostic and Statistical M anual of M ental 
Disorders, Third Edition, Revised (DSM III R) (Greenberg 1990). Classification of 
causes therefore remains difficult.
Fatigue: Rooted in  body or m ind ?
CFS has stirred up much discussion about the roots of fatigue. Several researchers 
have acknowledged that psychiatric disorders, particularly m ood disorders are 
common in patients w ith chronic fatigue (Greenberg 1990). Are these patients ill 
because they are depressed or are they depressed because they are ill? The terms 
"neurasthenia, brain fatigue, psychasthenia, adynamia, anxiety neurosis, neurotic 
fatigue"( Greenberg 1990), which were used in different epochs, point to the m any 
folded interpretation of the symptom of chronic fatigue. In truth, the syndrom e 
falls into the interstices betw een a num ber of medical specialities, including 
medicine and psychiatry. Many people consider a psychiatric diagnosis to be a 
stigma and therefore they might prefer to have a diagnosis of viral infection to be 
identified as a cause.
Today, the link between sadness and fatigue has been reinforced m any times. 
Engel and Schmale (1972) saw helplessness and hopelessness as central to the 
conservation w ithdraw al reaction, which they connected to the constitutional 
sym ptom  of fatigue. A lthough few studies have acknow ledged that fatigue 
makes a distinct contribution to the syndrom e of major depression, it remains
one of the identified criteria for the diagnosis of clinical depression (Nelson 1981). 
There appears to be a lack of data from sound research to underp in  the 
relationship betw een fatigue and depression, even though it seems to be a 
generally accepted fact. Greenberg (1990) noted, that 90% of patients w ith 
depression reported decreased energy. One typical sign of tiredness in depression, 
as shown in clinical experience, might be its worsening in the morning. This 
typical sign could distinguish this type of tiredness from the tiredness associated 
with other illnesses, but remains to be substantiated.
Anxiety has been seen as a correlate of fatigue. In a study among college students 
who complained of excessive fatigue, the symptom of anxiety was common and 
they also had higher scores on the Beck Depression Inventory than controlled 
subjects (M ontgom ery 1983). Anxiety could be seen as forerunner of or 
concom itant w ith fatigue. If the anxious state is relieved, a conservation- 
withdrawal process can result (Morris 1982), leading to feelings of tiredness and 
depression. Further research is needed to test such hypothesis. A sum m ary of the 
primary causes of fatigue in humans is represented in Table 1.1.
1.2. FATIGUE AND CANCER: INEVITABLE TWINS ?
Priority / Prevalence
Fatigue in cancer patients has been ranked as a major concern in the 1991 
(Mooney 1991) and again in the 1994 (Stetz 1994) American Oncology N ursing 
Society Research Priority Survey. A Fatigue initiative was started in 1994 and the 
American Oncology N ursing Society set out to develop a plan to dissem inate 
inform ation on fatigue. From that, the FIRE Program m e (Fatigue Initiative 
Through Research and Education) originated with research and education as the 
programme's primary focus (ONS News 1996).
Today, fatigue is recognised as the m ost common and perhaps the m ost 
distressing symptom reported by cancer patients. Due to methodological problems 
in defining and m easuring fatigue in cancer patients, figures on the exact 
prevalence of tiredness in patients with different types of m alignant tum ours or 
with different treatm ent schedules are scarce and difficult to compare (McCorkle 
1983, Piper 1989, W orld Health Organisation 1990, Blesch 1991, Butow 1991, 
Holmes 1991, Glaus 1993). More insight has been gained during  the last 10
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Table 1.1. Causes of fatigue: Primary, physical impact of cancer 
____________or other disease on specific locations of the body
Circulatory and metabolic adaptation failure
decreased oxygen carrying capacity
Metabolic disorders
hypercalcaemia, hyponatraemia, hypoglycaemia
Endocrine, hormonal disturbances
hypopituarism , hypoadrenocorticism 
hypothyroidism
Disruption of central nervous functions 
Chronic infections and humoral desorders
heart-, lung disease 
severe anaemia
renal disease, uraemia 
liver disease 
hyperparathyroidism
Addison's disease 
disease of pituitary and 
adrenal glands
brain disease
AIDS
Chr. Fatigue Syndrome? 
viral infections? 
cancer?
Immunological, auto-immune processes rheum atoid arthritis 
m ultiple sclerosis 
cancer?
years concerning the incidence of fatigue as a treatm ent side effect, especially 
when treatment entered the era of biological response modifiers (Haylock & Hart 
1979, Jamar 1982, Bruera 1988, Piper & Rieger 1989, Irvine 1994). The lack of 
proven therapeutic strategies to relieve this distressing symptom underscores the 
need for future research with an internationally agreed definition and validated 
measurement instruments for epidemiological fatigue research.
Aetiology of fatigue in cancer
Individuals w ith cancer might experience different types of fatigue or tiredness. 
They can, as healthy individuals do, experience acute tiredness as a consequence 
of exertion or performance at work, although they might be more vulnerable to 
fatiguability during active disease. This type of tiredness might be acute tiredness, 
localised primarily in specific muscle groups and be tem porary and resolved by 
rest and time. From clinical experience, chronic fatigue in cancer patients, 
proposed here to last more than two weeks and having a recurring character, is 
mostly not associated w ith exertion and represents a general fatigue state, 
affecting the whole person in body and mind. Even though objective fatigue is 
often reported as a decrease in strength and performance by severely ill cancer 
patients and also might be observable by others, the subjective feelings of fatigue 
remain difficult to analyse and to assess, although they m ight have a severely 
negative impact on the quality of life. The relationship betw een tiredness, as 
experienced in healthy individuals and tiredness, as experienced by cancer 
patients, needs further research in order to delineate specific features in patients 
with cancer.
Although some theoretical models have evolved in the last decade to explain 
fatigue in cancer patients, none of them could be tested scientifically (Piper 1993, 
W inningham 1994). The most frequently cited theoretical fram ework on fatigue 
in cancer is that developed by Piper (1987). This model (Figure 1.2.) addresses 
many potential causes of fatigue in cancer and stresses the m ultidim ensionality 
of the concept. The impressive diversity of possibly confounding influences 
represents the complex reality and researchers need to break down and weight the 
elements in order to test scientifically relevant, specific hypothesis.
Figure 1.2. Piper's integrated Fatigue Model
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Fatigue caused by the primary impact of cancer on the affected organs
The prim ary pathophysiological causes of fatigue in hum ans, as presented in 
Table 1.1., remain the same in cancer patients. According to the infiltration of the 
primary tum our or its metastasis, disturbances of the physiological system might 
follow. If pulm onary or cardiac function is insufficient, caused by local tum our 
mass, additional infection or severe anaemia, fatigue is caused by decreased 
circulatory capacity for oxygen supply. If the tum our impairs renal or hepatic 
function, fatigue might be caused by metabolic disorders. Cancerous destruction 
of locations of the horm onal system, such as adrenal glands or the pitu itary  
gland, m ay lead to fatigue due to horm onal, endocrine dysfunction w ith  
metabolic complications (Morant 1991). Tumour-infiltration in the brain can lead 
to fatigue due to increased cerebral pressure or destruction of central nervous 
functions. Many types of cancer, especially those of the lymphatic and blood- 
producing system, can lead to fatigue due to humoral deficiencies w ith decreased 
defence mechanisms and predisposition to frequent infections and bleeding.
Fatigue, as caused by the immunological responses to the tum our and fatigue as 
caused by the psychological demands from illness, take a special place in the 
development of fatigue in cancer and therefore these causes will be discussed in 
more detail later.
Fatigue caused by secondary effects of cancer
Fatigue and asthenins
Apart from the m any direct prim ary causes of fatigue, produced by the local 
changes through tumour-infiltration, there are other, secondary, paraneoplastic 
pathways (Table 1.2.). It has been proposed that the malignant process itself may 
secrete substances, also called "asthenins", which cause asthenia (Theologides 
1982). Asthenia, in this sense, has been associated with pathological fatiguability, 
loss of strength and generalised weakness (Bruera 1988) and can be seen as a 
major component of fatigue as defined earlier. Such asthenins are substances 
which cause morphological, biochemical or physiological changes in tumour-free 
muscle-tissue in cancer patients. These changes in the muscles are thought to be 
the causes of asthenia (Theologides 1986). In cancer patients w ith advanced 
disease, abnorm al electrophysiological changes in the m uscles can be
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Table 1.2. Causes of fatigue: Secondary, general impact of cancer 
on body and m ind
Cytokines: -defence mechanisms against the tum our
"A sthenins" -changes in muscle metabolism 
-muscle wasting
-change in energy transform ation
Interferons, Interleukines -impairment of protein synthesis
Tumour Necrosis Factor -weight loss
Increased energy expenditure -muscle loss
-increased effort to generate force
Paraneoplastic Syndromes -hypercalcaemia, hyponatraem ia 
-hypoglycaemia
Other symptoms of disease -immobility, sleep disturbance, pain 
and others
Emotional distress, coping -depression, anxiety, social isolation
Cancer treatm ent
chemo-, radio-, biotherapy, surgery -accumulation of waste products?
-reaction to necrotic tissue from cell break­
down?
-temporary organ- toxicity 
-side effects (nausea/em esis/anorexia) 
-central neurophysiological mechanisms 
-deficit of vitamins and nutrients during 
increased demands?
-tissue damage and healing
observed, independent from m alnutrition and loss of m uscle tissue (Bruera 
1988a). W hilst it is still unclear w hether these asthenins are produced by the 
tum our or by the immune system, it is also unclear whether the muscle changes 
are responsible for asthenia or whether they represent an epi-phenomena (Stiefel 
1992). Muscle wasting occurring in the course of advanced cancer was thought to 
be responsible for fatigue, because it requires patients to exert an unusually high 
amount of effort to generate adequate contractile force and changed m uscular 
metabolism may occur (St. Pierre 1992).
Fatigue: side effect of the body's response against the tumour?
A further hypothesis for fatigue has been described as " the body's inflammatory 
defence mechanism against the tumour", analogous to the situation in infectious 
disease. The secretion of cytokines, such as interferons, interleukins and tum our 
necrosis factors by monocytes and inflammatory cells, activated in response to the 
neoplastic process, involves a whole cascade of reactions and fatigue and 
associated phenomena may be expected to be caused by this underlying process 
(Morant 1991). However, not all tum our types activate the immune system and 
some might even cause immune suppression.
Chronic stim ulation by endogenous interferon-gam m a can be m easured as 
elevated neopterin levels as an indication of activated macrophages. Decreased 
levels of tryptophan, associated w ith increased neopterin levels m ay im pair 
pro tein  synthesis and m ay be a defence m echanism  against the active 
proliferation of tum ours (Denz 1993). Tryptophan is a precursor substance of 
serotonin which has also been used as sleep medication. A tiring effect could be 
expected from such a substance.
Endogen Tumour Necrosis Factor (TNF) leads, as the word suggests, to tum our 
necrosis but also to protein degradation, weight and muscle loss and anorexia 
(Beutler 1987). Some of the tum our necrosis factors are prim arily secreted by 
macrophages and monocytes but may also be produced by various tum our cells 
(Naylor 1990). A second (formerly) name of TNF is cachexin, which describes its 
devastating effects. Cachexia might be due to central effects of TNF bu t also to 
delayed gastric emptying (Bodnar 1989).
Fatigue and energy transformation processes in cancer
Patients w ith advanced cancer and cachexia typically dem onstrate m odestly 
increased rates of energy expenditure in the presence of diminished food intake 
due to anorexia and to gastrointestinal disturbances (Keller 1993). Rates of glucose 
production by the liver, gluconeogenesis and glycolysis to lactate (Cory cycle) are 
increased and fat mobilisation and oxidation are accelerated. A redistribution of 
body proteins away from muscle towards visceral proteins, resulting in marked 
muscle protein loss, can be observed (Keller 1993). The loss of muscle tissue, due 
to this mechanism, might be responsible for muscle weakness, which requires 
patients to exert an unusually  high am ount of effort to generate adequate 
contractile force, as has been discussed earlier. The energy analysis model in the 
context of fatigue in cancer patients, offered by Irvine (1994) (Figure 1.3.), pays 
regard to these changes in energy transform ation processes. The interaction of 
energy variables, such as sources, transform ation and expenditure  and 
characteristics such as weight loss, fatigue and activity intolerance are discussed in 
the model. It is suggested, that sources, transform ation and expenditure, as 
presented in the model, might present only the tip of the iceberg.
Conflicting results have been reported by Bruera (1989), who did not find any 
correlation between nutritional status, lean body mass, tum our mass, anaemia, 
type of treatm ent and asthenia scores in a study w ith locally recurrent or 
m etastatic breast cancer patients. The only positive correlation w as found 
between asthenia scores and depression. It remains to be tested, w hether patients 
with other types of cancer show an association between these variables. Referring 
to body weight, a study of weight loss in cancer patients showed that weight loss 
was experienced the least in patients w ith breast cancer, w ith  gastric cancer 
patients experiencing highest losses of w eight (De Wys 1980). It could be 
hypothesised, that different types and stages of cancer are associated w ith  
different am ounts and types of cytokine production, which goes hand in hand 
with tum our activity and its devastating consequences, one of which is weakness 
and fatigue.
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Figure 1.3. Energy Analysis Model
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Fatigue and paraneoplastic syndromes
Paraneoplastic syndromes, which might induce fatigue, are known in some types 
of cancer. Secretions of m ediators by the tum our, such as parathormone-related 
factors, antidiuretic hormone and similar substances may cause severe metabolic 
consequences such as hypercalcaemia, hyponatraem ia, hypoglycaem ia, of all 
which may cause fatigue. Hypercalcaemia, induced by osteolytic active substances, 
is frequently seen in patients w ith skeletal metastasis of breast cancer and in 
patients with non-small cell lung cancer. This frequently seen secondary disease 
can lead to m uscular weakness, fatigue, dehydration, hyporeflexia and further 
symptoms (Senn 1992).
Fatigue and its association w ith cancer treatment
Fatigue and surgery
The problem of postoperative fatigue is not well understood. Clinical experience 
shows that it improves w ith time. It is unclear w hether it is a consequence of 
tissue damage and healing, or whether it results from deconditioning because of 
immobility. Postoperative pain medication and nutritional dem ands may play a 
role. Depending on the type of surgery, the patient is confronted w ith changes of 
body image and function and needs energy to adapt to new conditions. If surgery 
leads to the identification of a diagnosis of cancer, psychological distress, such as 
anxiety and depression, might lead to a fatigued condition (Christensen 1986).
Fatigue and radiotherapy
Destruction of tum our cells by irradiation is an unusual condition for the body 
which is left w ith  the elim ination of waste products. Cell dam age and the 
reaction of the body to necrotic tissue have been discussed in the context of 
fatigue in radiotherapy patients. A lthough it is common, today, to attribute 
fatigue in patients w ith radiotherapy to the production of by-products of cell 
death, little is known to underpin this belief.
Side effects of radiotherapy usually are of a localised nature, based on the site of 
treatment. Fatigue is one of the few systemic side effects and has been found to 
increase towards the end of treatm ent (Haylock 1979, King 1985). A decrease of
fatigue during the pauses at weekends was observed in a study by Haylock (1979), 
who m easured fatigue w ith the Pearson Byars Fatigue Checklist. Contradictory 
findings have been reported from a study by Nail (1993) where fatigue did not 
decrease over the w eekend in pre- to post-treated  w om en undergo ing  
intracavitary radiation therapy for gynaecological cancer. King (1985) interviewed 
96 radiotherapy patients and found that they perceived fatigue as interm ittent 
early in treatment, but that it became a continuous state by the end of treatm ent 
and that it was worse in the afternoon or evening. King also observed higher 
fatigue levels before radiotherapy in patients w ith lung cancer than in patients 
with other cancer diagnosis. Somnolence was found in 100% of patients receiving 
cranial irradiation (Faithfull 1991). It can be argued, that somnolence in this 
condition either represents cognitive impairm ent through cerebral oedema or is 
caused by the cerebral disease itself rather than fatigue caused by irradiation.
These and further studies in radiotherapy patients lead to the generation of the 
following speculations: 1) Fatigue levels correlate primarily with characteristics of 
the disease. Fatigue levels of patients w ith  lung cancer m ight prim arily  be 
different from fatigue levels in breast- or gynaecological cancer. 2) Type and aim 
of radiotherapy, for example adjuvant in breast cancer or palliative in lung 
cancer, plays an important role. 3) Successful radiotherapy could relieve fatigue if 
it ameliorates the function of a specific organ, as for example the lung, by 
successfully decreasing tum our size and increasing the breathing capacity. 4) 
Adjuvant irradiation, for example after breast surgery does not increase any organ 
function or relieve distress but is perceived as an additional, fatiguing burden. 
These and many more questions deserve further investigation.
Fatigue and chemotherapy
As w ith  radio therapy, the m echanism s of fatigue-developm ent are poorly  
understood in the context of chemotherapy treatment. Cell damage and reactions 
to cell necrosis are, again, generally accepted explanations. In contrast to the 
usually localised effect of radiotherapy, chem otherapeutic cancer treatm ent, 
according to its type and intensity, might damage healthy cells as well as cancer 
cells everywhere in the body. This generalised influence on the whole body 
system m ight explain its severe impact. In m any studies, fatigue has been 
dem onstrated to be the m ost prevalen t side effect in pa tien ts receiving 
chemotherapy (Knoff 1986, Nerenz 1982, Meyerowitz 1983, Rhodes 1988, Bloom
1990, Blesch 1991). A hypothesis which evolves here, is that chemotherapeutic 
agents potentially reach cells of all organs, and that therefore they have the 
potential of inducing fatigue by effects on every organ and so can produce general 
fatigue as well as "organ-specific fatigue reactions", according to the specific target. 
This includes the hypothesis that the various cytotoxic drugs affect different 
organs in different ways.
Chemotherapy patients often relate fatigue directly to their treatm ent and clinical 
experience shows that they exhibit increased energy prior to the next therapy 
cycle. Intensity and duration are perceived differently by individuals and might 
be correlated with regimen and type of drugs. Richardson (1996) investigated the 
onset, pattern , duration, intensity and distress associated w ith  fatigue in 
chemotherapy patients. Data indicated that although fatigue may be essentially 
similar among groups receiving different chem otherapy regim ens, there is a 
significant individual variation in its severity and the am ount of associated 
distress. An increase of distress has been noted w ith progression of therapy (Love
1989) through a descriptive study of patients w ith  ovarian cancer w hich 
documented the fatigue trajectory through a chemotherapy cycle. Love's study 
gave researchers a helpful lesson: no difference was found between the patients 
and healthy individuals. The explanation for this unexpected finding was the 
timing of the measurement of fatigue used to compare the groups as it did not 
capture the occurrence of fatigue. Methodological aspects of measurement, such 
as timing, are potential biases, especially in chemotherapy patients.
Cytotoxic drugs might be the prim ary cause in these patients, although a variety 
of other influences need to be analysed. Other side effects of treatm ent, such as 
nausea, emesis, decrease of nutritional intake, unusual anaemia could be linked 
with higher fatigue levels. Antiemetic drugs, especially sedating substances, are 
expected to increase fatigue. These influences are supported by the clinical 
experience that fatigue in chemotherapy patients is most prom inent during and 
some days after treatm ent. The often heard hypothesis, that fatigue correlates 
with time of blood cell nadir, needs verification.
The four hypotheses, form ulated for fatigue in the context of radiation therapy 
(above), can all be formulated in the context of chemotherapy in cancer patients 
or in the context of combined treatment. The same principle questions rem ain to 
be answered.
Fatigue and biotherapy
In addition to the potential mechanisms for treatment-related fatigue as described 
earlier, biotherapy exposes patients to exogen and endogen cytokines. Interferons, 
Interleukin-2, Tum our necrosis factors and colony stim ulating factors are the 
m ost often used substances in cancer treatm ent. B iotherapy-related fatigue 
usually presents itself as part of a syndrome, the so-called flu-like syndrom e, 
including fatigue, fever, chills, myalgias, headache and malaise (Haeuber, 1989). 
Fatigue has been seen as a dose-limiting factor of treatm ent w ith  biotherapy 
(Piper and Rieger 1989). Cognitive deficits, such as the expression of m ental 
fatigue, have been associated w ith biotherapy side effects. In a study w ith ten 
interferon-treated cancer patients, neuro-psychiatric investigations revealed a 
lack of energy and reduced motivation to initiate activities. The cognitive and 
affective im pairm ent observed was similar to the symptoms found in patients 
with pathological processes in the frontal lobe (Adams 1984) and therefore it was 
concluded that patients w ith interferon therapy had experienced toxicity of the 
frontal lobe. The central mechanisms are thought to hold the possible key to 
explain fatigue in biotherapy patients. The theoretical fram ework, defining 
central and peripheral neuro physiological mechanisms of fatigue, developed by 
Gibson (1985), gives support to this type of fatigue (Figure 1.4.). The central 
mechanisms may include impaired spinal cord transmission, or recruitm ent of 
motor neurons (Piper and Rieger 1989) or "an exhaustion or m alfunctioning of 
brain cells in the hypothalamic region" (Poteliakhoff 1981).
Social and psychological adaptation to disease and treatm ent-dem ands are 
thought to have a major influence in radiotherapy as well as in chem otherapy 
and biotherapy. The need for more rest, as clinically seen in m any patients, needs 
adaptation of the working schedule. Some patients may prefer to in terrupt work 
for certain periods or to reduce it. If therapy comes into life as an extra time 
consuming factor, apart from usual work, it could be hypothesised that fatigue 
will be an outcome of overexertion. Aspects of fatigue and its relationship w ith 
anxiety and depression in the context of coping w ith cancer, will be addressed 
later.
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Figure 1.4. Central and Peripheral Mechanisms of Fatigue
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Fatigue and other symptoms from cancer and its treatment
Fatigue has been assigned a unique relationship to o ther sym ptom s by 
W inningham (1994), based on its effect on activity and functional status (Figure 
1.5.). Cancer patients are thought to become less active as a result of symptoms 
such as pain, nausea/vom iting, dyspnea, diarrhoea, fever, anxiety, depression, 
fatigue and others, resulting in a loss of energising metabolic resources. The 
outcome of decreased activity is described as secondary fatigue due to decreased 
energetic capacity (oxygen uptake, calories-consumption), leading to reduced 
functional status. Symptoms, which induce more rest and inactivity, m ight lead 
to secondary fatigue but also require treatm ents which could induce fatigue. 
Medications, such as antiemetic substances, pain- and sleep- medications, are 
known to have potential fatiguing effects. Conflicting findings make it difficult to 
know whether anaemia, as a symptom, causes fatigue. If anaemia is severe and 
causes inactivity, then secondary fatigue could be the consequence of reduced 
activity. In the light of W inningham's theory, immobilisation could be a fatigue 
inducing state. This fram ework represents a challenge for the profession of 
nursing, as mobility is an important concept in nursing care. However im portant 
the influence of activity and functional status on fatigue might be, it needs to be 
seen in the context of the prim ary and secondary causes of fatigue in cancer, as 
summarised in Table 1.1. and 1.2..
Fatigue, cancer, coping, anxiety and depression
Coping w ith cancer means dealing w ith a reality which healthy persons usually 
deny. If cancer, usually seen as a disease "of others", happening to others, 
suddenly happens in one's own life, the fragility of life cannot be denied 
anymore. The existential outlook of a person affected w ith a potentially mortal 
disease may need withdrawal to enable them to cope with the circumstances and 
fatigue may be a coping mechanism, expressed as feelings of depression. There is 
no scientific evidence to support the hypothesis, but it is generally accepted that 
depressed persons report chronic fatigue. Greenberg (1990) noted that 90% of 
patients w ith depression report decreased energy and that fatigue rem ains a 
criteria of the diagnosis of clinical depression. The validated instrum ent POMS 
(Profile of Mood States) w ith which mood disturbances are assessed, includes a 
sub scale to assess vigour and fatigue (McNair 1971). W eisman (1979) described
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Figure 1.5. Winningham's Psychobiological-Entropy-Model
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various meanings of "I feel very tired all the time" and notes, that long, drawn- 
out fatigue is both a cause and a symptom of emotional distress.
In cancer patients, it w ould seem im portant to distinguish betw een depression 
and fatigue, because different treatment approaches might be needed. It is difficult 
to rely on the results of existing studies because different m easurem ent 
instruments have been used in different populations, resulting in both positive 
(Jamar 1982, Bruera 1989, Piper 1989, Blesch 1991) and negative correlations 
(Srivastava 1989, Pickard-Holley 1991). It can be argued, that feeling sad and 
depressed is a reaction to the whole, life-threatening situation of a cancer patient 
and that tiredness results from the body's attempt to deal w ith disease, treatm ent 
and its consequences rather than as an expression of fatigue itself. In this sense, 
tiredness could be seen as a symptom of coping and depression. On the other side, 
there is evidence for physical causes of tiredness in cancer patients, as described 
earlier. The question of whether tiredness is a symptom of disease or a symptom 
of coping and depression or w hether it is a com bination of both, rem ains 
unanswered. It can be hypothesised that these two potential sources of tiredness 
should be seen as a differential diagnosis needing careful assessm ent and 
different treatm ent approaches. Consideration of the patien t history such as 
psychological difficulties in the past, social vulnerability, such as social isolation 
and lack of a supporting network, as well as disease-specific influences, such as 
brain tum our lesions or metabolic disorders, seem crucial in diagnosing causes of 
tiredness.
Anxiety, know n to prepare hum ans for danger, has been described as a 
forerunner of and concom itant w ith fatigue (Morris 1982). The relief of an 
anxious state might result in a depressive state or a failure to resolve causes of the 
anxious state m ight lead to exhaustion. Clinical experience shows, that cancer 
disease and its treatment can be sources of intensive anxiety over long periods of 
time. An interesting observation described by Simms (1993), was the finding that 
inclusion of lorazepam, an anxiolytic medication, into an antiemetic treatm ent 
for the prevention of chem otherapy induced nausea/em esis, reduced levels of 
post-therapy tiredness. It points to anxiety as a possible cause in the development 
of tiredness and fatigue.
If anxiety is a cause in the development of tiredness, information, education and 
counselling m ight be seen as im portant nursing interventions in preventing
tiredness in cancer patients. Self- control through the power of knowledge might 
prevent feelings of anxiety. It has been proposed, that anxiety is alleviated by 
reducing the area of "unknown" by information, education and counselling 
(Wilson-Bamett 1988, Glaus and Grahn 1995).
A study  by Kaasa (1991) has show n that tiredness can d isappear w ith  
disappearance of disease and treatm ent illustra ting  that after successful 
completion of treatment, fatigue does not persist. It was a follow-up study of 146 
form er patien ts w ith  testicular cancer, successfully trea ted  w ith  surgery, 
radiotherapy and chemotherapy and found that they were not only more satisfied 
with life but also felt significantly less exhausted after working and felt even 
stronger and fitter than an age-matched control-group. This finding suggests an 
im provem ent of quality of life satisfaction after successful recovery from 
potentially m ortal disease, which goes along w ith an im provem ent in energy 
resources, however these resources might be defined. The finding also supports 
the hypothesis, that tiredness correlates with type and stage of cancer indicating 
that successfully overcoming the disease also means overcoming cancer related 
tiredness, be it tiredness caused by physical, biochemical or psychological sources.
1.3. CONCLUSIONS
Fatigue does not yet have a universally agreed definition. Some hypotheses have 
been developed about the possible underly ing  m echanism s p ro p o sin g  
physiological, neuro- and psychological processes in both health  and disease. 
Fatigue can be seen as a protective regulator to m aintain health and to prevent 
breakdown. Age and gender, activity and psychological reactions have been 
discussed as factors which might influence vulnerability to fatigue in healthy as 
well as in diseased persons. In disease, fatigue becomes a sym ptom  of the 
im paired body-system  and of the im pact of chronic illness on hum an  life. 
Whereas it is not fully known today whether the Chronic Fatigue Syndrome is 
best classified as a psychological or physical diagnosis, there is growing evidence 
which suggests that depression and anxiety are both factors which m ay lead to 
fatigue and that fatigue might lead to depression. In cancer patients, it is evident 
that the physical, biochemical and psychological processes are interwoven. The 
prim ary impact of cancer-tissue on the organ system of the hum an body, as well 
as secondary causes induced by the tum our itself, such as cytokines, changes in
the energy transforming process, paraneoplastic syndromes and other symptoms, 
have been proposed as fatigue inducing factors. The causes of fatigue from cancer 
therapy, such as surgery, chemo-, radio- and biotherapy represent a different 
concept than that of fatigue which is induced by the tum our itself, even though 
the delineation between causes seems difficult.
The high prevalence of fatigue in cancer patients evident in recent publications, 
is unfortunately ham pered by problem s in definition and by the variety of 
methods used in its measurement which make it difficult to compare the results. 
Future research needs to deal w ith the definition of fatigue/ tiredness. W hat is 
the experience of tiredness in cancer patients in comparison w ith tiredness as 
experienced by healthy individuals? Is there a continuum of fatigue/tiredness in 
cancer patients which is useful and valid for its measurement? Such knowledge 
about cancer specific fatigue/tiredness will serve as a scientific base to identify the 
validity of the content of a cancer-specific tiredness measurement instrument. A 
valid and reliable m easurement will eventually provide the possibility to search 
for correlations of fatigue levels w ith possible causes and eventually to measure 
the effect of treatment strategies.
CHAPTER 2
STUDY 1:
A QUALITATIVE EXPLORATION OF THE CONCEPT OF FA T IG U E / 
TIREDNESS IN CANCER PATIENTS AND IN HEALTHY INDIVIDUALS
2.1. INTRODUCTION
Theories help to sum m arise existing knowledge into coherent system s and 
explain the nature of relationships among variables (Polit and Hungler 1993). The 
overall purpose of theory is to m ake scientific findings m eaningful and 
generalisable. Fatigue theorists have defined fatigue in healthy persons as a non­
specific state, indicative of a decreased level of vitality, which has the protective 
function of forcing the body to avoid further stress. It is said to allow recovery to 
take place, w ith exhaustion being the end of the fatigue continuum , forcing the 
body to stop functioning (Grandjean 1970). In patients w ith cancer, fatigue is 
known to be one of the major distressing symptoms (World Health Organisation
1990). Some theoretical frameworks are available to conceptualise fatigue in 
cancer patients (Piper 1987, Astair 1987, Cimprich 1992, W inningham 1994, Irvine 
1995) and have advanced fatigue research considerably. Further theoretical and 
empirical work is still needed to define and test causal relationships.
A major problem  is the lack of a common scientific language to nam e the 
problem  of fatigue in cancer patients. There is no clear definition about the 
continuum  of tiredness or fatigue. For example, w hat is the deviation from 
"norm ar tiredness ? W hat is "acceptable" fatigue in specific circumstances? If 
tiredness is a phenomenon in healthy as well as in diseased persons, is there a 
difference in its perception? Does tiredness precede fatigue? It could be argued, 
that when tiredness is perceived as an unusual, continuing distress, it is fatigue 
rather than tiredness. In the German language, tiredness (Mudigkeit) is not the 
sam e as fatigue (Erm udung). The Germ an translation  of fatigue is thus 
comparable to "fatigueability" (Ermiidbarkeit) or to get tired, suggesting that it is 
the consequence of unrelieved tiredness or "fatigueability", w hich leads to 
exhaustion (Erschopfung) (Weis, PONS English-German Dictionary 1990). It 
could be then said that it is the illness-feeling of unusual tiredness which 
represents "problematic or distressing tiredness" in diseased persons, such as
cancer patients. The continuum  could range from "no unusual tiredness" (keine 
ungewohnliche Miidigkeit), to easy tiring (leichte Ermiidbarkeit), to extreme, 
unusual tiredness (extreme, uniibliche Miidigkeit), to exhaustion (Erschopfung). 
This definition is in accordance w ith Piper's statem ent that "in contrast to 
tiredness, subjective fatigue is perceived as unusual, abnorm al or excessive 
whole-body tiredness, disproportionate to or unrelated to activity or exertion" 
(Piper 1993). As fatigue represents a foreign word in the German language, in this 
research its operational term is simply "extreme tiredness" .
Concepts thus play an im portant role in the developm ent of knowledge. The 
concept of fatigue/ tiredness is still unclear as it represents a variety of unrelated 
phenom ena (Piper, in Funk 1989). Its m easurem ent and treatm ent therefore 
requires a definition of these phenomena. The question still needing an answer 
is, "what is fatigue /tiredness that is experienced by cancer patients"?
2.2. AIMS
The aim of this study was to explore the concept of fatigue/ tiredness from the 
native's perspective in order to
- learn about the lived experience of tiredness /  fatigue in cancer patients,
- compare cancer patients experience with that of healthy individuals,
- generate theory concerning cancer specific tiredness/fatigue
2.3. METHODS 
Research approach and design
In order to learn from the individuals' experience concerning tiredness, a 
qualitative m ethod was used. Qualitative methods are particularly useful w hen 
describing a phenomenon from the emic perspective, that is, the perspective of 
the problem  from the "native's point of view" (Harris 1968). U nderstanding 
tiredness is difficult because its experience is subjective, m ultidim ensional and 
difficult to m easure quantitatively . This becom es especially tru e  w hen 
considering the vulnerability of cancer patients, whose disease not only can mean 
physical suffering but represents a life crisis. Symptoms such as tiredness m ight 
therefore be perceived and expressed in m any different ways. Q ualitative
m ethods allow understand ing , "verstehen", by m eans of an ind iv iduals 
em pathy, in tuition or im agination, and therefore goes beyond know ledge 
obtained by means of observation or calculation (Melia 1992). Such an approach 
seems m andatory when trying to understand a complex, subjective experience, 
such as tiredness/ fatigue.
Phenomenology or grounded theory?
Phenom enology is rooted in the philosophical tradition. It is a descriptive 
approach to research and has the objective of identifying the essence of 
behaviour, based on m editative thought. Its purpose is to p rom ote an 
understanding of hum an beings wherever they m ay be found (Ornery 1983), 
hence to generate theories, models or a general explanation (Field & Morse 1994). 
Although this approach might have seemed appropriate, the results w ould not 
have provided descriptions of the experience of the phenomenon under study.
Methodology designed to achieve an accurate description is grounded theory. The 
central idea of this approach is that theory is generated from and grounded in 
data by a process of induction, thus assuming the existence of a process. Glaser & 
Strauss (1967) argue that the data collected serve to generate rather than to prove 
hypothesis. Theory generation rather than verification is thus the ultim ate aim 
of the grounded approach. As it was also the intention to discover dom inant 
(exploratory) processes rather than m erely describe observations, a quality 
attributed to grounded theory, it was the preferred method. A further reason for 
choosing grounded theory was that fatigue and tiredness in cancer patients is not 
yet thoroughly understood.
It is apparent from the literature that selected aspects of both methodologies are 
confused, in particular susceptible to the "blurring trend" observed by Morse 
(1989),This means that elements of each methodology can be interchanged. Clarke 
(1995) suggests that the technique of grounded theory is not wholly incompatible 
w ith the Popperian m ethod in that a deductive element is inherent in the 
underlying theory. Chenitz (1994) agrees by saying that it is based upon  the 
judicious use of induction, deduction and intuition. Phenom enology and 
grounded theory research approaches are based on different assum ptions and 
therefore have a difference in purpose and methodological descriptions (Baker 
1992). The reluctance to apply a strict grounded theory approach m ethodology
may reflect the fact that Glaser and Strauss (1967) did not clearly describe the 
analytical capacity of their conception.
This study used an exploratory approach because little is yet known about the 
experience of tiredness from the emic perspective. Questions such as "what is it" 
or "how does it feel like" seemed appropriate to further understand the concept. 
This strategy is defined as inductive theory building, where the thought processes 
move from  specific ideas to m ore generalised ideas tha t resu lt in  the 
identification of concepts and potential relationships (Chalmers 1992). In this 
study, according to its qualitative design and grounded approach, hypothesis and 
theories were not preconceived but were allowed to emerge from the data while 
data collection was in progress and after data analysis had commenced (Field & 
M orse 1994). From an analysis of the litera ture, especially the fatigue 
measurement tools, there seemed to be a lack of unbiased research. Findings from 
the data were then compared with available knowledge.
Setting, study-population, selection
The study took place within an oncology departm ent of a teaching hospital in 
Switzerland. Cancer patients were selected weekly on w ard-rounds according to 
their availability. They had to meet the following criteria: gave oral consent to the 
conduct of an interview with the nurse researcher, had the necessary cognitive 
ability to report their experience and were able to speak the German language. In 
accordance w ith  qualitative strategies, no variables w ere controlled w hen 
selecting interviewees apart from (a) the exclusion of patients w ith brain tum ours 
as they might have been affected cognitively and (b) gender as it m ight have an 
influence on the experience of tiredness (Glaus 1993). Qualitative appropriate­
ness requires purposeful sampling, which was thus adopted, as participants were 
selected according to the needs of the study (Morse 1991).
The data collection- period in the group with cancer patients took place between 
August and September 1994. Data saturation was achieved w ith interview data 
collected from 20 cancer patients. As defined by the grounded theory approach, 
data saturation suggested that data collection should stop at that point. Data 
saturation refers to the sense of closure, that the researcher experiences, w hen 
data collection ceases to yield any new information (Polit & H ungler 1993). It 
confirmed Glaser's (1978) view that to get a full account of the phenom ena
under study 20-50 interviews are necessary to elicit major, repetitive themes of 
the topic under study.
The interview s w ith healthy individuals followed in N ovem ber 1994 until 
January 1995. The selection of the healthy individuals was determ ined by 
availability of willing persons in the working and personal environm ent of the 
nurse researcher, using the same criteria: those who orally consented to the 
conduct of an interview and were able to speak and understand the German 
language. Purposeful sam pling was again the selection of choice bu t using a 
sampling frame of age and gender variables, to make sure that the healthy group 
was similar in age and gender to the patient-group. The healthy individuals were 
included only if they did not suffer from chronic disease in order to ensure the 
difference between cancer patients and healthy persons. To have a comparable 
num ber of interviews in this group, data collection was continued until 20 
interviews were conducted; data saturation was well achieved at that stage.
The study was approved by the ethical committee of the hospital and permission 
obtained from the head of the department. Patients and healthy persons gave oral 
consent and were assured of confidentiality. A numbered participant list was kept 
separately from other information material. Interviewees could not be identified 
either on the tape or on the transcript.
Instrum ents, procedure
The interview m ethod
The interview m ethod, a predom inant m ode of data collection in qualitative 
research, was employed to collect information. As the aim of the study was to 
uncover the feelings, experiences and w ords of "the real fatigue-w orld", 
interviewees were given the opportunity to speak spontaneously about their 
experience.
There are a variety of interview styles w ith little uniformity and precision in 
their definition. For example they can be prearranged or unplanned, one-time 
basis or repeated over time, face-to-face or by telephone, solo or conjoint (Morse
1991), standardised or non-standardised, unstructured, in-depth or focused (Polit 
& Hungler 1993), open-ended or guided (Field & Morse 1994). Qualitative studies
typically employ unstructured or sem i-structured interviews in order not to 
reflect preconceived ideas about content and flow and can be undertaken w ith 
little or no organisation (Morse 1991). For the purpose of this study and in 
accordance w ith  the g rounded  theory  approach , the in terv iew s w ere 
unstructured. Previous knowledge and experience was therefore subordinated as 
"hidden agenda" (Oppenheim 1992) to the process of discovering the informant's 
perspectives concerning tiredness. The later interviews in the study became more 
structured as the prelim inary findings enabled questioning to become more 
focused. Topics for the questions were derived from the initial process of 
conceptualisation, w ith further ones added during the course of the interviews.
Even though the interview s them selves were unstructu red , three guided  
questions on the "hidden agenda" were asked if subjects did not m ention the 
topics spontaneously. The topics concerned: the occurrence of weakness, the 
occurrence of malaise and the linguistic description of tiredness. This deductive 
part of the study was done in order to compare the occurrence of these concepts 
with findings in the existing literature (Kobashi 1985).
All interviews were conducted by the same nurse researcher, on a one-time basis 
and scheduled for a convenient time. Most patient-interviews took place in the 
patient's room, or if there was a need for privacy or to prevent interruption, in 
the researcher's office. They varied in length from 30 to 50 m inutes. Open 
questions such as "what is it?" or "what does it feel like?" challenged the 
informant to talk about their own experience. Interviewing cancer patients about 
tiredness pu t an emotional strain on many of them as it concerned feelings of 
loss and coping w ith progressive disease. This was acknow ledged by the 
researcher by giving patients time for sobbing, slowly going back to discussion of 
more superficial topics. M aintaining rapport and trust were considered to be 
im portant in order to keep the patients talking, at the same time m aintaining 
their psychological well-being.
The interviews w ith healthy persons were emotionally less strenuous, even 
though they often became very personal. Many adm itted that they w ould not 
normally tell people that they felt tired. All interviews were tape-recorded with 
their permission. They showed no sign of "stage fright" once the interview  had 
started. Field notes were m ade to record special events. The whole text was 
transcribed by the nurse researcher in order to become familiar w ith the data.
Patient characteristics, biomedical information, Karnofsky Index
Data concerning gender, age, type and stage of disease and current treatm ent of 
the cancer patient group were collected from the medical record in order to assess 
comparability between individuals. The performance status was assessed by the 
nurse investigator using the Karnofsky Index Scale. This numerical scale from 0 
to 100 represents the patient's ability to perform  norm al activity, to do active 
work and the need for assistance; it has been widely tested and used for making 
clinical decisions (Schag 1984). The index was used to assess the impact of the 
disease on the individuals' activity and need for assistance.
Data analysis
The analytical process in grounded theory does not differ greatly from the 
processes used in other qualitative approaches. Researchers organise the data, 
analyse the content and search for integrative themes and patterns (Polit and 
Hungler 1993). The main difference lies in the fact that in the grounded approach, 
data collection and analysis occur concurrently based on the constant comparative 
m ethod which is seen as generating theory from data or the discovery of 
grounded theory (Glaser & Strauss 1967). This is in contrast with the generating of 
a conceptual framework from previous studies.
The purpose of this study was to generate constructs which w ould describe or 
explain the phenomenon of fatigue /  tiredness . Analysis started soon after the 
first interviews. The researcher read the transcripts line by line looking for 
significant incidents or phenom ena. Persistent w ords, phrases, them es or 
concepts were recognised and identified for later retrieval, using a highlighter 
pen. Themes were identified and numbers assigned to them in the text to identify 
appropriate content (Miles and Huberm ann 1984). The num bers were inserted 
into the text to identify appropriate content. The significant passages, m arked 
with the num ber of interview and line, were then extracted and filed separately 
under emerging codes and categories. To ensure reliability, a second researcher 
separately judged the assignment of codes to the significant passages.
The identified themes of the analysed interviews were then com pared w ith the 
data subsequently collected. As more information became available, themes had 
to be partially revised, the emerging concepts then sharpening the focus of the
study. Categories were generated by clustering themes that seemed to fit together. 
It soon became apparent that the expression of tiredness could be grouped at 
physical, cognitive and affective levels.
In order to organise the data, the emerging themes were registered in a Binary 
Matrix. This allowed the recognition of specific fatigue-patterns per person and 
the frequencies w ith which each theme occurred. Descriptive statistics were used 
to describe and present data.
Reliability and validity
Qualitative research methodologies offer valuable approaches to the under­
standing of hum an experience. Grounded theory analysis used in this study was 
consistent w ith  this research approach providing narrative as opposed to 
statistical material. The important question concerning validity is thus the trust 
worthiness of the data. A procedure to evaluate the quality of data in qualitative 
research, is the use of four criteria to establish its trustworthiness: credibility, 
transferability, dependability and confirmability (Lincoln & Guba 1985). The 
evaluation of these criteria will be discussed later. Interrater reliability was 
established for the coding frame by identification of codes related to significant 
passages from the interview texts by a second judge. The percentage of agreement 
between the two researchers was very high, w ith 95% of agreement in the group 
with healthy individuals and with 93% in the group with cancer patients.
2.4. RESULTS
2.4.1. Sample characteristics
The two samples consisted of 20 diseased and 20 healthy individuals. The mean 
age (66 years) was higher in the patient group than in the group of healthy 
individuals (56 years). There was an equal distribution betw een m ales and 
females in both samples. Seventy-five percent of patients suffered from active, 
progressive disease and 85% w ere undergoing  tum our-therapy , m ainly  
chemotherapy. Fourteen different types of malignant tum ours were registered. 
The Karnofsky Index reveals severe impact of disease in 60% of these patients. In 
all of the healthy individuals this Index was 100% (Table 2.1.).
Table 2.1. Sample characteristics
Cancer patients Healthy individuals 
N=20 N=20
Gender fem ale 45% 50%
m ale 55% 50%
Age m ean 66 y. 56 y.
range 42-81 29-70
Disease* state progressive 75%
stable 25%
Tum our therapy yes 85%
no 15%
Karnofsky Index >70 40%
<70 60%
*14 different types of cancer
2.4.2. Results from cancer patients
Emerging concepts of fatigue/ tiredness
The num ber of addressed themes in the 20 interviews with cancer patients was 
220 (multiple nominations possible), from which the 16 themes were developed. 
After the analysis of the first interviews, categories started to emerge as it became 
apparent that sensations of fatigue /tiredness were expressed as either physical, 
affective or cognitive experiences. This was based on differences between the 
expressions of tiredness in physical functioning and physical sensations, those of 
emotional feelings and those which indicated problem s in thinking. Even 
though the distribution across the three categories was different for individual 
patients, the distinction betw een them  rem ained robust to the end of data 
collection.
Occurrence, frequency and distribution of identified themes
Table 2.2. shows the 16 them es that were identified and how  they were 
distributed across the 3 main categories. Figure 2.1. shows the occurrence and 
frequency of the themes in cancer patients. Physical sensations were described 
most frequently (59%) followed by affective sensations (29%) w ith cognitive 
sensations being the least frequent (12%) (Figure 2.2.). Theme 16, malaise, was 
considered to be a separate concept as it was difficult to assign to any of the other 
categories.
Descriptions of experiences expressed by cancer patients
Decreased physical performance (theme 1) and feeling unusually tired, worn-out, 
were the most prom inent sensations reported. It was often associated w ith an 
inability to walk as far as before or with an inability to do physical activities as 
before. Typical descriptions (English translations of the German responses) for 
decreased physical performance included:
Table 2.2. Identified themes and categories of tiredness in cancer patients 
N=20
Physical sensations of tiredness (59% of all themes)
1 decreased physical performance (18/20)
2 w eakness/ no strength (17/20)
3 unusual need for sleep (more than before illness) (6/20)
4 unusually tired (more than before illness), feeling worn-out (18/20)
5 unusual need for rest (more than before illness) (15/20)
Affective sensations of tiredness (29% of all themes)
6 decreased motivation (7/20)
7 need to force oneself to overcome inactivity (5/20)
8 no energy (5/20)
9 sadness (11/20)
10 anxiety (4/20)
11 no fighting spirit (4/20)
Cognitive sensations of tiredness (12% of all themes)
12 lack of concentration (4/20)
13 problems in thinking (4/20)
14 tired in the head (4/20)
15 sleeping problems at night (3/20)
16 malaise (2/20)
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"When I walked up the stairs, I thought I wouldn't make it anymore"
" I just could not walk as far as I used to"
" Walking to the bathroom makes me feel extremely tired"
" The tour I have planned is four times less strenuous that w hat I am used to do" 
" I wonder how I did all the work last year on Christmas"
" I had only 7 minutes to walk from my flat and I thought, if only I was there 
already!"
Feeling unusually tired (theme 4), was categorised as a physical sensation as 
patients indicated that this form of tiredness described a lack of strength to carry 
on as usual and was experienced as a bodily sensation. It was expressed mostly by 
the simple w ord "tired", in combination w ith an am plifying adjective. The 
following expressions were typical:
" I feel unusually tired", " tired like mad", " finished"
" it is difficult to explain, it is simply tired"
" more and more tired", "dead-tired", "so tired", "very tired", "terribly tired"
" I was tired in earlier days, but never so much tired as now"
" constantly tired", "omnipresent tiredness", "heavily tired"
" the whole body is shattered", "worn-out", "tired all over the limbs"
" tired from the morning to the evening"
Weakness (theme 2) was equated w ith no strength and was the th ird  m ost 
frequently mentioned concept. The overwhelming impact of it as an experience 
is described by the following quotes:
" tiredness feels similar to weakness", "it feels weak, weak.."
" I had no strength anymore", " I feel much weaker than before"
" I do not regain strength, I feel weak", "its weakness, only weakness.."
" tiredness comes from weakness", "through tiredness I become weak"
U nusual need for rest (theme 5) the fourth most frequently occurring theme, 
could either mean the need to stop activities, to sit down, to have a break, or to lie 
down to rest. Typical quotes were:
" I am always concerned to have a possibility to sit down"
" then you only want to lie down, to close your eyes and rest, and that wish
becomes an addiction"
" I have problems in walking, I need to rest in between"
" then I just can't anymore and I lie dow n"," I want to lie down, anywhere"
" If I work in the garden, suddenly it feels as though the gasoline ran out and 
nothing goes anymore, I then need to lie down and wait until some gasoline 
runs in again"
Sadness (theme 9) is the most frequently identified affective sensation. Feelings of 
sadness were expressed by w ords or non-verbal expressions such as crying. 
Examples of verbal expressions were:
"tiredness feels like depression, it makes me feel listless, one has to fight against 
it"
"sometimes I feel sad because I cannot do as I used to"
"fatigue is a physical experience but there is also something psychological; if one 
thinks of being a death candidate, its not cheering you up"
"I am of no use to anything anymore"
"I have no interest anymore in what is going on in the world"
The remaining themes from the affective category (6, 7, 8, 10 and 11) describe the 
concepts of loss of motivation, the fight to overcome inactivity, loss of energy, 
anxiety and sense of fighting spirit.
Cognitive sensations included lack of concentration, problem s in thinking, 
tiredness in the head, (themes 12-13). They appeared less prom inent than  all 
other categories even though their impact seemed to be severe. Some quotes 
illustrate the impact:
" one is tired in the head, one likes to close the eyes"
" I cannot go on thinking, I am too tired"
" one forgets things, has difficulties to concentrate"
" I can't hold my thoughts in adequate structures"
" the brain is out of function"
Sleeping problems at night (theme 15) was mentioned by three patients, making 
integration into a category difficult. Malaise (theme 16) w as not identified 
spontaneously by cancer patients, two of them recognised its occurrence w hen
asking the question. A most interesting report came from a young male- cancer 
patient, who explained the experience of tiredness/ fatigue with following words:
"It is in the limbs, but also in the head, one is listless to read a new spaper or to 
watch television, it is "total tiredness".
Individual patterns of fatigue in  cancer patient
Figure 2.3. presents a Binary matrix of the identified themes, represented per 
interviewee. As can be seen, the overall distribution of aspects reported varies 
from person to person. Only the physical sensations appear consistently 
throughout all the interviews.
The linguistic description of fatigue by cancer patients
A linguistic exploration of how Swiss patients labelled their tiredness is presented 
in Table 2.3. (translated from Swiss-German). It represents the words used by the 
patients to describe what they perceived as tiredness.
2.4.3. Results from healthy individuals
Emerging concepts of fatigue/ tiredness
Interviews w ith the healthy persons were easier to conduct; their length was 
between 15-30 minutes and they usually did not stir up deep emotional feelings. 
One hundred  and forty-one descriptions were identified from the interviews, 
less than the num ber identified in the group of cancer patients (220). After the 
analysis of the first interviews, the same three categories as in the sam ple of 
cancer patients seemed appropriate, even though not all the them es were the 
same. Criteria to assign themes to a category were the distinction betw een 
physical, cognitive or affective expression.
Occurrence, frequency and distribution of identified themes
Table 2.4. shows the 16 them es that were used to code the data and their 
distribution into 3 categories. There were 7 physical sensations (themes 1 to 7), 4 
affective sensations (themes 8 to 11) and 4 cognitive sensations (themes 12 to
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Table 2.3. Linguistic analysis: words to describe "feeling tired" (miide)
identified by 20 cancer patients (translated from Swiss-German)
- I wouldn’t know a better word than tired. I usually say:
I feel so tired, I have to lie down
- worn out, worn out, it's (even) more than worn out
- no strength, no appetite, pressure on mood
- one does not know what is coming. Uncertainty is stressing
- it is difficult to explain 
- 1 do not feel well
- to be worn-out, shattered
- indifference, listlessness
- yes, it (tired) is the right word. The energy is reduced
- to be unsatisfied, indecisive, changeable, out of balance, aggressive? irritable
- could not find an other, better word than tired, worn out (schlapp)
- lazy, all lazy!
- can not find another word than "tired"
- I nearly couldn't any more
- desire to rest
Table 2.4. Identified themes and categories of tiredness in healthy individuals 
N=20
Physical sensations of tiredness (55% of all themes)
1 tiredness after a days work, as a rhythmic normality (18/20)
2 tiredness after physical exercise, as pleasant phenomenon (7/20)
3 wish to go to bed, to lie down, to rest, silence (6/20)
4 becoming slower (5/20)
5 having heavy limbs, legs, eyelids (11/20)
6 feeling exhausted, worn-out, cannot anymore (2/20)
7 weakness (asked question) (0/20)
Affective sensations of tiredness (21% of all themes)
8 loss of energy, interest (3/20)
9 feeling depressed (4/20)
10 wanting to withdraw, to avoid problems (3/20)
11 feeling impatient, irritable (6/20)
Cognitive sensations of tiredness (24% of all themes)
12 loss of concentration, forgetting easily, loss of attentiveness (7/20)
13 difficulty in finding words, to speak (1/20)
14 sleepiness (8/20)
15 thoughts going around in the head (before falling asleep), 
wish to "switch off" (5/20)
16 malaise (asked question) (2/20)
15). The concept of malaise (theme 16) and weakness (theme 7) were responses to 
guided questions in this group when they were not mentioned spontaneously.
Tiredness after a day's work as a rhythmic normality (theme 1), was mentioned 
most frequently (18 out of 20 persons). This was often related to pleasant, relaxing 
tiredness. Heavy limbs, legs, eyelids (theme 5) was ranked second in frequency 
and occurred as a consequence of work. Sleepiness (theme 14) was reported as 
som ething w hich comes suddenly  and m any individuals related it to the 
evening, when watching television. A typical description was the following:
" I do not feel tiredness as such, I suddenly fall asleep (when watching 
television)".
Tiredness as a pleasant phenomenon, after a special physical performance (theme 
2), was as frequent as was the loss of concentration or attentiveness and forgetting 
easily (theme 12). Loss of concentration and attentiveness was mostly related to a 
situation after a working day. The same was the case with the wish to lie down 
(theme 3). Affective sensations were not mentioned very often apart from the 
feeling of impatience and irritability (theme 11). Two people m entioned malaise 
(theme 16) identifying it as a problem. None of the healthy subjects felt that they 
were affected by weakness (theme 7). Figure 2.4. shows the occurrence and 
frequency of the themes from each category of the healthy individuals. Fifty-five 
percent of the healthy individuals identified physical sensations of fa tigue / 
tiredness, tw enty-one percent identified affective and tw enty-four percent 
indicated cognitive sensations (Figure 2.5.).
Individual patterns in healthy individuals
Figure 2.6. presents a Binary matrix of the themes represented by interviewee. As 
can be seen, no uniform pattern can be recognised, every individual has h is /h e r 
own experience of fatigue.
The linguistic description of tiredness by healthy individuals
A linguistic exploration of how healthy individuals labelled their tiredness is 
presented in Table 2.5. (translated from Swiss-German). It represents the w ords 
used by the healthy subjects, to describe, what they perceived as tiredness.
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Table 2.5. Linguistic analysis: words to describe "feeling tired" (miide) 
___________ identified by 20 healthy individuals (translated from Swiss-German)
- 1 feel k.o. (knocked out). I am at zero. Feel the need to go to bed 
- 1 might say: I did not feel well today
- shattered, ready to go to bed, need silence, to switch off 
- 1 was glad to be able to lie down
- 1 would not speak about that I would say: I am not very well today
(but I would say why), that depends on who asks the question 
- 1 was laying flat down, I also would say tired 
- 1 am on point zero. I am "fixed and finished". I want to lie down, 
to close my eyes and rest 
- 1 need to switch off, to rest, relax, doing nothing anymore
- I can’t anymore, do not find the words, can't join the discussion, feel dazed. 
There is no productive power
- I was completely finished
- 1 was shattered, down, exhausted, tired. Tiredness says: it is enough, you m ust 
stop
- I am so tired and still can not sleep, the thoughts turn around in my head 
- 1 was very tired
- 1 was very tired, it was time to hit the sack 
- 1 am ready to go to bed 
- 1 was laying flat down like mad
- I was tired, didn 't feel like doing anything
- I have had enough, my capacity is at it's limits
- Attentiveness decreases, also the level of being awake 
- 1 was dead tired
2.4.4. Comparison of the fatigue experience between 
healthy individuals and cancer patients
The identified themes in both sub-population
Table 2.6. shows the themes of both groups, ranked according to frequency. It 
reveals that different physical sensations of tiredness are dom inant in both 
groups. However, whereas the healthy people's tiredness is experienced as a 
circadian rhythm, indicated by heavy limbs from daily activity and by feeling 
sleepy after work, the cancer patients’ experiences were of decreased physical 
performance, feeling unusually, extremely tired or weak and a need for more rest. 
These highest ranked themes from the two groups characterise the im pact of 
tiredness and illustrate the difference between "healthy tiredness" and tiredness 
as a distress. The affective and cognitive themes appear to be similar for both 
groups so that even though tiredness is expressed at physical, affective and 
cognitive levels in both study samples, the nature of the identified them es 
reveals a difference between healthy tiredness and tiredness associated w ith 
disease.
W eakness and malaise in cancer patients and healthy individuals
Figure 2.7. shows the occurrence of malaise compared between healthy persons 
and cancer patients. Malaise was either denied by most subjects in both groups or 
it was unclear. Only 2 persons per each group felt that "Unwohlsein", the 
German version of malaise, was a reality. Figure 2.8. shows that weakness was a 
prominent concept associated with fatigue/ tiredness in cancer patients, w ith 85% 
stating, that it occurred. None of the healthy persons felt weak.
Table 2.6. Themes of tiredness identified in the two study samples 
________  (from open interviews)_______________________________
Healthy individuals (20)
(No. of subjects who nominated)______
18 tiredness after a working day, 
rhythmic event
11 heavy limbs, eyelids 
8 sleepiness
7 impaired concentration, 
loss of attentiveness, forgetting easily
7 tiredness after physical exercise, 
pleasant
6 wishing to go to bed, lie down, rest 
6 feeling impatient, irritable
5 becoming slower
5 thoughts turning around in the head 
when trying to fall asleep
4 feeling depressive
3 loss of energy, interest
3 wishing to withdraw
2 feeling exhausted, worn-out, 
can not anymore
1 difficulty in finding words, speaking
weakness: 12 no, 8 unclear 
malaise: 2 yes, 13 no, 5 unclear
Cancer patients (20)
(No. of subjects who nominated)
18 decreased physical performance
18 unusually tired, more than before 
illness
17 weakness, no strength
15 unusual need for rest, 
more than before illness
11 sadness
7 decreased motivation
6 unusual need for sleep 
more than before illness
5 need to force oneself to overcome 
inactivity
5 no energy
4 no fighting spirit 
4 anxiety
4 problems in thinking
4 lack of concentration 
4 tired in the head 
(mental tiredness)
3 sleeping problems at night
weakness: 17 yes, 3 no 
malaise: 2 yes, 13 no, 5 unclear
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2.5. DISCUSSION
What is the lived experience of tiredness/ fatigue
The value of this qualitative research project was the insight it has given into the 
experience of tiredness as lived by cancer patients and healthy individuals. No 
existing m easurem ent in strum en t or conceptual m odel d irec ted  the 
investigation as the aim was to learn from the data in order that a definition of 
tiredness/fatigue according to the experience of the study subjects could be 
obtained. The richness of the data obtained reflected the appropriateness of using 
this grounded analysis approach, allowing data from an emic perspective to be 
compared with existing theory.
Emerging concepts in cancer patients and their relation to existing theories
The concepts that emerged were different for cancer patients than for the healthy 
individuals. Most of the cancer patients expressed the four m ost prom inent, 
distressing concepts of tiredness w ithin a physical frame, such as decreased 
physical performance, feeling unusually, extremely tired, weak and in unusual 
need for rest. Decreased physical performance was frequently expressed as an 
inability to walk as far as before. Patients said they used energy saving activities, 
such as sw im m ing instead of walking or biking instead of walking, to take 
exercise or provide mobility but w ith decreased performance so that they were 
still able to support well-being. The sentence of one of the patients who said "I 
wonder how I did all the work before", suggests that patients compare their state 
with what has been before the illness. Patients described intensity and duration of 
the signs as abnormal, unusual. The fact that patients express physical experiences 
of tiredness as decreased strength looks as though it may be a key dimension 
which needs to be isolated as it could be an independent feature of tiredness. Most 
of the patients in this study suffered from advanced cancer disease and their 
Kamofsky Index was low. A low Kamofsky Index has been shown by Schag (1984) 
to correlate significantly with evidence of disease and intensity of reduced energy.
How can decreased strength or reduced energy be defined? What kind of energy is 
lacking, when decreased physical performance, unusual tiredness, weakness or 
unusual need for sleep interferes with daily living? The energy analysis m odel 
described by Irvine (1995) offers a theoretical explanation. In this model, energy is
defined as the capacity to do work on biological, psychological, cognitive and 
social levels. Hum ans depend on internal sources (e.g. sleep, rest, motivation, 
spirituality) and external sources (e.g. food, water and air) for their energy. The 
availability of energy in the system is determined by the body's physiological 
processing and its distribution. It is possible, therefore, that pathophysiological 
changes might d isrupt the process of energy transformation. Cancer treatm ent, 
sym ptom  distress and mood disturbances are described as energy response 
modifiers in Irvine's model, representing a constellation of factors, unique to 
cancer, that can modify energy sources, its transform ation and its expenditure. 
The model postulates that cancer cachexia represents a change in the energy 
transformation processes, characterised by loss of body weight, fatigue and activity 
intolerance. The emerging themes from the interviews in this study partially fit 
this framework w ith unusual tiredness, activity intolerance such as decreased 
motivation, the need to force oneself to overcome inactivity, unusual need for 
rest and sleep being attributes associated with a lack of energy.
W hilst the prom inent occurrence of weakness could be seen as activity 
intolerance, it is also possible that further energy response modifiers could be 
responsible for activity intolerance. For example M orant (1991) is considering 
cytokines such as asthenins, cachectins, interferons, interleukin-2 and other 
unknow n substances produced by the tum our or the im m une system  (as 
inflammatory response of the body against the tumour) as possible factors. Irvin's 
definition can be seen from a physical, psychological or social perspective. Since 
it could also be argued that not all cancer patients experience weight loss, fatigue 
or activity intolerance, it is possible that fatigue /tiredness may be related either to 
the type a n d / or stage of disease or to individual factors or to a combination of 
both the disease and the individual factors.
Physical expression of fatigue/tiredness was the most frequent and prom inent 
feature w ithin this study. W hether this finding can be generalised needs to be 
tested. It could be argued that patients find it easier to talk about physical 
experiences rather than their psychological experiences, a finding reported by 
other researchers (Kobashi 1985). Apart from the physical signs of tiredness, 
some, less prom inent psychological concepts emerged (Table 2.2.). Sadness was 
verbally or non-verbally expressed by 11 of the 20 patients. W hether sadness is an 
independent concept correlated w ith tiredness or sim ply an expression of 
tiredness, can not yet be answered. It is evident from clinical experience that
cancer not only affects patients physically but also psychologically and socially. 
Anxiety has also been expressed and decreased motivation may be psychologically 
based. The theoretical framework developed by Piper (1987) pays attention to the 
m ultidim ensionality of fatigue by describing the perceptual, physiological, 
biochemical and behavioural m anifestation of fatigue recognising the m any 
potential causes and factors that influence it. The theoretical fram ew ork, 
however, does not specify the relationship between the responses and the aspects 
which influence them, indicating the complexity of the phenomenon. O ur data 
suggest that the affective expression of fatigue might be strongly interwoven with 
the physical dimension. This raises a question of w hether there is a vicious 
circle, where sadness leads to tiredness (or vice versa), which then leads to 
decreased m otivation and inactivity (or vice versa), w ith the inactivity then 
leading to sadness (or vice versa).
The concepts concerned w ith problem s in thinking, lack of concentration, 
tiredness in the head, which emerged in our study, could be interpreted as the 
cognitive manifestation of tiredness. Patients appeared to suggest that some of 
these cognitive functions felt as though they were partially out of their control as 
indicated by one of the patients' quotes "my brain is out of function". Cimprich's 
(1992) theory of attentional fatigue links increased requirements or dem ands for 
directed attention with the development of attentional fatigue. She postulates 
that when demands exceed available capacity, the person is at risk of attentional 
fatigue. This form of fatigue could result in reduced effectiveness in basic 
cognitive or mental activities, such as acquiring information, planning, problem  
solving and performing tasks of daily living (Cimprich 1992). For cancer patients, 
the dem and for informational, affective and behavioural factors m ade by the 
disease and its treatment may increase the need for attention over long periods.
Further support for the cognitive expression of tiredness is given by Gibson (1985) 
in the two types of neuro physiological mechanisms which m ight be related to 
tiredness. One of these is a central mechanism (related to the brain, psyche and 
spinal cord) and the second is a peripheral mechanism (related to peripheral 
nerves, muscles and other influencing factors related to metabolites, electrolytes 
and others). It rem ains unclear, however, w hether the causes of central or 
peripheral mechanisms in cancer patients are the disease itself, the therapeutic 
interventions or whether dem ands for coping w ith the disease exceed available 
capacity. Fatigue has also been described as a "dose limiting factor" of treatm ent
with various biotherapeutic agents as the cause of mental fatigue and cognitive 
deficits (Piper and Rieger 1989a). As in our study none of the patients received 
biotherapeutic treatm ent, there m ust be other causes of cognitive dysfunction. 
For example, as the body itself produces biological response modifiers in order to 
fight the tum our (Morant 1981), expressions of tiredness could be seen as a sign 
of tum our activity.
The unusual need for sleep described by our patients fits the theoretical model 
incorporating the reticular activating system proposed by Astair (1987). The 
Reticular Activating System (RAS) is located in the reticular form ation of the 
m id brain  and m edulla and know n to be responsible for m ain tain ing  
wakefulness and alerting the cortex. When the RAS is inhibited, fatigue is an 
outw ard m anifestation which could occur through low ered sensory input, 
decreased response to input (e.g. sensory deprivation, immobility, isolation) and 
reduced cortical activity through chronic stimulation such as depression, anxiety, 
pain and narcotics. Astair (1987) links these mechanisms to a stress response 
hence explaining how they contribute to fatigue in cancer patients. As well as 
physiological and situational factors, she postulates that psychological factors lead 
to chronic fatigue and labels anxiety, depression or crisis as energy-depleting 
states. The cognitive and affective elements within this theoretical model are so 
interw oven that they are difficult to separate. Psychological factors need 
separating out if the model is to be useful for treatment strategies.
Malaise as an expression of fatigue/ tiredness ?
General malaise is said to indicate that an individual feels weak and tired and is 
unable to accomplish much. Kobashi (1985) in a study of cancer patients treated 
w ith radiotherapy found that malaise was highly correlated w ith "feeling ill, 
tired, not well and to be inactive". Malaise is also used as a quality of life 
indicator in the fatigue literature (Hiirny 1993). In our study, the German w ord 
"Unwohlsein" was used as Swiss people from the German speaking p a rt of 
Switzerland do not use the w ord malaise as it is rooted in the French language.
Respondents in this study perceived malaise differently. Some spoke of it in
terms of "feeling nauseated" whilst others referred to it as a general feeling of "ill- 
being". They did not mention any feeling of tiredness in association w ith it. Only 
2 out of 20 cancer patients felt that they experienced malaise. The same use of the 
concept malaise was apparent in the responses from the healthy individuals.
Only 2 individuals m entioned malaise (Unwohlsein), the others denied it or 
their responses were unclear. This suggests that malaise in the German language 
and culture is better used as measure of a wellness - illness dimension, rather 
than as a measure of tiredness.
Weakness: the same as tiredness?
Current research in fatigue recognises the need to define the concept of weakness 
(W inningham 1994, Piper 1989), particularly to establish w hether there is a 
difference between weakness and tiredness. In our study, general weakness was 
defined as an anticipatory, subjective sensation of a difficulty in initiating a 
certain activity. It represents the definition used in the syndrom e of asthenia 
which does not include any localised or regional weakness resulting from 
neurological or muscle disorders (Bruera 1988). This implies that there is a 
voluntary component to fatigue since an individual can still push h im /herself to 
perform  certain tasks. W hen weakness is used as a sym ptom  of neurologic 
syndrom es, on the other hand, there is no volun tary  com ponent in the 
performance of activities (Gordon 1986). In this study it was on these grounds that 
weakness from neurological damage was differentiated from weakness associated 
with normal neurological function.
In this study cancer patients reported weakness spontaneously in the context of 
tiredness; it was in fact one of the three most frequently mentioned expressions of 
tiredness, together w ith  feeling unusually  tired  and decreased physical 
perform ance. But w hereas decreased physical perform ance could  be a 
consequence of tiredness, it is more difficult to disentangle the concept of 
weakness from feelings of unusual tiredness. A possible solution is to use the 
notion of a voluntary component to distinguish the meaning of the two concepts, 
even though it leaves open a problem because decreased physical performance 
might limit the capacity to overcome tiredness. For, if one argues that tiredness is 
a consequence of decreased physical performance it leads to a vicious circle 
within all of the four most frequently mentioned expressions of physical fatigue/ 
tiredness: unusual tiredness leads to unusual need for rest, unusual rest leads to 
weakness, weakness leads to decreased physical perform ance (or vice versa), 
decreased physical performance leads to unusual need for rest (or vice versa), 
and so forth. W hat then needs to be explained, for treatm ent purposes, is how 
this vicious circle could be interrupted or at least slowed down by either physical
or emotional interventions. In an exploratory study, breast cancer patients 
receiving chem otherapy, who participated in a supervised, aerobic, interval 
training exercise program m e, showed an improvem ent in m ood that included 
corresponding changes in the perception of fatigue (MacVicar 1986). But the type 
of fatigue in the breast cancer patients might be different from fatigue in patients 
w ith advanced small cell lung cancer who are not receiving antineoplastic 
treatment. This hypothesis is supported by a report from St.Pierre (1992) who 
suggests that exercise could increase feelings of fatigue through the effects of 
tum our necrosis factor on skeletal muscle in patients w ith certain types of 
advanced cancer. This em phasises the need to separate  the vo lun tary  
components of fatigue from the physical components.
Data from our interview  study suggest that weakness (differentiated from 
weakness caused from neurological damage) is an inherent part of tiredness 
/fatigue in cancer patients. This is supported by the different w ay in which 
weakness occurred in healthy individuals, since healthy individuals' tiredness 
was not associated w ith  weakness. Twelve out of 20 healthy indiv iduals 
specifically said that their tiredness was not weakness and for 8 individuals it was 
unclear.
Differences in the perception of fatigue/ tiredness 
between healthy individuals and cancer patients
The healthy individuals in this study also reported physical, affective and 
cognitive expressions of tiredness bu t perceived them  on different grounds. 
Cancer patients spoke about a chronic, unpleasant, distressing, life- and activity- 
lim iting tiredness throughout the day, w hereas the healthy indiv iduals, in 
general, reported it as a pleasant, acute, normal, regulating phenom enon which 
helped them to schedule their daily rhythm and which disappeared after a good 
night's sleep. This relationship of tiredness to circadian rhythm  was described in 
a study comparing fatigue-profiles of healthy individuals w ith those w ho either 
had cancer or inflammatory bowel disease (Glaus 1993). M any of the healthy 
individuals perceived it as pleasant sign, indicating that it was time to relax, most 
of them relating it to the effects of work or to special physical exercise. Whereas in 
cancer patients tiredness was experienced as a "whole body feeling", in healthy 
individuals it was experienced locally in those parts of the body w hich were 
activated at work. Sleepiness in the healthy persons was experienced as period of
relaxation after work or during a break, whereas in cancer patients sleepiness was 
more a general, increased need for sleep or a feeling of tiredness in the head. 
Healthy persons did report depressive feelings, loss of energy or decreased activity 
as well as cognitive deficiencies, but these usually disappeared after rest. This 
recovery after rest was not necessarily the case w ith the cancer patients. As 
described above, malaise was not understood as tiredness in either of the groups, 
while weakness was only experienced by cancer patients. The results therefore 
suggest that tiredness in our sample of cancer patients represents an unusual 
tiredness w ith  distressing correlates w hilst tiredness in healthy people is 
perceived as a normal regulating phenomenon. Therefore while for both groups 
the expression of tiredness occurs on a physical, affective and cognitive level, the 
origin of its cause produced very different meanings, experiences and impact for 
each of them.
Different types of fatigue/ tiredness:
building a framework of physical, affective and cognitive expression
The research question of "what is it, w hat does it feel like", generated categories 
which represent fa tigue/ tiredness as an experience of the whole person; it 
includes both body and mind. The analysis illustrates expressions of tiredness, 
addressing the lived experience but not the consequences of tiredness, nor the 
causes. It produced three categories of physical, affective and cognitive fatigue/ 
tiredness. A similar classification system was constructed by Kobashi (1985) in his 
design of an instrum ent to m easure feelings of m alaise in pa tien ts w ith 
radiotherapy. It had four scales: a physical fatigue scale, a mental fatigue scale, a 
malaise scale and a psychological complaint scale. Yoshitake (1971) validated a 30 
item fatigue-symptom checklist in a healthy working population in Japan and 
devided it into three similar categories of "dull sleepy factors, decline of working 
motivation and projection of fatigue in some part of the body", which partially 
fits the categorisation of fatigue into physical, affective and cognitive expressions.
Steps in the development of fatigue - precursors of expression
A way of underpinning a model of physical, affective and cognitive fatigue /  
tiredness as an expression is to use the way Bruera (1994) explains pain which 
could explain the production of fatigue/ tiredness in the form of steps (Table 
2.7.).
Table 2.7. Steps in the production of fatigue/tiredness in cancer patients
Step
1. Nociception
2. Perception
3. Expression
Conditioning factors
Specificity: physical (type, stage of cancer, 
cytokines, biochemical factors 
metabolic disorders, treatment, 
energy transformation patterns) 
psychological: reactions, coping 
(anxiety, depression, fear)
Decreasing inhibitory pathways, threshold 
(affective state, coping mechanisms 
social support network, beliefs 
personality, general well-being)
at physical, affective and cognitive level
The production of pain is described in three steps nociception, perception and 
expression. The same steps could be used to explain the production of tiredness. 
Nociception might be specifically cancer related in origin and represent the causes 
of tiredness. These nociceptors could be explained as cytokines, regulated by the 
type and stage of disease, or as metabolic disorders accompanying cancer disease, 
as treatm ent related causes, as nutritional deficits through a disrupted energy 
transformation process and further causes. Nociceptors could also be explained as 
psychological causes such as depression, fear and anxiety. These nociceptors 
might primarily correspond with physical and cognitive expressions of tiredness.
Perception of fatigue may vary according to individual personality, a person's 
feeling of vulnerability, ways of coping with threat, general well-being and their 
social support netw ork which m ight then influence (decrease or increase) 
inhibitory pathw ays or m odulate threshold . Perception m ight prim arily  
correspond with the affective expression of tiredness.
Expression may vary according to the personality and hence determine physical, 
affective or cognitive level. Since it is not yet possible to m easure fa tigue/ 
tiredness at a cortical level, assessment has to be based on the patient's expression 
of fatigue/ tiredness. As this expression is influenced by factors that modulate the 
level of nociception, perception and expression, research needs to focus on 
measurement and interventions which work at these different levels.
Linguistic excursion to name fatigue/ tiredness in both sub-population
Analysis was undertaken to evaluate the w ording of the phenom enon by the 
subjects. It can, however, be recognised that healthy people associate tiredness 
more with humorous expressions (e.g. I was lying flat down like made, or its time 
to hit the sack and so forth). The words give the idea that tiredness is a norm al 
phenomenon in life, which indicates feeling "finished, at zero, flat, time to go to 
bed" (Table 2.5.). Cancer patients reported no hum orous expressions, rather they 
included loss of strength, uncertainty, unwellness, changes in m ood and they 
had more difficulty finding words other than "simply tired" (Table 2.3.). It is 
possible that the words used by the cancer patients are a mixture of physical and 
affective expressions of fatigue/ tiredness, whereas in healthy people they may 
only represent physical expressions.
Reliability and validity
Qualitative research m ethodologies offer valuable approaches to the under­
standing of hum an experience. The chosen method of grounded analysis in this 
study was consistent w ith this research approach and narrative m aterial, as 
opposed to statistical material, was generated. A semantic style of investigation 
was used. This raises the question about whether the data reflects the truth. A 
procedure to evaluate the quality of data in qualitative research has been outlined 
by Lincoln & Guba (1985) who recommend the use of four criteria to establish its 
trustworthiness: credibility, transferability, dependability and confirmability.
Credibility in qualitative research refers to confidence in the tru th  of the data 
(Polit & Hungler 1993). Credibility depends on how the investigation has been 
carried out. In this study the use of unstructured interviews, tape recording and 
transcription allowed collection of "the emic view" w ithout major distortion of 
data which in itself contributes to validity as it demonstrates credibility. Content 
analysis, identifying themes and building categories is on the other hand subject 
to interpretation. To reduce bias which may result, constant comparison was 
used in order to improve validity. Strict application of constant comparison, 
however, was difficult because there was a large data set m aking it difficult to 
cope with the analysis. In qualitative research, the issue is not w hether another 
investigator discovers the same concepts or interprets the data sim ilarly bu t 
whether the findings of an inquiry are worth paying attention to (Lincoln & Guba 
1985). In attem pts to provide "windows on the world", m any qualitative 
researchers do not meet the tight controls which are the hallm ark of scientific 
inquiry, a problem which is inevitable, given the "unscientific task" of describing 
social worlds (Clark 1995). Qualitative work serves the function of identifying and 
clarifying initial ideas. These ideas then need to be tested w ithin more controlled 
studies.
As data triangulation improves credibility, three approaches were used. M ultiple 
key informants were interviewed about the same topic, a second investigator 
judged the assignment of themes /  categories to the significant passages in the 
interviews (interrater reliability) and multiple, theoretical perspectives were used 
to interpret the data.
Transferability, which equates with generalisability of the quantitative approach 
(Polit & Hungler 1993), was achieved through the collection of life experiences 
from a sample of subjects who represent that population. Cancer patients were all 
experts on the phenom enon under investigation. However, a group of patients 
with different types and stages of cancer or who all were undergoing the same 
treatm ent might have yielded different results. The variables used to select the 
sample (cancer patients and healthy individuals) were age and gender. Mean-age 
turned out to be lower in the healthy population and could account for some of 
the difference between the ill and healthy people. Data saturation in both groups 
suggested generalisation that the data could be generalised to both groups under 
investigation.
Dependability, which is reflected in the stability of data over time and conditions, 
was not addressed in this study as interviews were conducted on only one time 
occasion. Confirmability, objectivity or neutrality of the data was supported 
through the agreem ent of the coding frame by a second judge. The high 
percentage of agreem ent betw een the two judges assures reliability of the 
identification of the codes but does not guarantee content validity as the coding 
frame was known to the second judge.
Researchers refer to quasi- statistics when computing the frequency w ith which 
certain themes are supported by the data. Frequencies cannot be interpreted in the 
same way as they are in quantitative studies because of imprecise sampling (Polit 
and H ungler 1993). Quasi-statistics may allow one to draw  conclusions if a 
phenomenon either does not or always occurs, such as weakness and malaise in 
this study. Frequencies d id  show dom inance in certain them es w hich is 
interesting for theory developm ent; how ever the occurrence of other, less 
frequent themes cannot be neglected, as frequency and the depth of data are both 
im portant.
2.6. CONCLUSIONS AND DIRECTIONS FOR FUTURE RESEARCH
The results of this study show differences in the characteristics of lived experience 
of fa tigue/ tiredness betw een cancer patients and healthy individuals. This 
finding is im portant for future research in cancer related assessm ent of this 
distressing symptom since it suggests the need to distinguish betw een fatigue/
tiredness as distress and fa tigue / tiredness as norm al life experience. The 
emerging concepts fit a theoretical framework which breaks fa tigue/ tiredness 
into expressions of physical, affective and cognitive fatigue/ tiredness. It has been 
argued that nociception, perception and expression could be considered as steps in 
the development of fatigue/ tiredness. A theoretical framework which is able to 
represent the different forms in which fatigue in cancer patients is expressed 
w ould generate new research strategies leading to new m ethods of assessment 
and treatment.
Further research is now needed to confirm the emergent hypothesis. Given that 
the concept remains robust, instruments could then be developed to assess the 
physical, affective and cognitive components. Because of its naturalistic nature, 
the results of our study cannot be generalised to a specific cancer population. It 
will be necessary to extend validation to include a large cancer patient sample. 
The variables which need to be considered include nociceptor-related factors 
(such as type and stage of the disease, treatm ent patterns, sym ptom s) and 
psychological aspects (such as anxiety and depression). Despite determ ining 
controlling variables, the holistic view of individual fatigue/ tiredness expression 
should not be lost.
In order to develop nursing strategies which target fa tigue/ tiredness, it is 
particularly im portant that one distinguishes between the three types of fatigue/ 
tiredness identified. Interrelationship betw een the three types needs to be 
examined. It was also argued that decreased physical perform ance, weakness, 
extreme tiredness, increased need for rest, inactivity, increased need for sleep, 
sadness or cognitive problems may become a vicious circle. Further research is 
thus also needed to detect measures which could interrupt this cycle. As nurses 
cope with deficits related to daily activities and w ith im paired quality of life, 
fatigue/ tiredness research represents a real challenge for nursing.
The identified descriptors of fatigue/ tiredness in cancer patients and healthy 
individuals and the tentative fram ew ork now  need to be com pared w ith  
descriptors and frameworks from currently available m easurem ent instrum ents. 
If none of the existing instrum ents include the identified  them es, the 
construction of a new fatigue assessment questionnaire will be considered. These 
processes are described in the next chapter.
CHAPTER 3
CONSTRUCTION OF A NEW FATIGUE ASSESSMENT QUESTIONNAIRE
3.1. INTRODUCTION
The qualitative exploration of the experience of the concept fatigue in cancer 
patients and healthy individuals in the previous study 1 (chapter 2) has given 
insight into the multidimensionality of this phenomenon. It was concluded, that 
it was expressed at physical, affective and cognitive level and that there was a 
distinct difference between fatigue in cancer patients and fatigue in healthy 
individuals. The interviews have resulted in specific descriptors w ith  which 
cancer patients name their fatigue. It is the aim of this chapter to compare these 
identified descriptors (chapter 2) w ith the ones used in currently  available 
measurement instruments. Applicability of the available instrum ents for further 
epidemiological fatigue research in cancer patients will be discussed. The 
developm ent of the new Fatigue Assessm ent Q uestionnaire (FAQ) will be 
justified and the process of the questionnaire development will be described.
3.2. REVIEW OF DIFFERENT TYPES OF QUALITY OF LIFE 
MEASUREMENT INSTRUMENTS, WHICH INCORPORATE 
ASSESSMENT OF FATIGUE OR TIREDNESS
References of the review are based on literature searches, using Medline w ith CD 
ROM over the period of 1988 to 1995. Further literature was detected by searching 
for studies in which fatigue was assessed as part of quality of life research.
C urrent literature show s that there is a gap in our know ledge about how  
tiredness /  fatigue in cancer patients should be defined and m easured. Existing 
fatigue-related research in cancer patients shows conceptual and m easurem ent 
differences (Piper 1993). There is no universal use of a continuum  of tiredness/ 
fatigue. W hat do patients mean if they fill in a visual analogue scale, indicating 
that they feel "very tired"? Is it an indicator of general well-being, thus an 
estimate of general quality of life (Hiirny 1993)? Articles w ritten by English 
speakers mainly use the definition fatigue to identify extreme tiredness. It could 
be said, that in the English language tiredness, which is perceived as unusual, 
continuing distress, is fatigue rather than tiredness. In the German language,
tiredness (Miidigkeit) is not prim arily a distress term attributed to disease or 
unusual effort. But tiredness becomes a distressing phenom enon w hen it no 
longer regulates a healthy balance betw een rest and activity b u t represents 
unusual, abnormal or excessive whole-body tiredness which is disproportionate 
to or unrelated to activity or excessive exertion (Piper 1993). As the word fatigue 
in the Germ an language does not exist, the definition "extreme, unusual 
tiredness" (in German: extreme, uniibliche Miidigkeit), is interpreted to mean 
fatigue. This clarification is needed in order that future fatigue research in a 
German speaking country can be compared.
Fatigue/ tiredness is a complex phenomenon which is often incorporated into 
tools which m easure a broader set of concepts. Few tools are constructed to 
measure fatigue per se. According to their aim and application, they address 
different underlying concepts and aspects of fatigue (McNair 1971, Piper 1989, 
Kobashi 1985, Hiirni 1993). Choice of items of existing tools mainly seem to be 
derived from clinical experience and existing literature.
The sub scale on vigour/ fatigue of the Profile of Mood States (POMS)
The original purpose of the Profile of Mood States (POMS) (McNair 1971) is the 
assessment of mood states in different populations. A sub scale of this validated 
and reliability tested instrum ent includes fatigue w ith the item s w orn-out, 
listless, fatigued, exhausted, sluggish, weary and bushed, in order to assess a mood 
of weariness, inertia and low energy level. The adjectives are rated  by the 
respondents on a five point scale from not at all, a little, moderately, quite a bit, 
extremely (0 - 4) (McNair 1971). Several time sets have been tested. However, 
most of the data reported are based on a one week period (McNair). Interestingly, 
the item tired was dropped during the instrum ent development phase, as tired 
and fatigued seemed to be a doublet in earlier tests. As this instrum ent is 
primarily used to assess mood disturbances, it m ight not represent symptoms of 
fatigue prim arily caused by physical disease, such as cancer. W eakness and 
malaise, which are probably m ore somatic expressions of fatigue are no t 
addressed either. How ever, self-rated fatigue-intensity has been show n to 
correlate significantly with the scores on the POMS sub scale for fatigue-inertia 
assessment (Blesch 1991). The same had been the case for the other sub scale 
concerning tension-anxiety, depression-dejection, anger-hostility and confusion- 
bewilderment (Blesch 1991). These findings support the idea that physical and
psychological expressions of the cancer experience may be difficult to disentangle. 
Furthermore it is unclear w hether psychological distress is a consequence of 
tiredness or whether tiredness is an expression of emotional distress.
The question remains of whether an emotional component of fatigue that differs 
from the physical sensation component exists. Celia used the POMS instrum ent 
to explore the relationship between psychological distress, extent of disease and 
perform ance status in 304 cancer patients (Celia 1987). Regression analysis 
indicated that fatigue and vigour were most highly related to the covariates in the 
model, with total mood disturbance and confusion close behind. The question of 
whether fatigue and vigour were the most "physical" symptoms (physical fatigue 
components) was raised and also whether they accounted for the association of 
performance status with the extent of disease. Total mood disturbance scores rose 
in a linear fashion w ith greater im pairm ent in perform ance status and w ith 
tension, vigour and fatigue sub-tests explaining most of this effect. Concerning 
tension, it could be supposed, that it is a response to stress which leads to 
tiredness and so contributes to loss of vigour and hence becomes expressed as 
fatigue.
The primary purpose of the POMS instrument would appear to be the assessment 
of mood states in different populations, with a main focus on fatigue originated 
by mood disturbances. The validity and reliability of this sub scale, out of the 
context of the whole POMS instrum ent, w ould need further reliability testing 
w hen used in a physically ill population. The whole instrum ent, including 65 
items, might be too long and non-specific as a feasible tool to be used in a cancer 
patient population w ith restricted energy. However, the tension-anxiety and the 
vigour/fatigue sub scales address fatigue from the perspective of mood, which is 
of high interest, if fatigue in cancer patients is being hypothesised as both  an 
emotional and a physical experience.
The Quality of Life Questionnaire- C30 (EORTC)
The European Organisation for Research and Treatment of Cancer (EORTC) has 
developed a core Quality of Life Questionnaire to assess quality of life in cancer 
patients (Aaronson 1993). A sub scale of this questionnaire includes five 
questions concerning fatigue and malaise, Likert format, range 1 - 4 .  Patients 
answer the questions in relation to the past week. This reliability and validity
tested instrum ent was used in a study which showed that fatigue and malaise 
were the m ost prom inent sym ptom s during six m onths after diagnosis and 
under cytotoxic treatm ent of small cell lung cancer patients. The authors 
concluded that fatigue and malaise can be used as an indicator of quality of life in 
this patient-population, bu t that the positive correlations of fatigue w ith  
psychological distress, role functioning, restriction of social activity and impaired 
general well-being, were more likely to represent consequences of fatigue and 
malaise than the experience of fatigue itself (Hiirni 1993).
The five items addressed in this questionnaire are: have you felt 1) weak, 2) 
physically well, 3) ill, 4) tired; and 5) did you need rest (during the past week). 
These items appear to be addressing the state of general well-being (being a quality 
of life questionnaire) and include the illness/wellness continuum , which could 
be interpreted as a m easurem ent of malaise. Weakness and tiredness are also 
included and there seems to be an emphasis on these through the assessment of 
the need for rest. These items are based on the theory that fatigue and malaise are 
caused by the disease process, its treatm ent and by psychological distress, thus 
representing a multidim ensional concept (Hiirni 1993). However, it seems that 
the components being measured refer more to physical tiredness than to fatigue 
as a mood state. The sub scale of this tool is likely to m easure fatigue from a 
physical perspective. Items related to mood are integrated into other parts of the 
questionnaire. The use of this sub scale, out of the context of the entire EORTC 
Quality of Life Questionnaire, would need further validity and reliability testing. 
The application of the entire, multidimensional quality of life questionnaire with 
its 42 items would be too broad and extensive for the purpose of exploring fatigue 
specifically in cancer patients.
Fatigue/tiredness in a selection of Quality of Life Questionnaires,
Abilities-, Functional Living-, Performance- and Activity- Indexes
A great variety of indexes are being used today to assess quality of life for different 
purposes. An ability index can be of help in the assessment of im pairm ent of 
daily living. As an example, the ability index of Izak and M edalie reflects 
subjective reactions, working abilities and social adjustment (Izak 1971). Fatigue is 
not mentioned in this index, even though many of the items could be used as 
indicators of fatigue or the consequences fatigue. To know more about the impact 
of fatigue, questions would need to include phrases like for example " how much
impairment has fatigue imposed on your ability to work?". The question remains 
whether im pairm ent concerning abilities can be strictly related to fatigue and 
whether causes of such impairment can be discriminated from fatigue.
A Functional Living Index m easures factors contributing to overall functional 
living. Examples of two such Indexes are the Functional Living Index and the 
Functional Assessment of Cancer Therapy Tool. The Functional Living Index- 
Cancer (FLIC) (Schipper 1984) measures distinct physical, emotional, and social 
factors. This instrum ent does not mention tiredness or fatigue but m any of the 
item s, again, could be seen as consequences of fatigue. The Functional 
Assessment of Cancer Therapy Tool (FACT) (Celia 1990) seems to include fatigue 
with the item "lack of energy". The item "forced to spend time in bed" could also 
be interpreted as an indicator of fatigue. While a functional or ability index is 
likely to be influenced by fatigue, it does necessarily account for the possible 
consequences of fatigue. The question emerges, "what kind of fatigue reduces 
abilities and functionality? Is it physical tiredness, weakness, or tiredness as a 
mood state?
The Breast Cancer Chemotherapy Questionnaire (Levine 1988) includes fatigue 
with the items "felt low in energy" and felt "tired or fatigued while hurrying" 
(during the last two weeks). A further item looks at "problems w ith fatigue or 
tiredness which lim ited usual social activities". This item pays regard to the 
impact or consequences of fatigue. However, the impact m ight be multicausal. 
The tool is especially constructed for breast cancer patients under chemotherapy 
and not for a general cancer population.
The Cancer Rehabilitation Evaluation System (CARES) (CARES Consultants
1988) includes fatigue w ith the items "I do not have the energy I used to", "feel 
tired after chemotherapy", "feel tired after radiotherapy" (past month, including 
today). This system compares actual fatigue perception in comparison w ith w hat 
it used to be and involves differentiation of therapy-induced fatigue.
The Quality of Life Index by Padilla asks for items related to general physical 
conditions, important hum an activities and general quality of life aspects (Padilla 
1983). Under physical condition it is asked " how m uch strength do you feel" 
(LASA, from none to normal). Impaired strength could be interpreted as fatigue 
or weakness.
The Karnofsky Performance Index (KPI) and the W orld H ealth Organisation 
(Zubrod) Scales are commonly used as proxy m easures for perform ance and 
quality of life. Their historical relevance and current high frequency of usage, 
despite their unidim ensionality, is remarkable. They represent an index of 
activity from normal to dead (Karnofsky 1948) and from normal to unable to get 
out of bed (Zubrod 1960). Performance could have a significant relationship with 
fatigue but might be caused by different sources . The KPI has been tested against 
the Cancer Inventory of Problem Situations (CIPS) concerning the components 
"self-care, daily activity, work and evidence of disease". The CIPS is a self­
administered instrum ent that assesses type and severity of problems confronted 
by cancer patients (Heinrich 1983). One item of the "evidence of disease- 
component" was described as "I do not have the energy I used to". In this study, 
patients who obtained the highest Karnofsky Performance Scores, rated by health 
care professionals, rated themselves as having some im pairm ent and 74% had 
reduced energy (Schag 1984). While statistically the KPI is a reliable instrument, it 
would appear, that the absence of guidelines for its use has created a certain 
degree of unreliability. In this study, the KPI was shown to have very good 
interrater reliability (Schag 1984). However, as fatigue is not necessarily a visible 
expression, specific assessment, by the patient himself, seems needed. Again 
questions emerge of w hy is perform ance im paired? Why does fatigue as a 
performance-impairing factor appear and is it a physical cause, a mood state, or 
both?
Symptom distress scales
Symptoms can be caused by the disease itself or its treatment. Scales have been 
widely used in the assessment of sym ptom  distress. Fatigue as a distress is 
incorporated in few of them. The symptom distress scale developed by McCorkle 
and Young, includes 10 symptoms, one of which is fatigue (McCorkle 1978). 
Patients are asked to pu t a circle around the num ber (ranging from 1 to 5, 
indicating "could not feel more tired" and "I am not tired at all"), that m ost 
closely measures how they perceive their distress at a specific moment of the day. 
Tiredness is defined as an non-specific state which could be part of norm al life.
Holmes developed and validated a measurement instrum ent to assess sym ptom  
distress in cancer patients with 11 items and used a linear analogue scale. Scores 
for each sym ptom  were obtained by simple m easurement (in mm), assigning a
value of 100 to the end of the scale, indicating 'normality' or the absence of 
distress; zero represented extreme distress and higher scores indicated less distress 
from individual items (Holmes 1991). The item fatigue was described as "could 
not feel more tired" at one end and as "I do not feel tired at all" at the other end. 
In a study using this instrument, including 51 chemotherapy and radiotherapy 
patients, the symptom "tiredness" was recognised as the cause of the highest 
distress (significant distress defined as arbitrary cut-off point of 50 mm), followed 
by "appearance", "mood" and "concentration" (Holmes 1991). Tiredness again, 
was not further defined.
Another example of a sym ptom  assessment scale is the Edm onton Symptom 
Assessment Scale, which has been developed for daily use in a palliative care 
population. It consists of 9 Visual Analogue Scales for 9 different sym ptom s 
(Bruera 1991). Interestingly, fatigue is not included as a symptom, even though its 
prevalence is supposed to be high in patients w ith advanced neoplastic disease. 
The dimensions of well-being, drowsiness, depression and activity are included 
and could be seen as indicators or consequences of fatigue. It seems, that fatigue is 
only slowly being recognised and acknowledged as a sym ptom  in its own. 
Another explanation would be, that it has been difficult to influence this kind of 
distress and therefore a nihilistic attitude prevails.
Sym ptom  d istress scales m easure tiredness un id im ensionally  and  give 
information about intensity and impact of tiredness. However, using such a scale 
alone, does not explain w hat the symptom represents. Is it a sym ptom  which 
expresses physical distress or a mood state or both? Furthermore, the definition of 
tiredness needs to be defined for cancer-specific tiredness, as it m ight not be 
comparable to tiredness in healthy individuals.
3.3. REVIEW OF FATIGUE-SPECIFIC MEASUREMENT INSTRUMENTS 
The Rhoten Fatigue Scale
Scales to m easure fatigue specifically have also been developed. The Rhoten 
Fatigue Scale is a 10-point subjective rating of fatigue severity, ranging from "not 
tired, full of energy, peppy" (0), to total "exhaustion" (10). This self-assessment 
scale was used to quantify fatigue in post-surgical patients and results were 
compared with results of an observation checklist, which was concurrently used
by the caregivers to document visible signs of fatigue (Rhoten 1982). It is doubtful 
whether subjective, self-reported fatigue can be compared with observations from 
caregivers, as they m ight impose their own judgem ent and visible signs might 
reflect responses to other distress. As subjectivity of fatigue requires self- 
assessm ent, m easurem ent by caregivers does not appear va lid  enough. 
Furthermore, the continuum of tiredness in post- surgical patients is likely to be 
different from the one in a general cancer population.
The Piper Fatigue Scale
The Piper Fatigue Scale m easures four dim ensions of subjective fatigue, 
tem poral, affective, sensory and severity (among these areas are 41 visual 
analogue scale items that yield a total fatigue score) plus three open-ended items, 
addressing perceived cause, relief measures and associated symptoms (Piper 1992). 
Fatigue is not further defined as a symptom, but its impact on daily living and 
possible indicators are assessed. Physical functioning and emotional feelings, 
possible indicators of fatigue, are addressed. This tool aims at m easuring fatigue 
as a physical state and as mood state, at the time of measurement. It is developed 
from an underlying fram ework of fatigue, which is m ultidim ensional (Piper 
1989). This tool measures intensity, temporal properties and distress but a cancer- 
specific fatigue-continuum  is not defined. It can offer the possibility  of 
recognising indicators and consequences of fatigue and allows calculation of total 
fatigue-scores. It seems to be the most comprehensive fatigue m easurem ent tool 
presently available. The design and selection of the items of the tool were guided 
by clinical experience and by the literature on symptom m easurem ent and of 
fatigue and pain in particular (Piper 1989). It has been successfully tested for 
validity and reliability (Piper 1992). The question of w hat patients m ean if they 
rate feelings of fatigue on the visual analogue scale, however, rem ains unclear. 
As the instrum ent is extensive its use could be helpful in individual assessment 
and care planning, rather than in large epidemiological studies.
Linear Fatigue Assessment Scales
A multiple Linear Analogue Fatigue Scale (LAFS) has been constructed to assess 
fatigue in cancer patients and in healthy individuals over a daily period The 
scales range from " I do not feel tired at all" to "I feel totally exhausted". 
Measurements were performed at the hours 07.00, 12.00, 17.00 and 21.00. The scale
was able to detect specific fatigue profiles over a daily period in healthy persons 
and in cancer patients (Glaus 1993). This scale primarily quantifies fatigue but 
through its repeated use over daily periods, assesses the characteristic impact of 
fatigue in a diurnal rhythm. While healthy persons started their day w ith a 
minimum of fatigue and showed high fatigue levels after work in the evening, 
cancer patients were significantly more tired in the m orning and stayed tired 
during the day, but were somewhat less tired in the evening. These profiles can 
give an im pression of w hether fatigue is a healthy, regulatory response or 
w hether it is a distressing, perm anent symptom. As w ith other instrum ents 
(McCorkle 1978, Holmes 1991) it is not able to assess the severity, nature or 
perception of fatigue. The author got the impression, that exhaustion was not the 
opposite of cancer specific tiredness, but rather the opposite of "no tiredness in 
healthy individuals". This emphasises the fact, that the "unusual tiredness" of 
cancer patients requires clarification of fatigue/ tiredness as a concept.
Kobashi developed a tool with 4 visual analogue scales to investigate malaise in 
95 cancer patients during radiotherapy treatm ent. The scales exam ined four 
components of fatigue. The first dealt with tiredness, with a scale anchored by "I 
did not feel tired yesterday" and "I felt very tired yesterday". The other scale's 
extremes were: "not active" and "very active", "not ill" and "ill", "not well" and 
"well", always referring to the condition of the previous day. These four items 
were considered to indicate a general condition of loss of energy. The scales 
turned out to be highly correlated with measurement of other fatigue symptoms. 
The clinical observation that complaints expressing malaise of cancer patients 
may increase w ithin a few weeks of radiotherapy, was corroborated by a 
statistically significant increase of the scores on a scale containing these four 
simple items (Kobashi 1985). The scale does address the illness /  wellness 
complex as well as the activity dim ension, which in some other tools are 
incorporated, but never measured as main components of fatigue. Only the sub 
scale of the EORTC quality of life questionnaire C 30, as described earlier, 
measures similar aspects, such as activity, illness/wellness, general well-being. It 
m easures tiredness as a non-cancer specific continuum  and looks at related 
components, which could be expressions or indicators of fatigue.
Lastly, these two m easurem ent tools show, that a relationship could exist 
between fatigue, general well-being, activity, quality of life and disease, w ith its 
physical and behavioural consequences. However, the emotional dim ension is
not being addressed specifically, such as for example the impact of sadness or 
anxiety on vigour and fatigue. Neither are the underlying sources or nature, nor 
the continuum of fatigue defined in these instruments.
The Pearson-Byars Fatigue Feeling Checklist
The Pearson-Byars Fatigue Feeling Checklist was originally developed to measure 
tiredness in airmen (Pearson Byars 1956). Individuals are asked to indicate their 
feelings six times a day. The items (phrases) range within a continuum  from 1 
(extremely peppy) to 10 (ready to drop). This instrum ent was created from a 
viewpoint of physiology, considering a healthy continuum from "feeling peppy 
and refreshed", to "feeling extremely tired" and "being ready to drop". The term 
"fatigue" is not being used in this scale, which might represent the characteristic 
nature of tiredness in healthy military persons. Tiredness as assessed here, does 
not seem to be addressed as a mood state and is seen as resolvable by rest, which, 
(as clinically experienced) is not necessarily the case in cancer patients. The author 
himself questions, w hether the checklist is unidim ensional. It seems, that it 
measures mainly intensity of physical tiredness. Pathophysiological aspects of 
tiredness /fatigue are not the underlying hypothesis of this checklist. Weakness 
and malaise are not included. The application of the viewpoint of physiology in 
healthy individuals m ight not be appropriate to investigate fatigue in cancer 
patients. Nevertheless, the scale has been tested in several clinical studies w ith 
comparable reliability and validity estimates ( Freel 1977, Haylock 1979, Jamar
1989). The post-war phraseology from the 1950s have been described as possibly 
outdated and difficult to understand by patients today (Winningham 1994).
The Yoshitake Fatigue - Symptom Checklist
Yoshitake developed a symptom checklist to analyse symptoms of fatigue. Thirty 
symptoms are divided into three categories: A) "dull, sleepy factors", B) "decline 
of working motivation", C) "projection of fatigue in some part of the body". This 
subjective report by individuals was primarily constructed for industrial workers 
in Japan, which explains the choice of its items. It describes a variety of symptoms 
of fatigue and pays regard to physical as well as psychological factors at work. It 
has been tested for validity- and reliability (Yoshitake 1971). Some authors used it 
with cancer patient populations (Haylock 1979, Piper 1989). This instrum ent has 
concurrently been tested in healthy individuals, cancer patients and non-cancer
patients (Glaus 1993). Category A symptoms (dull, sleepy factor) were the most 
frequent in all three sub-populations. A significant difference betw een the sub­
populations could be observed in category B (m ental sym ptom s) and C 
(projections into the body). Selected sym ptom s w ith a significant difference 
between cancer patients and the other subjects were: having a husky voice, being 
unable to straighten posture, becoming w eary while talking, feeling thirsty, 
unsteady while talking, feeling constrained in breathing, being anxious about 
things, feeling ill. Fatigue was presented as "whole body fatigue" in cancer 
patients, bu t as localised muscle fatigue in the healthy w orking population, 
which corresponded w ith an assessment of the spatial distribution of fatigue, 
which was done concurrently in this study. Even though this instrum ent had to 
be translated from English (originally Japanese) into G erm an and has a 
background of physiology (fatiguability in industrial workers), it could still show 
some specific fatigue-problems in cancer patients and distinguish between fatigue 
of healthy and diseased persons. This tool thus successfully distinguishes between 
physical, m ental and psychological fatigue sym ptoms and their expression. 
However, it does not pay regard to the intensity of fatigue, even though the 
frequency of fatigue symptoms could be an expression of its severity. It is not 
cancer- specific and represents fatigue too extensively from the view point of 
physiology in a healthy working population, which m ight not indicate a valid 
description of fatigue in cancer patients.
3.4. JUSTIFYING THE CONSTRUCTION OF A NEW FATIGUE
ASSESSMENT QUESTIONNAIRE:
Evaluating applicability of the reviewed instruments for further
epidemiological fatigue research in cancer patients
Selection of a m easurem ent instrum ent heavily depends on the purpose  of 
measurement and on the population concerned. If fatigue /  tiredness is assessed 
as one of several quality of life aspects or as a symptom among others, a quality of 
life questionnaire or symptom distress scale will be applicable. If the aim  of the 
study is to m easure fatigue specifically, a quality of life questionnaire does not 
apply. In the instruments which have been reviewed, tiredness/ fatigue is mainly 
addressed as the expression of the consequences of fatigue (Izak 1971, Padilla 1983, 
Schipper 1984, Levine 1988, CARES consultants 1988, Celia 1990). These 
consequences could be attributed to causes other than tiredness. For the intended
epidemiological fatigue research, the aim is to measure the actual experience of 
fatigue and not the consequences of fatigue.
The sub scale on fatigue in the EORTC Q30 questionnaire includes four 
important, simple questions which address tiredness directly (Hiirni 1993). This is 
done from a perspective of general well-being and quality of life. However, it 
does not address affective expressions of fatigue. The same attributes apply to the 
malaise-measurement tool developed by Kobashi (1985). The content analysis of 
study 1 (chapter 2) revealed the need for m ultidim ensional m easurem ent at 
physical as well as at affective and cognitive level.
The sub scale on v igour/ fatigue of the Profile of Mood States (McNair 1971) has 
been used and shown to be useful in fatigue-measurement in cancer patients. 
Items on this scale, however, are derived from sources other than from cancer 
patients' experience. Its emphasis on mood reflects its prim ary purpose. Items 
concerning physical expression of tiredness are scarce and therefore this sub scale 
does not apply in the m easurem ent of m ultidim ensional fatigue. Concerning 
valid ity  and reliability, the entire instrum ent has been w idely  tested  in 
populations other than cancer patients.
Many of the symptom distress scales include tiredness as a single item question. 
This restricted approach m easures one dim ension of a variety  of sym ptom  
distress. The concept of unusual tiredness in cancer patients is not defined in this 
context. A defined visual analogue scale w ith a definition of a reliable, cancer 
specific fatigue-continuum is needed to quantify the construct and its distress.
The reviewed perform ance indexes do not m easure tiredness b u t are rather 
indicators of general well-being and activity status. The Karnofsky Index, 
together w ith instructions for its use by care givers, has been show n valid, 
indicating a correlation between tiredness and performance in cancer patients. It 
could be very useful in fatigue- research as an external criterion variable. It also 
could help to distinguish between affective and physical expression of fatigue, 
comparing the Karnofsky Index (physical performance) w ith levels of physical 
and affective fatigue.
The reviewed, general fatigue m easurem ent tools have been developed for 
specific purposes. Therefore, their underlying theoretical fram ew orks differ.
Fatigue-research in industrial workers is based on the concept of physiology and 
needs different phraseology to capture the impact of tiredness on productivity or 
effectiveness; the background of physiology represents a different concept from 
that used as a background to pathophysiology in disease. Fatigue in cancer has a 
different nature, source and impact: cancer patients m ight not feel "refreshed, 
peppy or full of energy" in the morning, in contrast to active airmen, who are 
supposed to feel so after a period of rest (Pearson Byars 1956). The question of 
whether fatigue is a sign of depression, as assessed with the POMS instrum ent 
(McNair 1971), requires different parameters than if fatigue is considered to be a 
physical consequence of biochemical changes from cancer disease. The content 
analysis of study 1 (chapter 2) revealed at least partially different themes in cancer 
patients than those reflected in the items of these general fatigue m easurem ent 
instruments for healthy populations.
The Piper Fatigue Scale, probably the m ost sophisticated m odern  fatigue 
m easu rem en t too l developed  for cancer p a tien ts , g ro u n d e d  in  a 
m ultidimensional framework, measures fatigue from different view points w ith 
an emphasis on consequences of fatigue. This instrum ent might be very helpful 
in assessing consequences of fatigue on activities of daily living in individuals 
concerned and for individual care planning or developing coping strategies. It 
does not, however, include all identified themes from study 1 (chapter 2) and 
does not measure the direct experience of fatigue. The scale on fatigue itself does 
not differentiate betw een norm al and unusual tiredness. W ith its 42 items it 
would represent an unnecessary burden to the patients, as the aim is to measure 
epidemiologically the fatigue experience only.
From the analysis of the currently available instrum ents w hich incorporate 
fatigue it can be concluded, that the underlying theory of the questionnaire, the 
population concerned and the purpose of its use determ ine the selection of 
specific items or tools. None of these instrum ents fully correspond w ith  the 
identified descriptors from study 1 (chapter 2). Additionally, they either m easure 
aspects which are out of the scope for the intended epidemiological research and 
so represent an unnecessary burden for the patients, measure constructs other 
than the experience of fatigue, or they lack a corresponding underly ing  
multidimensional framework which would support content validity.
3.5. CONSIDERING VALIDITY AND RELIABILITY:
ESSENTIALS OF FATIGUE MEASUREMENT
Most of the reviewed instruments have been validated and reliability tested in 
some way. This does not necessarily mean, that they would be valid and reliable 
for use in any further investigation with a different, study population. To use one 
of these tools would run the risk of excluding im portant questions because the 
theoretical framework of the new study poses different questions. It remains to be 
reflected, w hether the research question can be answered w ith  such a tool, 
whether it is sensitive enough or if im portant information from the population 
under investigation may remain undetected by an insensitive m easure .
There is a tem ptation to select desired items or sets of items out of previously 
validated tools. This is, however, not a valid practice (Celia 1990). Selected items 
could, nevertheless, be chosen and validated in new populations. Translation of 
international instruments into a different language would again require validity 
and reliability testing to ensure adequate wording and to pay regard to cultural 
differences. Reliability and validity of a m easurem ent instrum ent m ust be 
established in order to ensure scientific research.
Reliability
A tool can no t be considered valid until it has dem onstrated satisfactory 
reliability. Reliability has been defined as the degree of consistency w ith which 
the instrum ent measures the attribute (Polit and Hungler 1993). Scale reliability 
has also been described as the proportion of variance attributable to a true score of 
the latent variable (De Vellis 1991). The latent variable is the underly ing  
phenom enon or construct that a scale is intended to reflect, it is the actual 
phenomenon of interest. Scale items are necessary because m any constructs can 
not be m easured directly, they are comparable indicators of the underlying 
construct. Scales are reliable to the extent that they are comprised of reliable items 
that share a common latent variable. A scale developed to m easure a latent 
variable is intended to estimate its actual magnitude at the time of m easurem ent 
for each person m easured. This unobservable "actual m agnitude" is the true 
score (De Vellis 1991).
Scale reliability is therefore the proportion of variance attributable to the true 
score of the latent variable. Variability in a set of items can be due to either actual 
variation across individuals in the construct that the scale is intended to measure 
(the true variation in the latent variability) or it can be due to error. Error may 
reflect any remaining or unshared variation in scale scores, for example unclear 
wording, unintended double meaning.
Scale reliability therefore is reflected in internal consistency of the scale items. A 
scale is internally consistent to the extent that its items are highly intercorrelated, 
thus m easuring the same thing, implying strong links betw een items and the 
latent variable (De Vellis 1991). Internal consistency reflects, w hether certain 
items within one test make a difference in the total of scores obtained.
A m ethod to examine internal consistency is to calculate coefficient alpha, 
typically equated w ith Cronbach's coefficient alpha (Cronbach 1951), where all 
possible ways of dividing the measure into two halves are being used. The total 
variation of item-scores is devided in two components: the true scores (true 
difference in patients) and the score differences caused by everything but the true 
difference (error). Computing alpha partitions the total of variance among the set 
of items into true scores and error scores. The proportion of the true scores equals 
alpha, which equals 1 - error variance. A value of .70 has been suggested by 
Nunnally (1978) as lower acceptable bound for alpha, others have described 
values betw een .65 and .70 as m inimally acceptable, betw een .70 and .80 as 
respectable, and between .80 and .90 as very good. It has been cautioned that a long 
scale should be shortened if it shows values above .90, because the reliability of 
alpha increases w ith the num ber of items and longer scales have a narrow er 
confidence interval around it than alpha computed for shorter scales (De Vellis
1991).
However, reliability can not be assumed if Cronbach's alpha is high, as internal 
consistency alone can not guarantee reliability. The replication of the relationship 
between items in a further test m ust be possible (Fox 1995). A part from the 
num ber of items, sample size, the probability level set for detecting error, the 
difference that is considered significant, heterogeneity and other sources, have an 
influence. For the calculation of alpha for items with dichotomous answers, a 
special version of alpha, the Kuder-Richardson formula 20, has been suggested 
(Nunnally 1978).
Other types of reliability compufron to examine internal consistency, involve 
having the same people completing two separate versions of a scale or the same 
version on multiple occasions. If two parallel forms of a scale exist and the study- 
population complete both forms, correlation can be com puted, reflecting the 
alternate forms reliability. A reliability measure of this type is called split-half 
reliability and has the aim to eliminate bias from item order. Instrum ents may be 
split in "first-half last -half" items or in "odd-even" items because several factors 
may influence the reliability of answers, such as fatigue towards the end of the 
instrument, better answering the items as individuals go along (practice effect), 
failure to complete the entire set or things like changes in prin t quality of the 
questionnaire.
Stability of an instrument reflects how constant scores remain from one occasion 
to the other. The assessment of stability through the procedure of test-retest, 
using the same instrum ent in two different occasions, can show reliability 
through computing of a reliability coefficient. This stability test seems appropriate 
for attributes w ith enduring characteristics. Its approach has disadvantages in 
fluctuating states. Fatigue is a fluctuating construct, and therefore stability of a 
fatigue measurement-tool is difficult to be assessed by the test- retest method.
Interrater reliability, also called equivalence, refers to the association of two or 
more judges. This is an issue, if observer-rated tests are used. In fatigue research, 
this approach seems difficult, because the observation might capture responses to 
different things than the phenomenon of fatigue itself. The subjectivity of fatigue 
makes it difficult to be assessed by a person other than the person under study.
A part from internal consistency and stability, other factors m ight influence 
reliability. Clear definition of the role of the investigator and the responder 
during measurement and a standardised measurement procedure seems crucial.
Knowledge of reliability of the instrum ent is useful in the in terpretation of 
research results. If data fail to support a research hypothesis, one possibility might 
be, that the instrum ent used was not representative or unreliable. To use an 
instrument w ithout knowledge of its reliability is taking a large gamble, as there 
is no way of telling how much the results can be trusted and the study results are 
in danger of having to be disregarded.
Validity
Even if an instrum ent has shown to be reliable, there is no guarantee of its 
validity for an intended purpose. The measurement of an attribute of fatigue can 
be consistent, reliable and still not be valid, if the attribute does not really reflect 
fatigue, but something else. Validity refers to the degree to which an instrum ent 
measures what it is supposed to be measuring (Polit and Hungler 1993).
Validity concerning fatigue m easurem ent is connected w ith the question of 
whether what we ask for and measure, represents the phenomenon experienced 
by the patient. Content validity refers to the question of whether the content area 
in a test is representative. This necessarily means, that experts need to analyse 
and judge the item 's adequacy. Concerning fatigue, indicators m ust first be 
defined for use in a cancer patient population. The selection of items in existing 
fatigue measurement tools mostly was guided by clinical experience, professional 
expertise, existing literature, dictionaries and others (McNair 1971, Piper 1992, 
Aaronson 1993). Their seems to be a lack of grounded data on "what fatigue is" or 
"what it feels like" as described by cancer patients themselves. The qualitative 
research m ethod used in study 1 (chapter 2) appeared appropriate  for this 
purpose, as the information presently available is mainly based on sources other 
than the patient himself (Field and Morse 1985). Such grounded data can either 
confirm items in specific tools or reveal that patients from "the real world" feel 
differently.
It could be assumed, that the best experts to identify descriptors of fatigue would 
be cancer patients themselves. As content validity is more difficult to evaluate if 
the domain under investigation is poorly defined, there w ould seem to be high 
priority to enlarge the body of knowledge by studying cancer patients' perception 
of fatigue w ith qualitative research methods. Com parison of expressions of 
fatigue betw een healthy persons and cancer patients could help to clarify 
differences between norm al transitory tiredness and tiredness as a perm anent 
distress in cancer patients.
The establishment of available criteria, w ith which the m easures on the target 
instrum ent can be compared, allows criterion related validity assessment. The 
relationship betw een the scores on the instrum ent and some external criterion 
can support validity. A validity coefficient is computed by using a mathematic
formula that correlates the scores on the instrum ent with scores on the criterion 
variable (Polit and Hungler 1993). While another validated instrum ent could be 
used as external criterion to examine the correlation betw een new tools and 
established  in strum en ts to show  concurren t and  convergen t valid ity . 
Unfortunately, no fatigue m easurem ent instrum ent is available in the German 
language to examine the correlation with a new instrument.
Construct validity refers to the degree to which an instrum ent m easures the 
construct under investigation. In fatigue research, it seems difficult to establish 
construct validity of ah instrum ent, because the concept of fatigue is poorly 
defined. An approach to support the degree of evidence of construct validity 
could be the "known groups technique" (De Vellis 1991) where different groups, 
such as healthy individuals and cancer patients, would be expected to differ on 
the critical attribute and some group differences would be reflected in the scores. 
Construct validity can also be assessed by factor analysis. Factor analysis of a new 
instrum ent could be compared w ith factor analysis of established instruments: 
identification of different factors would provide evidence of discriminant validity 
or the opposite would provide evidence for convergent validity. Factor analysis 
can also provide validity information if a preconceived theoretical framework is 
consistent w ith the factor analytic solution.
Some further pragm atic aspects m ay determ ine validity  of an instrum ent. 
Com pletion of the investigation could be used as eligibility criterion and 
assessment at the end of the study, including drop-outs, is needed to evaluate 
feasibility. The m ethod of data collection, for example interview or self-report, 
m ight im pose m ore or less bias on sensitive item s due to aspects of 
confidentiality. Subject burden has to be considered as fatigued cancer patients 
present a vulnerable population. Lengthy and time consum ing fatigue tools 
might lead to an increase in missing data, which has been described as a major 
problem with the analysis in quality of life data (Smith 1993). The determination 
of the time span for which data are collected for a specific purpose, as well as the 
tim e-point of m easurem ent, is crucial. Another analysis problem  is that data 
from a fatigue m easurem ent tool could be confounded by other factors. Their 
potential impact on the results m ust be delineated and the set of dependent 
variables, the criterion variables, m ust be clearly identified. Specification of 
details of procedures and classification of subjects into identifiable groups are
critically im portant to the conclusions. Sample size requirem ents need to be 
considered, if meaningful research data are to be generated.
An instrum ent is not validated per se bu t rather the application of the 
instrument. If "truth" is to be established in science, knowledge of reliability and 
validity of a measurement instrument is imperative.
3.6. DEVELOPMENT OF A FATIGUE ASSESSMENT QUESTIONNAIRE 
FOR THE USE IN A GENERAL CANCER PATIENT POPULATION: 
METHODOLOGY
The lite ra tu re  review  show ed tha t the available fatigue m easurem ent 
instrum ents did  not fit the in tended research purpose of m easuring  the 
experience of fatigue epidemiologically in cancer patients. They are either 
developed for populations other than cancer patients, do not measure fatigue on 
its own or do not measure the experience but rather the consequences of fatigue. 
Valid inform ation from cancer patients, which reflect the true experience of 
fatigue, is needed to develop a fatigue m easurem ent tool for specific research 
purposes. The qualitative, grounded research approach from study 1 (chapter 2) 
revealed such information and generated knowledge concerning the experience 
of fatigue and now serves as a basis to substantiate or weaken items from existing 
tools and to direct the content of a new fatigue assessment questionnaire. The 
steps in its development are described in the last part of this chapter. They have 
been carried out in accordance w ith the guidelines for scale developm ent, as 
described by De Vellis (1991).
Step 1: Item generation
A patient-as-expert approach was taken, when 20 cancer patients w ith different 
types and stages of disease explained w hat they felt, w hen they experienced 
tiredness /fa tigue . The interview s were unstructured  w ith the aim  of not 
imposing already existing descriptions. Only one guided question w as asked 
concerning occurrence of weakness and malaise, if this was not m entioned 
spontaneously in the interview. This was done because it rem ains unclear, 
w hether weakness and m alaise are the same phenom ena as tiredness. Data 
saturation w as well achieved after 20 interviews. After transcrip tion , the 
interviews were content analysed (chapter 2). Sixteen themes could be recognised:
Decreased physical performance, w eakness/ no strength, unusual need for sleep 
unusual tiredness, unusual need for rest, decreased motivation, need to force 
oneself to overcome inactivity, no energy, sadness, anxiety, no fighting spirit, 
lack of concentration, problems in thinking, tired in the head, sleeping problems 
at night. Malaise was recognised by only two of 20 patients, while weakness was 
mentioned spontaneously by most of them (by 17 out of 20).
These 16 themes were expert statements from the persons concerned and thus 
valid descriptions of tiredness in this general cancer population. In the next step, 
it had to be examined, w hether these experiences really were different from 
experiences of a healthy population. Twenty healthy individuals described their 
experience of tiredness w ith the same methods of data collection and analysis. 
Again, only one guided question was given concerning occurrence of weakness 
and malaise, if it was not m entioned spontaneously in the interview . Data 
saturation was well achieved after 20 interviews (described earlier). Fifteen 
partially different themes could be recognised:
Tiredness after a days work (diurnal, as rhythmic normality), tiredness as a 
pleasant phenomenon (after exercise), wishing to go to bed (or to lie down, to rest, 
silence), becoming slower, having heavy limbs, feeling exhausted (or worn-out, 
can not do anymore), loss of energy, feeling depressive, w anting to w ithdraw , 
feeling impatient, loss of concentration (or forgetting easily, loss of attentiveness), 
difficulty to speak, sleepiness, thoughts going around in the head, w ishing to 
switch of.
Malaise was experienced by only two of the 20 healthy individuals and weakness 
was experienced by none of them.
Step 2: Reduction of redundant items
The items should capture the essence of the construct fatigue/tiredness and 
reflect overt m anifestations of this latent variable. The scales purpose was to 
measure these manifestations. The total of 31 items from the two study  sub­
populations could be reduced to a total of 22 items. This was due to overlapping 
items in the two groups ( sadness, loss of interest, need for rest, malaise). 
Problems in thinking, speaking, tired in the head were sum m arised under 
difficulties to concentrate. Loss of fighting spirit and decreased m otivation were
summarised under the item loss of interest (the word motivation was considered 
difficult to be understood by the population under study). Tiredness after a 
working day and pleasant tiredness after physical exercise were pooled due to 
their common nature.
Redundancy here m eant to reduce item s w hich were sim ilar, unclear or 
seemingly irrelevant. The extraction of the items from interviews w ith  patients 
concerned, supported validity in most of them. The length of the questionnaire 
had to be considered. The shorter a scale, the less burden it places to respondents. 
Nevertheless, brevity tends to reduce reliability and the optimal trade-off between 
brevity and reliability had to be considered (De Vellis 1991).
Step 3: Building categories of themes /items:
During content analysis of the interviews and identification of expressions and 
descriptions of tiredness, the emerging themes increasingly seemed to fit into 
three categories of physical, affective and cognitive expression of fatigue (chapter 
2). Current literature seems to use items which are derived from physical or 
affective or cognitive origin, bu t only the m easurem ent tool developed by 
Yoshitake (Yoshitake 1971) has made a distinction between "dull sleepy factors", 
decreased motivation" and projection of fatigue feelings into the body. This 
theoretical perspective does not explain anything concerning the cause of the 
phenomenon. Nociceptors might be cancer specific, while the perception and the 
expression might be dependent on personality, history and supporting network. 
Results of the interviews led the researcher to build subgroups of items which 
pay regard to different expressions of fatigue at physical, affective and cognitive 
levels. These different levels could also be called different facets of the construct 
under study. Fatigue /tiredness here showed different facets and it seemed 
important to differentiate between different facets of tiredness and other different 
constructs. It had to be kept in mind, that all items should m easure the same 
latent variable (De Vellis 1991).
Step 4: Comparison of identified items w ith items in the reviewed literature
The items of the sub scale on "Vigour/ Fatigue" of the Profile of Mood States 
(McNair 1971) include the themes worn-out, fatigued, exhausted, which were also 
identified in the interviews. The EORTC quality of life questionnaire sub scale on
fatigue (Hiirny 1993) includes the items weakness, physical unwellness, tiredness, 
need for rest, as also identified in the interviews. The Piper fatigue scale (Piper
1992) includes some of the identified items but mainly measures consequences of 
fatigue, which is not the primary target for further, planned studies. The same is 
the case in the other quality of life questionnaires, ability- or performance indexes 
reviewed; apart from the item "felt low in energy or no energy", which also was 
identified in the interviews, no further description of fatigue itself was identified. 
The scale described by Kobashi (Kobashi 1985) includes the them es tiredness, 
activity, illness and wellness. The Pearson-Byars Fatigue checklist (Pearson Byars 
1956) only has one item in common w ith the descriptions in the interviews, 
which is "extremely tired"; the others, ranging from the continuum  "bursting 
with energy" to the one "ready to d ro p / dead tired" seem of different nature 
compared to those identified by cancer patients. The Yoshitake Symptoms of 
Fatigue Checklist (Yoshitake 1971) also assesses several sym ptom s concerning 
difficulties w ith  concentration (heavy head , difficulty  in th ink ing  and 
concentrating, difficulty to pay attention) and affective expressions (anxiety, 
impatience), as well as the illness feeling, which have also been identified in the 
interviews.
The symptom distress scales reviewed, merely used the anchor-words "not tired 
at all" and "exhausted or could not feel more tired". In contrast to that, the 
patients in study 1 (chapter 2) spoke about extreme, unusual tiredness.
Step 5: Identification of new items from the interview-study
Com parison of items in the reviewed literature and items identified in the 
interview -study (chapter 2), showed partial correspondence. The rem aining 
items /  themes from the interviews, which were not found verbatim in the other 
instruments, were decreased physical performance, sleepiness at day time, need to 
force oneself to overcome inactivity, unusual need for sleep, becoming slower, 
w ishing to switch off thoughts, sadness, w ishing to w ithdraw  and sleeping 
problems at night. The item pleasant tiredness after a hard day's work or after 
physical exercise, which was identified in the interview -study w ith healthy 
individuals, was not found in other instruments either.
3.7. SCALE CONSTRUCTION
Step 6: Questionnaire design
Determine the method: justifying self-assessment
Due to the subjectivity of fatigue, a self-reporting m easurem ent approach was 
selected. Because of the subjective nature  of sym ptom  distress, the "gold 
standard", has been said to be an assessment by the patient himself (Bruera 1991). 
Distress is perceived as subjective reality by the patient himself and has to be an 
accepted fact for caregivers. Fatigue-measurem ent has sim ilarities w ith pain- 
assessment, where it has been described to be a prerequisite for treatm ent to 
respect the statement: "pain is whatever the patient says it is, whenever he says it 
is" (Me Caffrey 1979). Doctors and nurses can only suspect the intensity of fatigue 
or observe signs or symptoms, which might be expressions of or responses to 
fatigue.
Determine the m ultitude of dimensions
The interviews revealed that tiredness /  fatigue was experienced in more than 
one dimension (chapter 2). Multidimensionality requires m easurem ent from the 
viewpoint of its distress or negative impact on quality of life (Calmann 1987). 
This criterion was respected w ith the integration of questions concerning the 
dimensions of physical, affective and cognitive fatigue. Two additional linear 
analogue scales were constructed to explore the dimensions of quantity of fatigue 
and its severity (distress). The anchor words for the tiredness scale included "I do 
not feel unusually tired" and "I feel completely exhausted". This definition of the 
continuum  was developed from the w ords expressed in the interview s w ith 
cancer patients and makes a clear distinction between tiredness as norm al life 
experience and tiredness as unusual experience.
Determine response categories and format for measurement
The selection of the response categories was based on the aim to discrim inate 
differences in the underlying attribute. As the instrument had to be easy to fill in 
and as preven tion  from unnecessary bu rden  had  to be considered , the
dichotomous "yes/ no" form at was used. This form at allows non-am biguous 
answers and forces the respondent to make a clear decision. Concerning the 
tiredness items of the questionnaire, it was intended to receive a clear indication 
of whether the different items were part of the construct of fatigue, which would 
be favoured by the yes/no  answer. Even though variability is a desirable quality 
of a measurement scale (De Vellis 1991), variability concerning each item was not 
given highest priority in this case. Variability was expected to be m easured by 
summing up the items in future tests.
For the included scales to measure unusual tiredness and its distress, the format 
of the Visual Analogue Scale (VAS) was chosen. High variability was necessary to 
sensitively m easure its quantity. Even though the interpretation of physical 
space, as it relates to values of the continuum, m ight be very subjective, VAS 
have been considered very helpful in the m easurem ent of quality  of life 
(Bindemann 1987). As tiredness is a very subjective phenom enon, a very 
sensitive m easurement tool seemed adequate.
Subject burden and feasibility had to be considered cautiously because the 
investigation had to be carried out in a vulnerable, possibly tired population. To 
be acceptable to ill persons, fatigue-assessment tools m ust be short and easy to fill 
in. Reducing subject burden and research-induced fatigue m ust be considered 
(Piper 1993). However, if a tool m easures a composite of distinct factors, a 
distinction in correlation data m ust emerge, if not it could be argued, that the 
instrument is little more than an elaborate way of asking "how do you feel?" Low 
subject burden is being provided by the use of the single item approach, which is 
a critical issue, when attentional fatigue may be present (Winningham 1994). This 
is especially true, if repeated measurement is needed. Tools need to be simple, 
effective, bu t not expensive, not time consum ing and no t exhausting for 
debilitated patients. Q uestionnaire length is therefore a critical aspect and 
redundancy of overlapping themes m ust be considered. Feasibility also concerns 
the reading level and easy understanding of the instrum ent by persons w ith a 
considerable range of educational background seems crucial.
Selection of the Time span
The questions concerned three time frames: today, last week and last m onth. A 
variety of time spans was reported in the reviewed literature, ranging from right
now, today, yesterday, last week, last fortnight and last m onth. During 
chemotherapy, a distressing symptom might occur in the first days of application, 
whereas in a period of rest during which a patient recovers from short time 
effects, it might be different. Which period should be reported: the rest period, the 
treatm ent period - or both? (Van Dam 1984). It has been suggested, that a 
theoretical justification for limiting the time span can be based on the distinction 
between state m easures (how people feel, react at a particular moment, given 
time frame) and trait measures (how people feel, react in general, w ithout time 
frame). The essence of a trait measure is stability over time, state m easures are 
expected to fluctuate w ith conditions that affect the relevant construct under 
investigation (Huismann 1987). Shorter time frames are recom m ended in the 
use of assessment of treatment-related toxicity at a particular moment in order to 
m inimise potential confounding by the trait disposition of the individual. 
Current literature reveals, that the issue of time span has received relatively little 
attention. For the purpose of this study, the time frames "today, last week and last 
month" were selected. This decision takes into account that there m ight be 
changes over short tim e-periods, such as tiredness due to chem otherapy, but 
there might also be tiredness due to tum our activity over longer periods of time. 
It also takes into account, that memory effects play a role: it seems easier to 
remember today or yesterday than last month. Conversely, experience shows that 
tiredness can become a chronic state, which could have similarities w ith aspects 
of trait, such as stability over time.
3.8. OUTCOME:
THE FATIGUE ASSESSMENT QUESTIONNAIRE (FAQ)
At this stage, a list of 22 questions, developed from the 22 items selected from the 
interviews, was generated. The ordering of the questions followed according to 
the frequency w ith which items had been mentioned by the interviewees. The 
closed-ended, dichotomous (yes/no) questions were constructed in a w ay that 
they could easily be answ ered by self-assessment. W ording w as carefully 
monitored for clarity, sensitivity, brevity, freedom from bias (such as for example 
including more than one idea) and reading level. Questions were related to the 
three time frames "today", "last week", "last month", so that each question w ould 
receive three answers by circling "yes" or "no". In addition to that, tiredness was 
assessed quantitatively w ith Linear Analogue Scales (LASA) for the time frame
"today, last week, last month" and one further LASA was used to assess whether 
this tiredness was perceived as a distress during the time being measured. This 
distress of tiredness was considered to be a global assessment of the severity 
impact of fatigue. The questions and the measurement of unusual tiredness by 
LASA were accompanied by short, written instructions on how to use them. The 
first version of the Fatigue Assessment Questionnaire (FAQ) is presented in 
Appendix 1 (in German and translated from German into English).
Further ongoing research can only be successful w ith reliability and validity 
tested instrum ents. Results of such a validation study w ould guide further 
development of the instrument, allow adaptations and help to improve validity 
and reliability. Unbiased measurement could then offer a key to the development 
of therapeutic nursing, medical or psychological support measures.
At this stage, the FAQ was ready to be analysed and tested in a validation study. It 
was planned to use it in cancer patients and in healthy individuals. Among the 
healthy individuals, medical research experts were planned to be involved in 
order to test the use of the questionnaire and to comment on it. These next steps 
are described in chapter 4.
CHAPTER 4
STUDY 2
TESTING THE FATIGUE ASSESSMENT QUESTIONNAIRE (FAQ)
IN HEALTHY PERSONS AND IN CANCER PATIENTS
4.1. INTRODUCTION
In the past decade, measurement of fatigue has become an im portant quality of 
life issue, especially in the field of nursing (W inningham 1994). Lack of 
clarification of the concept has led to difficulties in its m easurem ent. Studies 
about prevalence, correlates and possible causes are difficult to compare due to 
the methodological differences (Piper 1993). A review of currently  available 
fatigue m easurement instruments has led to the conclusion, that for the purpose 
of epidemiological research w ith aims to measure the experience of fatigue in a 
general cancer patient population, no valid instrument was available. Previously 
conducted, unstructured interviews with cancer patients and healthy individuals 
(chapter 2) therefore formed the basis for the analysis of the descriptors of fatigue 
from the perspective of those concerned. These descriptors were compared with 
items in available instrum ents and then used to construct a self-report Fatigue 
Assessment Questionnaire (FAQ). Construction of this scale has been described in 
chapter 3. As research can only be successful with reliability and validity tested 
instruments, the FAQ now needs to be scientifically tested.
4.2. AIM OF THE STUDY
It was the aim of this study to test the new Fatigue Assessment Questionnaire 
(FAQ) in relation to reliability and validity, feasibility and acceptability and to 
further generate knowledge concerning the concept of fatigue in cancer patients.
4.3. STUDY DESIGN, SETTING, POPULATION AND SELECTION
A non-randomised, explorative, prospective design was used to test the fatigue 
questionnaire in healthy individuals and in cancer patients. The inclusion of a 
sub-population of healthy individuals could be described as a quasi-experimental 
design, as they served as a base line sub-population in order to distinguish
between healthy and diseased individuals. With a cross-sectional design, the 
phenomena under investigation were captured as they manifested themselves at 
the period of data collection and were related to external variables. A descriptive 
and correlational approach was used to portray  the characteristics and to 
investigate interrelationship among variables of interest.
Study setting and population
The study was conducted at the Department of Internal Medicine C (Oncology, 
Haematology, Gastroenterology) of the Kantonsspital St.Gallen, Switzerland, a 
900-bed teaching hospital. Subject accrual took place from March to June 1995.
The study population included two sub-populations:
1) 77 healthy individuals, working in the hospital setting as nurses, doctors, 
technicians, secretaries, volunteers.
2) 77 consecutive cancer patients, who came to the hospital for treatm ent and 
care.
Selection/ entry criteria
The healthy sub-population was selected according to availability  in the 
environment of the researcher in the hospital. Criterion for being classified as 
healthy was the ability to perform fully and as usual at the job setting and in the 
personal env ironm ent, w ith o u t d isease-induced  lim ita tion . To assu re  
representativeness of the healthy sub-population and to fulfil the criteria of 
homogeneity, age and gender were controlled. Subjects also had to be able to 
understand and read the German language.
The sub-population w ith cancer patients was selected according to their 
availability in the departm ent. For the period of accrual, every incom ing 
inpatient w ith known neoplasia was considered for investigation, if possible 
within the first three days of admission to pay regard to changes due to further 
treatment or deterioration. In the outpatient department, subjects were selected 
on one of each week-days (five full days) in order to avoid selection bias by 
selection of specific patient-groups w ho were scheduled on specific days.
Representativeness of this sample was given as it included a general cancer 
patient population.
Criteria for exclusion from the study were: not yet histologically confirmed 
neoplasia, cognitive impairment, known brain metastasis, psychiatric disorders, 
not understanding/ reading the German language.
4.4. METHODS
Instrum ents
The Fatigue Assessment Questionnaire (FAQ)
The Fatigue Assessm ent Q uestionnaire (FAQ) for self-assessm ent (German 
version) was used to assess expression, quantity and distress of fatigue w ithin the 
time spans "today, last week, last month". The questionnaire m easures the 
physical, affective and cognitive expression of fatigue with 22 items and quantity 
and distress of fatigue with linear analogue scales. As the purpose of use of the 
FAQ was epidemiological fatigue research, items had dichotomous answers (yes/ 
no), which was expected to result in clear cut decisions by the patients. The first 
version of the FAQ is presented in Appendix 1 (in German and in English).
The Hospital Anxiety and Depression Scale (HADS)
This scale was used at the same time to assess the items within the time span of 
"last week". This scale was originally developed to detect anxiety and depression 
in medical patients. Concepts of emotional and physical illness are separated and 
evidence was presented that the scale scores were not affected by the presence of 
bodily illness (Zigmond 1983). The scale has been translated into the German 
language and reliability and validity has been established with success (Herrmann 
1991). The scale includes 7 items concerning depression and 7 items concerning 
anxiety. This instrument was chosen because of its ability to distinguish between 
emotional and physical symptoms, which is especially im portant in a population 
with cancer. The aim was to detect anxiety and depression as separate concepts in 
relation to tiredness and to assess their correlational occurrence.
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The Karnofsky Index
For the sub-population of cancer patients, the Karnofsky index was assessed by the 
investigator. This numerical scale from 0 to 100 represents the patients ability to 
perform normal activity, the ability to do active work and the need for assistance 
in activities of daily living (Karnofsky 1949). It has been widely tested and used for 
making clinical decisions in the treatment of cancer (Schag 1984). This index was 
expected to show correlations between activity status and tiredness.
Patient characteristics: socio-demographic, health related and medical data
Patients and healthy individuals were asked to fill in a questionnaire concerning 
socio-demographic and health related data: Date and place of investigation, 
initials, age, gender, profession, ability to work, marital status, regular intake of 
m edications. Concerning health status, subjects responded to the question, 
whether they 1) were healthy, 2) were healthy but suffered from acute disturbance 
(e.g. influenza), 3) suffered from a chronic disease and if this was the case, from 
which disease.
For the sub-population of cancer patients, additional, medical data were collected 
by the investigator: type of tumour, stage of disease, tumour-activity, treatm ent 
and kind of treatm ent at the time of the investigation and within the last 6 weeks 
(none, chem o-, horm one-,im m une-therapy, rad io therapy , surgery), o ther 
medications and in-/outpatien t status. These data were expected to be useful to 
detect correlations between tiredness and external variables in cancer patients.
Procedure
Before the start of data collection, the investigator had to train  the research 
assistant concerning the application of the self-assessment instrum ents (how to 
fill in, sequence of application, time frames required,) and how  to use the 
Karnofsky scale, which revealed the need for guidelines, as had been described by 
Schag (1984). Careful briefing was expected to avoid introduction of bias.
The first 5 patients served as pilot-users to test the comprehensibility of the new  
questionnaire and to assess the feasibility of the instruments in this population. 
Little adaptations had to be made. This also was the case in the forms concerning
socio-demographic data and medical data collection and referred especially to 
questions of coding, the translation of data into categories of num eric form, to 
ensure easy transfer from w ritten documents to com puter files for statistical 
analysis.
Questionnaires were coded with numbers to provide for confidentiality. The first 
20 questionnaires w ere sent to healthy individuals, all of them  leading 
physicians, most of them involved in research. They were not only asked to fill 
in the instrum ents bu t w ere invited  to share their experience of the 
questionnaire and to comment on it. This was done in order to get a judgem ent 
on the structure and comprehensibility of the tiredness-questionnaire from a 
view point of users-as -scientists. Three of them wrote a helpful com m ent (2 
adjectives in a question, questioning m eaning of words). The other healthy 
subjects were approached individually, apart from a group of nurses (20 nurses) 
who were instructed in a group session.
Cancer patients were approached individually in the outpatient departm ent or at 
the bedside by the researcher, according to the selection criteria. They were first 
asked for their willingness to participate and for oral consent. Patients were 
assured confidentiality in the sense that only the researcher would have access to 
the data and be able to identify the person. The purpose of the inquiry was then 
explained and instructions were given on how to fill in the questionnaire and in 
which order to do it (first the fatigue questionnaire, the HAD Scale, followed by 
the dem ographic data sheet). This ordering of the instrum ents w as chosen 
because socio-demographic data m ight anti-m otivate people for the inquiry. 
Most of the patients were then left alone to complete the instrum ents, which 
were picked up later. At this occasion, open questions could be answered and the 
questionnaire was screened for missing data and patients asked, w hether these 
were left out by purpose. This method of data collection is said to ensure a high 
response rate, accurate sam pling and a m inim um  of interview er bias, while 
perm itting interviewer assessments, providing necessary explanations and giving 
the benefit of a degree of personal contact (Oppenheim 1992).
Statistical analysis
Data were transferred from w ritten docum ents to a data base (File maker). 
Statistical analyses were perform ed with the statistical program  SAS, w ith  the
exception of the Cronbach alpha correlation coefficients, which were calculated 
w ith STATA 3.2. Descriptive statistics were used to classify data and to give 
information about the characteristics of the study population. For statistical 
analysis, the dichotomous answers in the tiredness questionnaire first required 
coding. Fisher's 2-tailed Exact Test, was used to test differences in proportions in 
2 x 2  contingency tables form ed by cross tabulation of item s from  the 
questionnaire w ith  health-status (healthy persons versus cancer patien ts, 
univariate discrim ination). The Phi C orrelation Coefficient (preferred for 
dichotomous variables) was used to examine the m agnitude of the association of 
health status w ith the items of the questionnaire for the three different time 
spans of their measurement (Polit and Hungler 1993).
Logistic regression (preferred if nominal measurement is involved) was used to 
analyse the relationship between items (multivariate discrimination) and health- 
status and to determine redundant items. Logistic regression is a m ethod used to 
predict or explain the values of one variable in terms of the remaining variables 
(Nigel 1993). P-values for the results of logistic regression were calculated using 
the Wald-Chi squared test.
Construct validity of the instrum ent was examined by factor analysis (results 
from varim ax rotation, prom ax rotation as well as procrustes rotation). By 
construct validation it is attem pted to ascertain if the relation betw een the 
variables m easured is consistent w ith prior expectations on the basis of an 
underlying theory of the aspects investigated (Jones 1987). Factor analysis is used 
to disentangle complex interrelationship among variables and identifies which 
variables go together as unified concepts or factors. It is described as a method for 
exam ining dim ensions of complex characteristics and used as an heuristic, 
hypothesis-generating technique (Bortz 1985). Internal consistency of the 
tiredness questionnaire w as exam ined using Cronbach A lpha correlation- 
coefficients.
The Wilcoxon test (used instead of t test, because of skewed data) was used to test 
for differences between healthy and diseased individuals concerning m edian 
scores of fatigue and fatigue-related distress and m edian scores from the HAD 
scales. The Pearson Correlation Coefficient was used for the correlation between 
intensity of tiredness and its distress, Karnofsky Index (interval scale) and the 
HAD Scales (ordinal scales). To examine criterion related validity, tiredness was
compared betw een healthy and diseased individuals w ith the Wilcoxon test. 
Differences in proportions concerning items of the HAD scales in healthy and 
diseased individuals were tested with the Chi squared test and estimated w ith Phi 
coefficients, differences of location were assessed with the Wilcoxon test. Content 
validity was supported by the fact, that the questionnaire items had been collected 
in open ended interviews with cancer patients and healthy individuals and that 
these interviews had been content-analysed according to a grounded theory 
approach until data saturation was achieved ( Field and Morse 1985).
Ethical approval /  patient consent
The study was approved by the ethical committee of the Kantonsspital and by the 
medical and nursing director of the department. Patients and healthy individuals 
were asked for oral consent to be involved in the study. Confidentiality was 
respected by coding of the questionnaires.
4.5. RESULTS
Characteristics of the healthy individuals
One hundred and five healthy individuals were asked to participate in the study. 
N ineteen did  not send back the questionnaire, 86 w ere re tu rned , w hich 
represents a response rate of 82%. Nine of them  were not eligible for the 
follow ing reasons: re tu rn ing  em pty questionnaire (4), no health -re la ted  
inform ation given (2), cancer (1), m issing data (2). Eventually, 77 healthy 
individuals were eligible for the study, which represents eligibility of data in 90%. 
Table 4.1. presents the characteristics of the sub-population w ith  healthy 
individuals. Females and males were equally distributed. Fifty-six percent of the 
healthy individuals were females, 44 percent males. Mean age was 54 years 
(Standard deviation 12.82) (range 18-76). Eight out of the 77 healthy individuals 
suffered from a chronic health disturbance, other than cancer. All 77 subjects of 
this sub-sample considered themselves as in a healthy condition. Assessment of
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Table 4.1. Characteristics of the sub-populations
cancer patients 
(N=77)
healthy persons 
(N=77)
Gender female
m ale
48%
52%
56%
44%
Age m ean
range
53 y. (SD 15.77) 
17-78
54 y. (SD 12.82) 
18-76
M edications
(others than cancer drugs)
23%
Karnofsky Index 100 
80-90 
below 80
30%
56%
14%
Diagnosis lung cancer 12% 
breast cancer 16% 
lym phom as/leuk. 30% 
gastrointestinal cancer 19% 
other tumours 23%
Disease State distant metastasis 
regional metast. 
disease free
75%
14%
11%
T reatm ent chem o-therapy
horm one-therapy
im m une-therapy
radio-therapy
surgery
81%
9%
5%
8%
1%
Status inpatien t
outpatient
43%
47%
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medication-intake revealed that few individuals used psycho tropic drugs (3%), 
sleep medication (1%), pain medication (1%). Twenty-three percent of this sub­
population used however, some other type of medication.
Characteristics of the cancer patients
Ninety-eight cancer patients were asked to participate in the study; 9 of them 
rejected, 3 did not return the questionnaire, which represents a response rate of 
87%. Nine patients did not qualify (problems of language (3), w orsening 
condition (4), unclear diagnosis (1), cognitive inability (1). Seventy-seven cancer 
patients were finally eligible, which represents eligibility of data in 88% of the sub 
population.
Table 4.1. also presents the characteristics of the cancer patients. Females and 
males were equally distributed. Forty-eight percent of them were females, 52% 
were males. Mean age was 53 years (Standard deviation 15.77, range 17-78). Cancer 
diagnoses were classified into lung cancer, breast cancer, lym phom as/leukaem ia, 
gastrointestinal cancers and other solid tumours. The Karnofsky Index was 100 in 
30% of the patients, 80-90 in 56% and below 80 in 14%. Seventy-five percent 
suffered from systemic disease, 14% from regional disease and 11% were w ithout 
tum our evidence. Fifteen of the 77 patients (19%) had no treatment. Eighty-one 
percent received cancer treatm ent, including chemo-, horm one-, im m une- 
therapy and radio-therapy at the time of investigation and only 1% had surgery 
within the last 6 weeks. Fifty-seven percent of the cancer patient sub-population 
were treated in the outpatient department, 43% were hospitalised.
Individuals needed approximately 15 minutes to complete the study forms. Most 
of them did it independently, only a few patients needed some assistance.
Univariate discrim ination of the questionnaire-items 
between the two sub-populations in three time spans
The 22 items of the tiredness questionnaire were examined according to the three 
time spans "today”, "last week" and "last month" and were statistically analysed 
using the Fisher's 2-tailed Exact test, to discriminate responses from healthy 
individuals from those of cancer patients. Results are presented in Table 4.2. . For 
the time span "today", highly significant differences (P <0.01) were found between
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healthy persons and cancer patients for the items decreased physical performance, 
unusual, extreme tiredness, weakness, sleepiness at day time, unusual need for 
rest, fight to overcome inactivity, becoming slower and loss of energy, loss of 
interest and general unwellness. Weak significance (P <0.05) was found for the 
items pleasant tiredness, heavy limbs, impaired attentiveness, unusual need for 
sleep, wish to switch off thoughts, sleeping disorders. No significant difference (P 
>0.05) was found for the items exhaustion, im paired concentration, sadness, 
feeling impatient, anxiety and wish to withdraw.
Comparing the time span "today" w ith the time span of "last week", only two of 
the weakly significant items change: pleasant tiredness and sleeping disorders 
become significant for "last week" (from weakly significant for "today"). The 
items anxiety and impaired concentration became weakly significant (P<0.05) for 
"last week" but were not significant for "today". The items heavy limbs, impaired 
attentiveness and wish to switch off thoughts became non-significant for "last 
week" bu t were weakly significant (P <0.05) for "today". Four further items 
remained non-significant for the time span "last week".
Comparing the time span of "last week" with the time span of "last month", only 
one of the significantly different items changed: anxiety increases in significance 
for "last month". The item sleeping disorders was weakly significant for "last 
week" but not significant for "last month". The items im paired concentration 
and sleeping disorders lost significance for the period of "last m onth", in 
comparison with "last week", as they were for the time span "today".
Items with no change over the three time spans
Decreased physical performance, unusual tiredness, weakness, sleepiness at day 
time, unusual need for rest, fight overcoming inactivity, becoming slower, loss of 
energy and general unwellness remained highly significantly different between 
healthy and diseased individuals through all three tim e spans (P <0.01). 
Significance was found in all three time spans for unusual need for sleep (P < 
0.05). No difference between healthy and diseased individuals in all three time 
spans was found for the items exhaustion, sadness, feeling impatient and wish to 
w ithdraw (P>0.05).
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Magnitude of the association between health status with items
Examining the m agnitude of the association of health status with the items of the 
questionnaire for the three time spans, rather modest Phi coefficients were found 
(Table 4.2.). Moderately high (above 0.40) are those of the items decreased physical 
performance, weakness, fight overcoming inactivity, becoming slow and loss of 
energy. Moderately low ( under 0.20) were the items pleasant tiredness (minus 
values), exhaustion, heavy limbs, attentiveness, concentration, sadness, feeling 
impatient, anxiety and wish to withdraw.
Logistic regression of the questionnaire - items 
in the two sub-populations in three time spans
Logistic regression was carried out to analyse the relationship between the items 
and to detect redundant items. Results are presented in Table 4.3. . From the 22 
item s, 11 rem ained significantly different betw een healthy  and diseased 
individuals at a significance level of 0.20 for the time span of today, 10 for the 
time span of last week and 12 for the time span of last month. The items pleasant 
tiredness, decreased physical performance, weakness, fight to overcome inactivity 
and becoming slower remained significant over all three time spans. The items 
unusual, extreme tiredness, unusual need for rest, im paired concentration, 
unusual need for sleep, w ish to switch off thoughts and general unwellness 
showed no significant discrim ination from other items, they rem ained non­
significant over all three time spans. Due to their conceptual importance, these 
items were retained for further analysis. As the item  "wish to sw itch off 
thoughts" had shown only weak difference for today in the univariate analysis 
and now showed no difference in the multivariate analysis, it was considered to 
be deleted for further analysis.
Investigation of the three time spans measured
Results from 77 cancer patients
In the sample w ith cancer patients, the Phi Coefficient was calculated for all 
questionnaire items and cross correlation of the time spans to d ay /la s t week, 
today/last month, last w eek/last month were calculated in order to examine the 
influence of the time frame on items. Results are presented in Table 4.4. . Cross 
correlation between today and last week showed that 16 items had a correlation
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between 0.70 and 0.96, w ith loss of interest and becoming slower being ranked 
highest. Five items, exhaustion, feel impatient, anxiety, loss of energy and wish to 
withdraw, showed a correlation coefficient between 0.50 and 0.69 and only 1 item, 
sadness (0.33), was under 0.50. Cross correlation between today and last m onth 
showed only the 5 items heavy limbs, weakness, becoming slower, w ish to 
switch off thoughts, and loss of interest, w ith a correlation coefficient between 
0.70 and 0.77, 12 items between 0.50 and 0.69 and 5 items, exhaustion, sadness, 
feeling impatient, unusual need for sleep and anxiety, under 0.50. For the cross 
correlation between last week and last m onth, 12 items showed a correlation 
between 0.70 and 0.85,10 items between 0.50 and 0.69 and no item under 0.50.
Factor analysis of the questionnaire items:
Exploring the theoretical concept of fatigue in cancer patients
Questionnaire items were examined for their relationship among each other and 
for identification of unified concepts, using factor analysis followed by varimax 
rotation. Results are presented in Table 4.5. (factor-related items printed in bold). 
Three factors and 7 single factor- items were identified. Factor 1 comprised 6 
items, presenting predom inantly physical tiredness aspects such as decreased 
physical performance, weakness, sleepiness at day time, unusual need for rest, 
fight overcoming inactivity and loss of interest. Factor 2 comprised 5 items with 
affective and cognitive aspects, such as im paired concentration, im paired 
attentiveness, sadness, feeling impatient and anxiety. Factor 3 comprised 3 items 
which presented a different kind of physical tiredness, such as pleasant tiredness, 
exhaustion and heavy limbs. Seven items were not identified w ith one of the 
three factors, even though their factor loadings were highest among factor 1, apart 
from becoming slower which had higher loadings in factor 2. The item wish to 
switch off thoughts was deleted for reasons described earlier.
A confirmatory factor analysis (procrustes rotation) was done additionally in 
search of support for the researchers previous tentative theoretical framework of 
tiredness. Results did not differ essentially from those obtained by varim ax 
rotation.
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Theory development
Relating results of the factor analysis to the researcher's previous concept of 
fatigue
Prior to factor analysis, the researcher had developed a theoretical framework to 
explain the expression of tiredness in cancer patients. The framework constituted 
of three types of expression, namely physical, cognitive and affective tiredness, as 
it had been suggested by the results from earlier described, qualitative research. 
This concept is presented in Table 4.6. . Reliability coefficients (Cronbach alpha) 
were calculated for the sub scales of the original concept, which was 0.82 for the 
physical, 0.69 for the cognitive and 0.69 for the affective expression of tiredness. 
This framework only partially complied with the items in the sub scales from the 
factor analysis (Table 4.6.). Items from factor 1 (r=0.84) mainly equalled physical 
expression related to the functional capacity of the body. The items of factor 3 
(with unsatisfactory Corr. coeff. of 0.47) also represented some kind of physical 
tiredness, rather physical sensations or feelings. Items of Factor 2 (r=0.63) could 
partially be allocated to cognitive and affective tiredness of the original concept. 
Single items appeared to be linked with all three levels of expression.
Attempting to synthesise results from factor analysis with professional 
judgem ent
The researcher's previous theoretical concept of tiredness was then com pared 
with the results of factor analysis. In an attem pt to explore the different concepts, 
results from factor analysis were tentatively linked to a new proposed framework 
(Table 4.7.). This new framework suggested the acceptance of factor 1 as the 
expression of physical tiredness with the 5 identified items (Scale A). Removing 
loss of interest, despite statistical assignment to factor 1, was done because there 
was no theoretical explanation for its integration into factor 1. For factor 2, 
cognitive tiredness items were separated from the affective tiredness scale items 
to form two separate sub scales (Scales C and D). In the sub scale for affective 
tiredness, feeling impatient was deleted because of unreliability in the context of 
affective tiredness (r=0.54).
The reliability coefficient of factor 3, presenting sensations or feelings of physical 
tiredness, was too low (0.47) to form a valid sub scale. As unusual tiredness could
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be seen as sensation or feeling, it was added to these items and together they 
constituted a sub scale, which presented physical sensations of tiredness (Scale B).
The items unusual need for sleep, wish to withdraw, sleeping problems at night, 
together w ith feeling im patient and loss of interest were deleted because they 
could not be assigned to any sub scale, neither theoretically nor statistically. 
Eventually, 16 items were grouped in 5 sub scales (Table 4.7.) w ith reliability 
coefficients (Cronbach alpha) of 0.86 for scale A (physical functioning tiredness), 
0.66 for scale B (physical sensations tiredness), 0.67 for scale C (cognitive 
expression of tiredness), 0.67 for scale D (affective expression of tiredness) and 0.64 
for scale E (general sensations of tiredness).
Correlation of type of tiredness / fatigue w ith intensity and distress of fatigue, 
HAD scores and health status
Pearson Correlation Coefficients were calculated to examine the relationship of 
tiredness, as conceptualised in a new tentative framework, w ith its intensity and 
distress (see also results of factor analysis). Results are presented in Table 4.8.. 
Intensity of tiredness showed higher correlation w ith physical expression of 
tiredness than with cognitive and affective expression. Distress correlated slightly 
higher than fatigue itself with all types, especially w ith cognitive and affective 
expression. The relationship between type of tiredness and HAD scales remained 
rather non-specific bu t consistent. HAD Anxiety scores show ed h igher 
correlation w ith affective tiredness than w ith the other types and the HAD 
Depression scores did not reveal any difference in relationship to the different 
types of tiredness.
Differences between type of tiredness, as defined in the attem pted synthesised 
concept and health status were examined comparing tiredness scores from the 
questionnaire in the two sam ples, using the W ilcoxon rank sum  test for 
differences in location. Results are also presented  in Table 4.8. Physical 
functioning- tiredness was significantly different in the two samples w ith a P 
value of 0.001. Physical sensations-tiredness also showed significance (0.002) as 
well as cognitive expression (0.02). Affective expression of tiredness d id  not 
reveal a difference in relation to health status (0.46).
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Assessment of intensity  and distress tiredness/ fatigue and the correlation w ith 
Kamofsky Index and HAD scores
Intensity of tiredness, as assessed with the LASA scale on tiredness, is presented 
in Table 4.9. . Healthy individuals showed a consistent increase from today to last 
week to last month, whereas cancer patients showed equal intensity of tiredness 
today and last week and tend to increase for the period of last month. The 
difference betw een m edian intensity of tiredness in the two sam ples was 
statistically significant, however even stronger for today (P 0.001) than for last 
week (P=0.004) and last month (P=0.006), as calculated with the Wilcoxon test.
The same was the case for the distress caused by tiredness. M edian distress, 
presented in Table 4.9., was higher in cancer patients (43 mm) than in healthy 
individuals (28 mm), which presents a significant difference (0.003).
The relationship of the Karnofsky Index with tiredness intensity, its distress and 
the HAD Scale was also examined. Results are presented in Table 4.10.. Low and 
equal correlation is shown for correlation of the Karnofsky Index w ith intensity 
and distress of tiredness. The correlation w ith the HAD Depression scores was 
higher than w ith the HAD Anxiety scores. The relationship of the HAD Scales 
was higher for tiredness distress than for tiredness intensity. Relatively low 
correlations were found between tiredness and anxiety and depression scores.
HAD Scale scores in the two study-populations
The HAD Scales were also examined in relation to the two samples. Results are 
presented in Table 4.11.. Discrimination between healthy and diseased persons 
revealed low Phi Coefficients concerning anxiety (between 0.16-0.28) as well as 
concerning depression (between 0.11 and 0.37). Chi squared tests show ed 
significance (< 0.01) for the anxiety item anxious ideas (presentiments), weak 
significance ( < 0.05) for ability to relax and restlessness and for the depression 
items only feeling held back differed significantly, no other item was weakly 
significant. The median for anxiety was not significantly different in the two sub­
populations, the median for depression was weakly significant (0.02).
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Table 4.9. Intensity and distress of tiredness assessed with LASA Scales 
in healthy individuals (N=77) and cancer patients (N=77)
Time span healthy
individuals
cancer
patients
m edian  (mm) m edian  (mm) P*
today 13 38 0.001
last week 24 38 0.004
last m onth 29 44 0.006
Distress of tiredness 28 43 0.003
m edian (mm)
* Wilcoxon Test
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Reliability and validity of the Fatigue Assessment Questionnaire (FAQ)
Internal consistency of the original, entire tiredness assessment questionnaire 
was examined w ith the Cronbach's alpha test and revealed a high reliability 
coefficient of 0.88. Reliability of the sub scales as defined by factor analysis could be 
confirmed for the factor 1 items with a reliability estimate of 0.84 (Table 4.6.).
The items of the questionnaire had been derived from interview s of cancer 
patients and healthy individuals and content validity therefore was supported by 
the fact that items reflected the true experience of those concerned. Content 
validity was also supported by the significant differences between cancer patients 
and healthy individuals in specific items, sensitively reflecting the "unusual 
tiredness" items and "healthy tiredness" items (Table 4.2., 4.3.). No other, 
validated comparable instrument was available to be used as an external criterion 
to examine convergent and concurrent validity. Criterion related validity of the 
questionnaire was supported by the differences shown in results obtained in the 
two different health status in healthy and diseased individuals (Table 4.2., 4.3. and 
4.9.). Cross correlation of items related to the time span of m easurement revealed 
the higher Phi coefficients for the measurement period of today and last week 
(Table 4.4.) and supported appropriateness of the measurement periods for today 
and last week.
4.6. DISCUSSION
Qualitative data as valid foundation of the study
The purpose of this study, the developm ent of an instrum ent to m easure 
tiredness/ fatigue in cancer patients, applicable for epidemiological research, was 
an ambitious project. As knowledge from experience and from the literature was 
not sufficient to conduct the planned research reliably, previous research w ith 
qualitative research m ethods was first needed to explore valid descriptors of 
tiredness. The expert knowledge gained from the previous qualitative interview 
study with cancer patients and healthy individuals (chapter 2) therefore was used 
to build the foundation for this research project. As interviews are a form of self- 
report, the researcher can assume that the information given by the interviewee 
is accurate. However, the quality of data generated by this type of qualitative
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research has been described as largely dependent on the skills and expertise of the 
interviewer (Guba and Lincoln 1981). These aspects were considered cautiously 
and issues of rigor were addressed in chapter 2.
Com position of the questionnaire-item s from cancer patients as w ell as from 
healthy individuals
The construction of the questionnaire included first reduction of redundant 
items which were derived from the interview study. Although some items were 
equally observed in healthy individuals as well as in cancer patients, however, 
many turned out to be specific to either group. Items which did concur in both 
groups were therefore unified for the questionnaire but all group-specific items 
were retained with the aim of detecting cancer specific fatigue. It could be argued, 
that specific items from the group of healthy individuals could have been deleted 
from the questionnaire. This was not done because the possible absence of items 
reflecting "healthy fatigue" w ould show w hat was not occurring in cancer 
patients; thus the absence of the expression of "healthy tiredness" w ould sharpen 
the picture of fatigue in cancer patients.
This strategy was supported by the results of this study. The delineation of cancer 
specific tiredness became more evident by the differences between the two groups. 
For example the items decreased physical perform ance and weakness were 
significantly stronger in cancer patients, whereas pleasant tiredness and heavy 
legs were significantly stronger in healthy individuals (Table 4.2.). Pleasant 
tiredness even showed minus values for cancer patients (Table 4.2. and 4.5.). It 
turned out to be a privilege of healthy persons to feel pleasantly tired. This 
knowledge brings up the question whether activity, such as for example physical 
exercise would be able to change the type of tiredness in diseased persons. This 
activity /  rest balance pattern will be related to theory later in the discussion.
Comparison of questionnaire content w ith items of instrum ents described in  the 
literature
There is a real difference in description of tiredness betw een existing 
m easurem ent instrum ents and the items in the new questionnaire. W hereas 
scales derived by psychologists, such as the POMS scale (McNair 1971) use 
descriptions derived from psychology, quality of life m easures, such as the
EORTC questionnaire  (H iirny 1993), include  d escrip tions re la ted  to 
wellness/illness and symptoms. A questionnaire developed by a nurse mainly 
assesses impact and consequences of fatigue (Piper 1992). This reveals that the 
purpose of measuring fatigue is most important and that the instrum ent m ust fit 
the research purpose. The description of fatigue in tired airmen (Pearson Byars 
1956) differs considerably from w hat is experienced as fatigue in cancer patients. 
In contrast, a cancer specific instrument would not be sensitive enough to assess 
tiredness in healthy airmen. In this light, the decision to identify the descriptions 
of fatigue in cancer patients by interviews support the content validity of the 
questionnaire for the purpose of the intended study. For example, no other 
instrum ent asked for decreased physical performance, which turned out to be a 
prom inent feature of fatigue in the cancer population  under study. The 
instrum ent had first of all to reflect the true experience of fatigue in cancer 
patients.
Age, gender and disease-characteristics
It had been reported that age and gender accounted for the variance of symptoms 
and that younger patients were more likely to report fatigue (Nerenz 1986). This 
factor was excluded because age and gender were equally distributed in the study. 
The group of cancer patients consisted of a severely ill population w ith a wide 
variety of cancer types, m ainly in advanced stages and m ainly undergoing 
chemotherapy. Results obtained from a specific cancer population in only one 
stage of disease and with only one type of treatment might have shown different 
results. As it was the aim to develop a questionnaire for a general cancer 
population, it seemed appropriate to include a general cancer patient population 
in the study.
Univariate and multivariate discrimination of items between cancer patients and 
healthy individuals in three time spans
Concerning the time span "today", mainly physical descriptions of tiredness and 
general indicators of tiredness were significantly stronger in cancer patients than 
in healthy individuals (Table 4.2.). Affective and cognitive expressions did not 
differ in the two groups. This could be explained by the fact that the time period 
of today is too short to assess cognitive and affective symptoms or that people do 
not want to disclose affective attitudes.
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However, anxiety and impaired concentration increased in im portance for the 
longer time span of one week, despite the fact that other mainly cognitive and 
affective items remained insignificant in both groups. Anxiety even increased in 
significance over the time period of one month. This suggests that anxiety might 
be more of a trait m easure (reaction w ithout time frame) rather than a state 
measure (reaction w ithin a time frame) (Van Dam 1984). W hether the affective 
signs remain undetected by the insensitivity of the tool or by the wish of people 
not to disclose such feelings to others, remains to be uncovered by further studies. 
Findings of other researchers have also suggested that patients m ay have less 
difficulty in expressing physical problems than emotional distress ( Kobashi 1985). 
The correlation of tiredness with anxiety/depression levels as m easured w ith the 
Hospital Anxiety and Depression Scale (HAD Scale) (Table 4.8., 4.10., 4.11.) in this 
study, also showed rather low correlations and only one item of the depression 
scale differed significantly between cancer patients and healthy individuals. A 
further explanation for this lack of difference between the two groups could be a 
real lack of difference between the groups concerning anxiety and depression, 
which from clinical experience is difficult to accept. Findings of this study are 
controversial w hen compared to studies which detected correlations betw een 
mood disturbances and fatigue levels. Blesch (1991) described correlations of 
scores of the Profile of Mood States (POMS) sub scales with self-reported fatigue 
scores in patients w ith breast and lung cancer. There is therefore a question of 
whether anxiety and depression is more easily detected by the POMS Scales than 
by the HAD Scales.
Decreased physical performance, unusual tiredness, weakness, sleepiness at day 
time, unusual need for rest, fight overcoming inactivity, becoming slower, loss of 
energy and general unwellness remained highly significant in cancer patients in 
all time spans. This can be explained by the fact that overall values in these items 
were very high in this study group. It supports the predom inance of these 
physical items in the concept of fatigue in cancer patients.
Surprisingly, exhaustion did not appear to be more relevant in one of the two 
groups. Derived from experience, it is possible that exhaustion is a feeling that 
appears following intensive physical activity in healthy persons and at the very 
end of advanced disease. No majority of either group filled in the assessm ent 
form after an intensive physical exercise or at the very end of life. In this sense, 
exhaustion can be seen as the end of the fatigue continuum  w ith  different
meanings for diseased and healthy individuals. It suggests that for healthy 
persons exhaustion equals pleasant tiredness, experienced after physical stress and 
for cancer patients it equals highest intensity of tiredness experienced as distress 
and life limiting impact.
According to the results from the logistic regression analysis (Table 4.3.), some 
items appeared to be redundant. This could be explained by the fact, that the inter­
relationship between some items was very high, reflecting very similar concepts. 
Unusual, extreme tiredness m ight be equal to unusual need for rest or w ith 
unusual need for sleep or loss of energy or general unwellness. The concepts 
appear very sim ilar having a general im pact on individuals. In order to 
conceptualise fatigue and to analyse its component, all items will be retained in 
the questionnaire for further analysis.
Reliability of the time frame of measurement
The time span of today seemed inappropriate for the m easurement of tiredness. 
Healthy persons experienced more pleasant tiredness in the time span of last 
week than they did for the time span of today. This can be explained by the high 
probability w ith which healthy individuals had a hard  w orking day or an 
intensive physical activity during last week, which is less probable for the time 
span of today, especially if m easurement is being taken in the morning. This 
supports the choice of a one week m easurement period for critical items. Some 
other critical items in this tool, especially for cancer patients, were feeling sleepy 
during  day-tim e, unusual need for rest, exhaustion, again  especially if 
measurement was being taken in the morning.
The highest correlation was seen between the results obtained from the time 
spans today and last week. This period paid regard to the fluctuating construct of 
tiredness which might differ between one day to the other. The one week period 
seemed less affected by unusual short term events. However, treatm ent variables 
need to be controlled to obtain valid results for a specific m easurem ent purpose. 
In cancer patients, treatm ent and treatm ent-rest periods m ight induce relevant 
differences, as has been observed by other researchers who concluded that peak 
levels of fatigue could well have been found at another time period than at the 
actual tim e of m easurem ent (Pickard-H olley 1991). This underlines the 
importance of controlling confounding variables such as treatm ent strategies.
The theoretical justification of the time frame by the differentiation between state 
and trait measures (Huismann 1987) has been described above. From this study it 
can be suggested that tiredness itself represents a m ixture of trait and state 
measure. It m ight be more of a state measure after chemo- or radiotherapy but 
might be rather a trait m easure if tiredness is related to tum our activity over 
longer periods of time.
The lower Phi coefficient values were found between the time span of today and 
last month, indicating that the longer the time span, the lesser the symptoms 
might be remembered. Memory effects on validity of data might be crucial (Van 
Dam 1984).
Intensity of tiredness, its distress and its correlation with other variables
The continuum  of tiredness in other studies was defined w ith "I do not feel 
tired" to "I feel completely exhausted" (Holmes 1991, McCorkle 1978, Piper 1989). 
The LASA Scales in this study, describing the continuum "I did not experience 
unusual tiredness" to "I felt completely exhausted", as well as its distress was 
found to be sensitive and reliable, as the difference between healthy individuals 
and cancer patients was significant (Table 4.9.). The definition of unusual 
tiredness to capture tiredness which exceeds norm al diurnal tiredness was 
considered appropriate to address fatigue in cancer patients, as it was identified in 
study 1 (chapter 2).
Correlation between the Karnofsky Index and tiredness intensity and distress was 
very low, which may be explained by the fact that 86% of the patient population 
had an Index of higher than 80. Again, no correlation was found betw een the 
results of the HAD scale and tiredness, excluding the difference betw een study 
groups concerning the Depression- item "feeling to be held back" (Table 4.11.).
Reliability and validity of the questionnaire
Reliability of the entire tiredness questionnaire has been confirmed. Satisfactory 
reliability could be confirmed for the sub scale w ith physical tiredness-item s. 
Even though reliability coefficients were lower for the cognitive and affective 
factors, the study suggests the need for further research to identify the source and 
impact of affective and cognitive signs. Identification or rejection of further sub
scales need to be supported in a study w ith a larger population. Validity 
concerning content has been established by significant discrim ination of 
instrument-items between cancer patients and healthy individuals and by the use 
of items derived from self-reports from the populations concerned. Investigation 
of the time frame has confirmed the reliable use of the time span of past week.
Contribution to the understanding of fatigue in cancer patients:
Using factor analysis as hypothesis generating technique
Factor analyses were carried out to examine construct validity and to identify sub 
scales and possible unified concepts. Factor 1 (Table 4.6.) could be confirmed with 
satisfactory reliability. Again this cluster comprised mainly physical items apart 
from loss of interest. Loss of interest seems a logical consequence of decreased 
physical capacity and reduced activity. Here it becomes clear that psychological 
reactions are interw oven w ith physical experiences. The item s on factor 2, 
representing only affective and cognitive aspects had a higher reliability than 
factor 3, which unified pleasant tiredness w ith exhaustion and heavy limbs, 
yielding another kind of physical tiredness sensations, possibly to be seen as 
decrease in physical capacity. Results from factor analysis suggested that their was 
a clear physical com ponent inherent and predom inant in tiredness and that 
affective and cognitive item s were involved bu t that their w as no clear 
knowledge to support the hypothesis of a physical, affective and cognitive model 
of expression of tiredness. Even though this categorisation w as sim ilarly 
described by others (Yoshitake 1971), it m ust be treated w ith caution because 
confounding variables m ight play a role. It could be argued that affective 
expression of tiredness, such as sadness, m ight be an expression of the whole 
situation and that sadness is more a sign of depression due to the life-threatening 
circumstances than an expression of tiredness. The concept of physical, affective 
and cognitive tiredness needs to be further examined.
The attempt to synthesise the previous concept of fatigue and the results of factor 
analysis ended in a sophisticated instrument with five sub scales (Table 4.7.). This 
theoretical exercise was helpful in developing ideas but a tool w ith five small sub 
scales poses difficulties for testing reliability. Readdressing the items and adding 
some further items from the original interviews is a possible way forw ard for 
further use of the instrum ent as a whole and for further exploration of the 
concept.
Researchers who developed similar sub scales guided by factor analysis were 
Kobashi (1985) and Chalder (1993). Kobashi identified a physical fatigue scale, a 
mental fatigue scale and a general condition scale when he examined patients 
undergoing radiotherapy. The physical scale does not include weakness or 
decreased physical performance but rather includes the items derived from the 
Yoshitake sym ptom  checklist (Yoshitake 1971), which was developed for a 
healthy working population (Kobashi 1985). Chalder developed a physical and a 
mental scale, examining patients in a general practice setting. The physical scale 
concurs w ith some of the physical signs in this study, including rest, sleepiness, 
weakness. However, the validity of questionnaire- items can be questioned if they 
are derived from populations other than cancer patients and if they are generated 
by professionals only.
In this study, factor analysis is pointing to unified concepts w ithin the instrum ent 
and these can help to develop the understanding of the construct under test. The 
physical expressions of tiredness were prominent and the question is whether the 
measurement of the physical items, included in factor 1, would be sufficient in a 
fatigue-measurement instrum ent for cancer patients. However, the affective and 
cognitive aspects, unified in factor 2, can not be disregarded and together with the 
content validity given by cancer-patient-generated items, this study suggests the 
non-physical items should be included in the questionnaire. In further research 
w ith  a larger cancer-patien t-population , factor analysis w ill give m ore 
information on the quality of fatigue in cancer patients. In order to achieve this, 
evaluations will need to target qualitative aspects in addition to intensity or 
quantity of tiredness. This seems especially im portant to direct the fu ture 
development of supportive strategies.
Evolving hypothesis: The activity /inactivity - vicious circle phenom enon 
- a major physical concept of tiredness in cancer patients?
The clear identification of physical expressions of tiredness leads to the need for 
further theory development. In this study, the unusual need for rest turned out 
to be a strong, cancer specific expression of tiredness measured in all time spans 
(Table 4.2.). The need to rest seemed to contradict the hypothesis that exercise 
relieves tiredness (Winningham and Nail 1994). Results of this study suggest that 
there could be a vicious circle (Figure 4.1.): unusual tiredness leading to unusual 
need for rest which, in turn, leads to weakness which then leads to decreased
Figure 4.1. The Activity / Rest Imbalance in Fatigue: 
A Vicious Circle Phenomenon ?
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physical performance, to problems in overcoming inactivity, to unusual tiredness 
and so forth. Becoming slower, loss of energy, loss of interest and general 
unwellness could be seen as inherent and also as vicious circle type consequences 
of this activity /  rest imbalance. The question rem ains, w hether there is a 
possibility to interrupt this circle by exercise or whether this predeterm ined circle 
can not be interrupted as long as the original cause of tiredness, such as cancer or 
treatment measures can not be eliminated.
It was found that in a research based nursing rehabilitation programme, the non­
exercise group reported twice the fatigue intensity than the exercise group (Mock 
in Press). However, are such programmes applicable to patients w ith adjuvant 
chemotherapy as well as to those w ith advanced disease and to which cancer 
population can it safely be offered? With which m easurem ent instrum ent can 
success or failure be reliably measured? The frequent use of the POMS scale 
(McNair 1971) measures psychological expression of tiredness but it remains to be 
substantiated whether physical exercise induces relief from depression or relief 
from physical tiredness. This cannot be assessed by scales that do not measure 
physical as well as psychological tiredness symptoms explicitly.
The W inningham 's Psycho biological-Entropy Model, a theoretical concept of 
fatigue (Figure 1.5., chapter 1), emphasises the need to determ ine the optim al 
balance between restorative rest and restorative activity or exercise. Part of the 
model relates fatigue to activity and functioning (Nail & W inningham  1994). 
However, precaution for the use of exercise has been reported due to the most 
complex and m ainly unknow n m echanism s of fatigue in cancer pa tien ts 
(W inningham 1991, St. Pierre 1992). The ac tiv ity / inactivity-vicious circle- 
hypothesis derived from this study, fits the theoretical energy deficit concept of 
Winningham. However, it can only be one concept influencing the production of 
tiredness, as many further potential causes and etiologic factors, as described in 
the theoretical model by Piper (1993), m ight play a role. The results from this 
study give these influencing factors a new weighting in the sense that tiredness is 
strongly associated with activity and rest patterns which are primarily determined 
by physical sources. Whether the affective and cognitive responses can be seen as 
specific expression of tiredness in cancer patients or whether they are to be seen as 
general expression of the whole disease-situation, is not yet clear.
4.7. CONCLUSIONS AND DIRECTIONS FOR FURTHER RESEARCH
A tiredness assessm ent questionnaire has been developed to analyse the 
experience of tiredness /  fatigue in cancer patients. The item s for the 
questionnaire were derived from interviews w ith cancer patients and healthy 
individuals and considered to be valid descriptors of how fatigue is experienced 
by those concerned. The inclusion of descriptors derived from  healthy 
individuals distinguished the type of tiredness experienced in cancer patients, 
thus reflecting the absence of health-specific expressions of tiredness. Some new 
items, which are not included as signs or expressions of tiredness in available 
questionnaires or scales, were identified in the interviews and integrated in the 
new Fatigue Assessment Questionnaire (FAQ).
The use of the new instrum ent FAQ in this study w ith 77 healthy individuals 
and 77 cancer patients allowed reliability and validity tests and contributed to 
theory of fatigue. A previous framework, which classified fatigue as physical, 
affective and cognitive expressions, was completed w ith the finding, that the 
physical expression of fatigue m ight be more dom inant than  affective and 
cognitive expression. The physical dominance of fatigue in cancer patients was 
presented as decreased physical perform ance, unusual tiredness, weakness, 
sleepiness at day time, unusual need for rest, fight overcom ing inactivity, 
becoming slower, loss of energy and general unwellness. These signs of fatigue 
were tentatively summarised and put forward as a physical component of fatigue. 
A hypothesis was form ulated, presenting this component as a vicious circle- 
phenomenon, involving rest and activity imbalance. Although it suggests that 
tiredness in cancer patients is expressed at physical, affective and cognitive levels, 
the results of the study argue for a high weighting of the physical expression.
Investigation of the time frame of measurement of tiredness indicated that the 
use of the time span "last week" may be the most valid and reliable time frame. 
Intensity and distress of tiredness as m easured w ith the linear analogue scale, 
show ed significant differences betw een the two study-populations, w hich 
supports validity of the definition of the tiredness continuum , distinguishing 
tiredness from unusual tiredness.
Reliability and validity of the questionnaire as a m easurement instrum ent of the 
experience of tiredness in cancer patients has been supported , including its
feasibility and acceptability by this vulnerable population. For the purpose of an 
epidemiological research project in cancer patients, the instrum ent needs small 
adaptations, such as the inclusion of a few further items for affective and 
cognitive signs as derived from the interviews, in order that the theoretical 
fram ew ork can be fu rther investigated using factor analysis technique. 
Random isation of the item s to determ ine the sequence of item s in  the 
questionnaire is needed to prevent researcher induced sequence-bias. The use of 
the measurement period "one week" can be practised confidently. The limited 
num ber of 22 questionnaire-item s w ith dichotom ous answers, related to the 
m easurement for one time span, will allow its use in further studies w ith large 
populations with limited energy. After a first, successful development period, the 
FAQ will be used for further research with the aim of identifying groups of 
cancer patients at risk and eventually to evaluate therapeutic strategies. At the 
same time, further studies mean the continuation of the validation process of the 
questionnaire.
CHAPTER 5
STUDY 3
THE RELATIONSHIP BETWEEN FATIGUE 
AND TYPE AND STAGE OF CANCER
5.1. INTRODUCTION
The previous chapters of this thesis showed that the concept of tiredness/ fatigue 
is still ill defined. Its qualitative exploration in chapter 2 gave new insight into 
the experience of fatigue in healthy persons and cancer patients. The comparison 
of these findings with concepts in existing measurement instrum ents showed a 
lack of valid instrum ents for cancer patients and eventually  led to the 
construction of the new Fatigue Assessment Questionnaire (FAQ) (chapter 3), 
which was then tested in cancer patients and healthy individuals (chapter 4). The 
next study is an attem pt to measure the relationship of fatigue in cancer patients 
with different types and stages of cancer, using this new FAQ. At the same time, 
the study allows a further validation process of FAQ in a larger cancer patient 
population.
5.2. REVIEW OF THE LITERATURE
Fatigue and tiredness have become frequent research topics in the last years. 
Tiredness and exhaustion seem to be attributes of modern society. The biological 
meaning and aim of tiredness, as described by the fatigue theorist Grandjean 
(1968), lies in the fact that nature conducts the behaviour of hum ans and animals 
through feelings of fatigue to help the body to find its balance between rest and 
activity, thus being a life sustaining state, similar to other physiological needs, 
such as thirst or hunger. It is difficult, however, to capture tiredness, which is in 
transition from a "healthy, life sustaining state" into a life-distressing sign or 
symptom of an approaching disaster or breakdown. This has become especially 
clear during the past years, when the new diagnosis "Chronic Fatigue Syndrome" 
(CFS) stirred up m uch controversy (Greenberg 1990). Is it a disease, a postviral 
syndrome or a sign of psychological disorder? Apart from tiredness in the CFS, 
tiredness itself cannot be seen as a disease and occurs in healthy as well as in 
diseased individuals.
Base line data between healthy individuals and cancer patients
To determine the significance of tiredness as a sign of physical or psychological 
distress, the identification of base line levels and experience of tiredness in 
healthy individuals is required. Data of a large survey (1971-1974) of American 
adults between 25 an 74 years of age were used to explore self-perceived fatigue. 
Fourteen percent of males and 20 percent of wom en reported suffering from 
fatigue (Chen 1986). This means that the prevalence of fatigue in cancer patients 
should be higher than that, in order to justify the conclusion, that cancer patients 
differ in their fatigue experience from the general population. It is unknow n 
w hether results from that time period can be com pared w ith  the fatigue 
experience of today.
So far, most cancer fatigue research projects have failed to include a control 
group. A study by Irvine (1994) compared the fatigue experience of 104 cancer 
patients, mainly women with breast cancer, under chemo- and radiotherapy, with 
the fatigue experience of 53 healthy women. The first m easurem ent was taken 
before the beginning of therapy and at this time point, no significant difference 
was found between breast cancer patients and healthy individuals. Levels of 
fatigue, however, increased in the course of treatment in cancer patients and then 
were significantly higher than in the healthy population. The lack of difference 
between the two study populations before start of treatment poses the question of 
whether breast cancer, itself, is a non-fatigue inducing type of cancer. In a further 
study, investigating fatigue in 12 patients w ith ovarian cancer, no significant 
difference was found in comparison with 12 healthy women (Pickard 1991). The 
lack of difference may be explained by the small sample or m ay be related to 
ovarian cancer as a non-fatigue inducing cancer.
Even though it has been difficult so far to demonstrate that healthy individuals 
experience less fatigue than cancer patients w ithout treatm ent, it can be 
hypothesised that the quality of tiredness m ight be more distressing in disease 
than in health. A study, comparing fatigue levels over daily periods in 30 healthy 
persons and 20 cancer patients, suggested different tiredness profiles w ith 
different impact (Glaus 1993). Whereas cancer patients experienced distressing 
tiredness all day long, healthy persons experienced pleasant tiredness in the 
evening only. Again, a mixed cancer population and small sam ple size lim it 
generalisability of these results.
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In the previous study of this thesis (chapter 4), 77 cancer patients w ith mainly 
advanced cancer, receiving chem otherapy, and  77 healthy  ind iv idua ls 
documented their tiredness and its distress w ith linear analogue scales. The 
m edian intensity and distress of tiredness was significantly higher in the group 
with cancer patients for the time period of today, last week and last m onth than 
for the group of healthy individuals (Table 4.9., chapter 4). These findings 
suggested that a difference in fatigue base line values between cancer patients and 
healthy individuals exists, but the heterogeneity of patients with a wide variety of 
tumour-types and treatments made it difficult to identify fatigue base line data for 
cancer patients with specific types of cancer.
Fatigue and its relationship w ith type and stage of cancer
Clinical experience suggests that there is a relationship between different types of 
cancer and fatigue. Hiirny (1993) dem onstrated that 43% of 83 small cell lung 
cancer patients suffered from fatigue before initiation of chemotherapy. Intensity 
of tiredness decreased only very little during six cycles of chem otherapy, in 
contrast to cough, which decreased significantly during treatment, thus indicating 
successful treatment (Hiirny 1993). If lung cancer itself was the cause of fatigue, it 
could have been suggested that with successful cancer treatment, fatigue would 
have decreased as well. It could also be possible, however, that chem otherapy 
might have caused fatigue. An investigation in 69 women w ith non small cell 
lung cancer (limited disease), prior to treatm ent, indicated, that 59% of them  
suffered from reduced energy (Sarna 1994). Reduced energy was dem onstrated 
with difficulties in household chores (33%) and interference w ith w ork (28%). 
Three quarters of the patients were not satisfied with their level of activities. The 
fact that women in this study had limited disease and that they were untreated 
when assessment took place, suggests very strongly that the type of cancer (lung 
cancer) is responsible for the development of fatigue-distress. Blesch (1991) found 
no significant difference between chemotherapy- treated patients w ith lung and 
breast cancer: two thirds of the patients in both groups experienced m oderate to 
severe fatigue. It is not possible to identify whether fatigue in these patients was 
induced by the disease or by the treatm ent. In another study, high levels of 
tiredness were observed in patients w ith head and neck cancer (very small sub 
sample) and in breast cancer, using the GLQ-8, an 8 item LASA instrum ent to 
m easure specific side effects of cancer and cancer treatm ent (Butow 1991). 
How ever, the lack of balanced disease groups, the varie ty  of trea tm en t
interventions and small numbers in the sub-groups diminish the relevance of
the study.
Fatigue and type of cancer: are there specific, asthenin-producing tumours?
It has been proposed that the malignant process itself may secrete substances, 
w hich cause asthenia (Theologides 1982). A sthenia has been defined as 
pathological fatiguability, loss of strength and generalised weakness (Bruera 1988), 
which can be seen as major components of fatigue. A further hypothesis that is 
discussed is the prom otion of a defence mechanism of the body against the 
tum our where cytokines, such as interferons, interleukines and tum our necrosis 
factors may be secreted and so induce fatigue (Morant 1991). A study with 87 non­
small-cell lung cancer patients tested w hether metabolic derangem ents were 
related to a systematic inflammatory response. Increase in energy expenditure, 
weight loss and plasma levels of different Tumour Necrosis Factors (TNF) were 
measured. Tumour stage was found to be significantly different between weight- 
losing and weight-stable patients and levels of inflamm atory m ediators were 
increased (Staal-van den Brekel 1995). It could be argued that weight loss induced 
by tum our growth involves fatigue and therefore inflammatory mediators are co- 
responsible for its development. As inflammatory mediators seem to be tum our- 
specific, the correlation of fatigue with specific types of cancer can be suggested 
from this viewpoint.
Increased rates of energy expenditure and cachexia in cancer patients m ight be 
related to such immunological processes (Keller 1993) and may further increase 
fatigue. From a study, aimed at testing the effect of specific tum our-types on 
neuromuscular function in rats, it was concluded, that the development of neuro 
myopathy was more intensive in rats with Epithelioma Guerin than in rats w ith 
fibrosarcoma. These results supported the hypothesis of a hormonal influence by 
the neoplasm on the neurom uscular system. These results were compared w ith 
clinical observations in tum our patients and an overall reduction of sensory 
exibility in different patients was noticed and a decrease of the general 
myoelectrical activity was observed (Koczocik 1994). This kind of research may 
advance our knowledge about fatigue and the detection of new substances, which 
could at least partially account for the development of fatigue in specific types of 
tum ours.
Several of these publications discussed suggest inflammatory m ediators and /  or 
immunological processes as potential causes of fatigue in cancer patients. In 
contrast, a recent study suggested that the Chronic Fatigue Syndrome (CFS) was 
associated with an increased susceptibility to cancer. Data from a cancer registry in 
the United States of America were reviewed subsequent to a reported outbreak of 
a CFS-like illness betw een 1984 and 1986, concentrating on N on-H odgkin 
lym phom a and brain  tum ours. An upw ard trend in the incidence of brain 
tumours, which could be related to a national upw ard trend for this disease, was 
noted (Levine 1994). This was not the case for patients w ith  Non-H odgkin 
lymphoma. M ethodological difficulties were considered. Further studies are 
needed to investigate possible associations between CFS and cancer, including 
expected latent periods for specific tum ours. This interesting theory looks at 
fatigue as cause or precursor of cancer, while most current studies have looked at 
fatigue as a consequence of disease and treatm ent. The relationship betw een 
specific tum our types and fatigue could be suggested as a linking factor between 
the two theories.
New substances have been detected in the last years, which are now tested in 
patients w ith fatigue. A pilot test of physiological fatigue indicators in 15 healthy 
controls show ed the correlation of rising salivary m elatonin levels in the 
evening and night-time hours with a corresponding decline in body tem perature 
(Anderson 1996). It suggests that melatonin, a neurotransm itter associated w ith 
the s leep / wake cycle, also has an influence on fatigue in cancer patients. 
W hether different types and stages of disease play a role in the production of 
m elatonin needs to be further examined. From the interventional view point, 
promising hypotheses could be tested.
The influence of other symptoms on fatigue in patients w ith cancer
Today, fatigue is recognised as the most common and probably most distressing 
symptom reported by cancer patients, even though methodological problems and 
differences in m easurem ent make it difficult to compare available research 
(Holmes 1991, W orld Health Organisation 1990, Piper 1989, McCorkle 1978). A 
recent study, investigating the incidence and severity of sym ptom s in 1000 
patients w ith advanced cancer, showed that fatigue, together w ith  pain  and 
anorexia, was consistently among the 10 m ost prevalent sym ptom s (Donnelly
1995). This study supports the idea that tiredness correlates w ith advanced stages
of cancer but it does not differentiate between types of tum ours. It has been 
hypothesised that there is an interrelationship betw een sym ptom s and that 
fatigue, as a primary symptom of disease or treatment, leads to secondary fatigue 
due to decreased activity as a consequence of other symptoms, such as pain and 
immobility (Winningham 1994). This could explain the high incidence of fatigue, 
especially in advanced disease and when intensive treatm ent w ith side effects is 
involved.
Another study showed that the num ber of sym ptom s and fatigue in cancer 
patients before chem otherapy were significant predictors w hen analysing 
outcomes in 229 cancer patients individually (Jones 1994). This study emphasises 
that fatigue is a pre treatm ent symptom, which supports the hypothesis that 
fatigue is associated with type and stage of cancer. However, in this study fatigue 
was measured with sub scales of the Profile of Mood States (McNair 1971), which 
m ight represen t m easurem ent of m ood states, possibly associated w ith  
uncertain ty  and anxiety before s ta rt of cancer trea tm en t, ra th e r than  
m easurement of multidimensional fatigue.
The influence of treatment- effects on fatigue
Interesting observations have been made between the development of fatigue in 
patients w ith different tum ours during therapy. Fatigue levels in patients w ith 
lung cancer were observed to be higher before and during radiotherapy than after 
( Haylock 1979). This may cautiously be explained by the fact that the decrease of 
tumour burden results in lower fatigue levels due to better oxygen exchange, less 
breathing distress or less production of cytokines. In contrast to that, patients with 
localised breast cancer, receiving adjuvant radiotherapy, experienced higher 
levels of fatigue after treatment than before (Kobashi 1985). This may be explained 
by the fact that there was no primary tum our bulk to be reduced by the treatment, 
but that patients experienced fatigue as side effects of adjuvant radiotherapy. It 
could be concluded that palliative radiotherapy can reduce fatigue, especially if 
the functional capacity of the organ concerned can be increased by the treatm ent 
and that adjuvant radiotherapy m ight increase fatigue, because these patients 
have no tum our burden and are in good condition, bu t experience side effects of 
the treatment. This would support the idea that fatigue can correlate w ith  type 
and stage of the disease, but that in different situations different causes of fatigue 
need to be distinguished.
The influence of treatment side - effects on fatigue in cancer patients
Fatigue is known as one of the few systemic side effects of radiation therapy. It has 
been found to increase towards the end of treatment (King 1985, Haylock 1979). In 
many studies investigating fatigue in relation to chemotherapy, fatigue has been 
dem onstrated to be the most prevalent side effect (Blesch 1991, Rhodes 1988, 
Knoff 1986, Meyerowitz 1983, Nerenz 1982). An increase has been observed with 
progression of therapy (Love 1989). Investigations of fatigue in patients w ith 
different chemotherapy regimen indicated similar fatigue levels am ong groups 
receiving different chem otherapy regimens (Richardson 1996). A very recent 
study in 715 women with localised breast cancer showed that fatigue scores were 
highest among those receiving a combination of radio- and chemotherapy (Woo
1996). Fatigue has been seen as the dose-lim iting factor of treatm ent w ith 
biotherapy (Piper and Rieger 1989). These studies show that the influence of 
cancer treatment is an important factor concerning fatigue. As it is unrealistic and 
unwanted to reduce or even omit cancer treatm ent because of fatigue, it will be 
im portant to provide cancer patients undergoing different treatm ent regimens 
with anticipatory guidance. However, a challenge in future studies will be the 
identification of the underlying causes of fatigue, as there are no base line data 
which indicate w hether the type and stage of the disease, or the treatm ent, or 
both, are ultimately responsible for fatigue. This knowledge is needed to develop 
scientifically based interventional strategies .
The possible influence of coping w ith cancer on fatigue
Clinical experience shows that coping w ith a life threatening disease involves 
feelings of sadness and anxiety. Positive correlations between fatigue, sadness and 
anxiety in cancer patients have been established (Blesch 1991, Bruera 1989). The 
question of w hether fatigue is a symptom of the disease or an expression of 
coping, or both, cannot yet be answered. Looking at cancer as a life crises, 
especially if the disease progresses, requires paying regard to the physical and 
biological changes as well as to the emotional aspects. It seems difficult to 
disentangle physical and em otional tiredness w hen disease is bodily  and 
em otionally overw helm ing. Because of the in terventional potential, it still 
remains im portant to analyse how far fatigue is rooted in emotional distress. 
Patients w ith different types of cancer in advanced stages m ight be at risk of
experiencing fatigue not only physically but also emotionally due to the effort
needed to cope with the circumstances.
The influence of the selection of the m easurem ent instrum ent on the results of 
fatigue research in cancer patients
The lack of validated instruments to measure fatigue/ tiredness in cancer patients 
has m ade it difficult to compare the results from available research. The 
frequently used vigour /  fatigue scale of the Profile of Mood States (POMS) 
(McNair 1971) m easures fatigue mainly from a psychological viewpoint. Other 
instrum ents are either too long and burdensom e (Piper 1989) or are not 
constructed and validated for a cancer population (Yoshitake 1971, Pearson /Byars 
1956). As part of this dissertation, the new Fatigue Assessment Questionnaire 
(FAQ) has been developed and tested (chapters 3 and 4). The FAQ, developed 
from the cancer patients' perspective, m easuring fatigue from the physical, 
affective and cognitive dim ension (in the Germ an language) prov ides an 
instrument designed from the patient's point of view. It is therefore ready to be 
used in the following epidemiological study, which at the same tim e w ould 
perm it further validation of this new instrument. The instrum ent is described 
under the section "methods" of this chapter.
5.3. THE AIM OF EPIDEMIOLOGICAL THE STUDY
It was the aim of this epidemiological study to test the hypothesis that levels and 
expression of fatigue correlate more with certain types of cancer than w ith others 
and that fatigue is more prominent and distressing in advanced and active cancer 
disease than in limited and inactive cancer. This multivariate hypothesis predicts 
a relationship between the type and stage of cancer and fatigue, which is deduced 
from the theory that fatigue is a m ultidim ensional concept w ith a dom inant 
biochemical, disease-related cause, as proposed earlier (chapter 4).
At the same time, this hypothesis-testing study represented a further validation 
process for the new FAQ and therefore includes the aim of testing the reliability 
and validity in a larger cancer patient population.
5.4. RESEARCH APPROACH, SETTING, PATIENT-SELECTION 
AND STUDY-POPULATION
The hypothesis was tested using a quantitative, explorative research approach. It 
had to be explorative because the base line values in different cancer-patient 
populations were not known. The application of the FAQ in a large study 
population required a quantitative approach. It was an epidemiological cohort 
study, using a prospective, non-randomised, cross-sectional study-design. It had 
to be prospective because measurement of fatigue, a fluctuating, subjective state, 
could not be taken retrospectively. Randomisation was not used because the 
study was explorative, although measures were taken to exclude selection bias. 
The cross-sectional design was chosen because the aim was to m easure the 
occurrence of fatigue epidemiologically in patients with specific tum our types. A 
descrip tive  and  corre la tional app roach  w as used  to  investiga te  the 
interrelationship among variables of interest.
The study was mainly conducted w ithin the in- and outpatient services of the 
Medizinische Klinik C, Kantonsspital St.Gallen/ Switzerland. D uring the last 
months of data collection, further patients were included from the departm ents 
of radio-oncology and gynaecology of the same hospital, from a private oncology 
practice setting and from the oncology-outpatient departm ents of two other 
hospitals. In total, four institutions were involved in the study. Patient accrual 
took place from October 1995 until June 1996.
Every patien t adm itted  to the w ards of the departm ent w as approached 
systematically w ithin the first three days of adm ission in o rder to prevent 
diagnostic and therapeutic influences on the experience of fatigue. Every patient 
who visited the medical oncology outpatient departm ent during a random ly 
selected time period (one day per week, rotating) was also asked to participate. 
This m ethod was chosen to exclude selection bias as the investigator was not 
available full-time for the study. Patients in the other adjacent institutions were 
selected according to the investigators availability.
The study population included patients with the following types of cancer: breast 
cancer, lung cancer, malignant lymphoma (including myeloma), gastrointestinal 
cancer (including oesophagus-, stomach-, pancreas-, gallbladder- and liver cancer), 
cancer of the ovaries and testicles, gynaecological cancers (cervix, endo­
m etrium, vagina), melanoma and "other types of cancer". This w ide range of 
cancer disease-types was selected in order that the testing of the hypothesis could 
remain explorative. For this reason, power analyses to determ ine sam ple size 
were difficult because uncertainty existed concerning baseline data.
Exclusion criteria were: 1) Patients w ith a diagnosis of brain tum our or known 
brain m etastasis, due to their potential influence on the experience and 
perception of fatigue, 2) Patients w ith leukaem ia, because of the potential 
influence of acute blood disorders, infections and complications and 3) Cognitive 
impairm ent, psychiatric disorders and inability to understand and speak the 
German language.
Patients were not approached for the study if they were not informed about a new 
diagnosis of cancer.
Ethical considerations
The study was approved by the ethical committee of the Kantonsspital St.Gallen. 
The medical and nursing directors of all involved departm ents and institutions 
confirmed their agreement and support of the investigation.
Patients were asked for participation by their caregivers and had to give oral 
consent for involvement in the study. They were assured confidentiality. Their 
names were kept in a separate list (to prevent a second approach) and the 
questionnaires were coded to assure confidentiality.
5.5. METHODS
Instrum ents
The Fatigue Assessment Questionnaire (FAQ)
The new Fatigue Assessm ent Q uestionnaire (FAQ), developed at the In ter­
disciplinary Oncology Centre St.Gallen (chapter 4), was used to assess expression, 
intensity and distress of fatigue. This m ultidimensional, 22 item questionnaire 
(in German) concerning physical, affective and cognitive expression of fatigue, is 
a self assessment tool w ith dichotomous answers for m easurem ent of the time
span of last week. Additional Linear Analogue Scale Assessment (LASA) Scales 
concerning fatigue intensity and distress are included (Appendix 1, first version, 
in German and translated in English). This instrum ent was used because there 
was no other cancer- specific fatigue m easurement instrum ent available which 
was short and easy to use, validated in the German language and which was 
appropriate for epidemiological fatigue research, involving a large, diseased 
population, vulnerable to fatigue. The items of the instrument were generated in 
previous, qualitative interviews w ith cancer patients and healthy individuals 
(chapter 2), which supports content validity. Internal consistency was confirmed 
in the former study of cancer patients and in healthy individuals and the scale 
showed an overall reliability coefficient of 0.88 (Cronbach alpha) w ith a major 
physical sub scale and a psycho-cognitive sub scale (chapter 4). Before beginning 
with data analyses in this hypothesis-testing study, the FAQ was first factor 
analysed again on the basis of the new and larger study population and these 
results theoretically underpinned the construction of a physical, affective and 
cognitive sub scale and suggested minor adaptations of the questionnaire. These 
adap tation  processes are described later under the section "results" and 
"psychometric properties of the FAQ" in this chapter.
The Hospital Anxiety and Depression Scale
This scale was originally developed to detect anxiety and depression in medical 
patients. Concepts of emotional and physical illness are separated and evidence 
was presented that the scale scores were not affected by the presence of bodily 
illness (Zigmond 1983). The scale has been translated into the German language 
and reliability and validity has been established w ith success in patients w ith 
cardiac disease (H errm ann 1991). The scale includes 7 item s concerning 
depression and 7 items concerning anxiety and relates to the time span of "last 
week". This instrum ent was chosen because of its ability to distinguish between 
emotional and physical symptoms, which is especially im portant in a population 
with cancer. As it is not yet known whether fatigue is a physical symptom of the 
disease and its context or whether it is an expression of depression, the aim was to 
detect anxiety and depression as separate concepts in relation to fatigue and to 
estimate their correlational occurrence.
The Karnofsky Index
This Index is a validated, num erical scale from 0 to 100 and represents the 
patients ability to perform normal activity, the ability to do active work and the 
need for assistance in activities of daily living (Karnofsky 1949). Established 
guidelines for its use were considered; it has been widely tested and used for 
clinical decisions (Schag 1984). This Index was considered to show correlations 
between activity status, stage of disease and tiredness and was estimated by the 
researcher.
Patient characteristics: socio-demographic, health related and medical data
Patients were asked to fill in a self assessment form with questions about gender, 
age, self-perceived health status, cancer history, regular intake of medications, 
social context, em ploym ent situation and place of investigation. A dditional 
medical data were collected by the investigator from the medical documents: Date 
of diagnosis, type and stage of tum our at the time of investigation, tum our 
activity, tum our-treatm ent w ithin the last 6 weeks, other regular medications 
and in- or outpatient status. These data were needed to test the relationship 
between fatigue and disease so that the hypotheses could be tested.
Procedure
The research assistant, the nurses and doctors involved in this study first needed 
careful instruction to avoid introduction of any bias. As the questionnaire had 
already been tested before in the same institution (chapter 4), it could be used 
w ithout further piloting. Patients were approached by their caregivers, who 
invited them to participate in the study. If they agreed to co-operate, they were 
approached individually by the researcher, who explained the study and asked for 
oral consent. Confidentiality was assured and instruction given to fill in the 
forms in the following order: 1. Fatigue Assessment Q uestionnaire (FAQ), 2. 
HAD Scale, 3. Socio-demographic and health related data. This sequence was 
chosen because socio-demographic data might anti-motivate people to co-operate 
in the study. Most patients were left alone in a quiet place to fill in the 
questionnaire, w hich was picked up later by the researcher, opening the 
opportunity to have a personal contact, ask questions or to screen for missing 
data. Some out-patients were in a hurry or under some other pressure (e.g. left
glasses at home) and preferred to take the questionnaire with them and to send it 
back in a prepared (addressed and stamped) envelop. The researcher or w ard 
physician collected the biomedical data. In m any situations, however, results 
from examinations had to be awaited because tum our-activity and -stage was 
unclear at the time of the research intervention.
Data analysis
Data were transferred from written documents to a data base file (File maker). 
Statistical analyses were perform ed w ith technical support from the statistical 
unit and the quality of life office of the Swiss Institute for A pplied Cancer 
Research in Bern, using SAS and Splus.
Descriptive statistics were used to classify data and to give information about the 
characteristics of the study-population. Inferential statistics were used to identify 
the significance of differences in fatigue, anxiety and depression between different 
groups of the study population. Significance testing was performed by using the 
Kruskal-W allis Test concerning the com parison of fatigue, anxiety and 
depression between type and stage of cancer and to examine further influencing 
factors, such as treatment, age and gender. Differences in proportions were tested 
with the Chi-squared test. For the three largest disease groups, fatigue was further 
analysed by two way ANOVA with the variables disease and stage, using type III 
error sums of scores (SAS Proc GLM). Correlation between results of different sub 
scales of fatigue m easurem ent, anxiety and depression was calculated w ith 
Pearson correlation coefficients.
Construct validity of the FAQ was examined by factor analysis after prom ax 
rotation. This m ethod was used to ascertain the relationship betw een the 
variables measured and prior expectations on the basis of the underlying theory 
of the aspects investigated (Jones 1987), to further examine types of fatigue as 
defined in the previous study (chapter 4). Internal consistency of the FAQ as a 
whole and also its hypothesised physical, affective and cognitive sub scales were 
examined using the Kudar Richardson 20 formula, a special form of Coefficient 
alpha (for dichotomous answers). The internal consistency of the sub scales was 
also examined w ith the Pearson correlation coefficients of the items w ithin the 
sub scales (for interval and ordinal scales, to test that correlation is different from
zero). Correlation between all items of the whole questionnaire was analysed
with Pearson correlation coefficients.
5.6. RESULTS
Characteristics of the study population
Of 682 consecutively asked cancer patients, 68 patients refused to participate in the 
study and 31 did not return the questionnaire, which represents a response rate of 
86% (Table 5.1.). A further 71 patients were not able to fill in the questionnaire 
due to language and other problem s as described in Table 5.1.. Only 13 
questionnaires from 512 patients were not able to be evaluated, which represents 
97 % evaluable questionnaires, of which 98% were completed in the hospital 
setting and 2% at home. Four hospitals with six departm ents were involved in 
the m ulti-institutional study. The final convenience sam ple consisted of 499 
cancer patients.
Patient characteristics are presented in Table 5.2.. Median age was 58 years for all 
participants and there was no major difference in age, with 59 years in females 
and w ith 56 years in males. Sixty-one percent of women outnum bered 39% of 
men. Eighty-two percent lived together with others, 12% lived alone. Thirty-five 
percent of the whole study population were full-time employed, 15% w orked 
part-time. Eighteen percent were unable to work due to their illness and 32% 
were retired.
Further disease characteristics of the patients are presented in Table 5.3.. From the 
499 cancer patients, 51% suffered from metastatic and 14% from localised disease, 
35% lived w ith disease in remission. Slightly m ore than half of the study  
popu lation  (58%) w as undergoing  cancer trea tm ent at the tim e of the 
investigation. Forty-two percent of the whole study population  show ed a 
Karnofsky Index of 100 and an Index of 80-99 was observed in 50%, an Index of 60- 
79 in 7%, and only 1% showed an Index of less than 50. This explained the low 
rate of self-assessed need of assistance in activities of daily living, which was only 
2% of the whole study population. Eighty-one percent of the patients were treated 
on an outpatient basis, 19% were hospitalised.
Table 5.1. Patient participation, response rate, acceptability, feasibility of the
__________ Fatigue Assessment Questionnaire (FAQ)____________________
Patients eligible to participate in the study 682 (100 %)
Reasons for patient-non-participation:
Patient refusal 
Questionnaire not returned
68
31
Response rate 583 (86 %)
Further reasons for patient-non-participation:
Physically or psychologically not able to fill in quest. 
Cognitive im pairm ent 
Language problems 
Selection error
23
11
33
4
All participants 512
Completed questionnaires 
Questionnaires not evaluable
512
13 ( 3% )
Evaluable questionnaires 499 (97 %)
Questionnaires completed at home 
Questionnaires completed at the treatment setting*
02 % 
98%
* Participating institutions:
Kantonsspital St.Gallen
Medizinische Klinik C 63 % (316)
Gynaecology Department 7 % ( 36)
Radio Oncology Department 3 % ( 16)
Inselspital Bern, Institute of Oncology 16 % ( 78)
Private Oncology Practice (Dr. Spati) 6 % ( 31)
Regionalspital Herisau, Oncology Department 5 % ( 22)
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Table 5.2. Patient characteristics I: Age, gender, social situation, employment
(n= 499)
m edian  range percentages
m edian range
Age all m edian (years) 
range (years)
58
18-91
Age females median (years) 
range (years)
59
19-91
Age males m edian (years) 
range (years)
56
18-86
Gender female
m ale
61 % 
39 %
Social situation living alone 
living with others
18 % 
82 %
Employment, working 100%
50-99 %
1-49 %
unable to work 
retired
35 % 
10 % 
5%  
18 % 
32 %
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Table 5.3. Patient characteristics II: Disease stage, treatment, Karnofsky Index, 
need of assistance in activities of daily living, treatm ent setting 
(n= 499)
Percentages
Cancer stage localised 14 % ( 70)
metastatic 51 % (256)
in remission 35 % (173)
Cancer treatm ent yes 58 % (291)
Cancer treatm ent no 42 % (208)
Active disease cancer treatment yes 78 % (217)
Inactive disease cancer treatment yes 22 % ( 61)
No cancer treatment in active disease 36 % ( 79)
in inactive disease 64 % (138)
Karnofsky Index 100 42 % (212)
80-99 50 % (248)
51-79 7 % ( 35)
<50 1 % ( 4)
Need of assistance in yes 2 % ( 10)
activities of daily living* no 98 % (488) (1 missing)
Treatment setting inpatient 19 % ( 94)
outpatient 81 % (405)
* Patient self-assessed
Table 5.4. presents the distribution of different types of cancer. The diagnosis was 
breast cancer in 30% of the patients, malignant lymphoma (including myeloma) 
in 23%, gastrointestinal cancer in 13%, lung cancer in 6%„ cancer of the testis in 
6%, ovarian cancer in 5%, gynaecological cancer in 5%, malignant melanoma in 
3% and other types of cancer in 7%. Median duration since diagnosis varied from 
33 to 71 months.
The type of antineoplastic treatm ent involved is presented in Table 5.5.. Thirty 
percent of the patients underw ent chem otherapy, 11% horm onetherapy, 2% 
im m unotherapy and in 2% it was radiotherapy. Seven percent received a 
combined treatment. Forty-one percent of the patients had no cancer treatm ent 
w ithin the last 6 weeks. Approximately half of the study population received 
some other, non-cancer specific medication (Table 5.6.). In 37% this was some 
medication for a medical condition other than cancer, such as for cardio-vascular 
disease, in 14% it was pain m edication, in 7% sleep m edication, in 5%  
psychoactive drugs and 3% received corticosteroids at the time of investigation.
Psychometric properties of the Fatigue Assessment Questionnaire (FAQ)
Content validity of FAQ was originally supported by the fact that the items of the 
instrument were derived from descriptors of fatigue, as identified in qualitative 
interviews by cancer patients themselves, who can be seen as experts in this 
respect (chapter 2). A previous study, testing the questionnaire in healthy 
individuals and in cancer patients, supported content validity (chapter 4).
Table 5.7. shows that all FAQ items were reported by the whole study population 
and that again the items of the sub scale "physical fatigue" were more frequently 
registered than the affective and cognitive ones. Cognitive and affective items 
were reported in less than 30% of patients. Table 5.8. shows that the percentage of 
reported items varied in specific patient groups, thus being sensitive enough to 
detect differences. Lung cancer patients reported most items, apart from the items 
"feeling tense and wish to switch off thoughts", which were more frequently 
reported by patients with cancer of the testicles. The replicated use of all items in 
this study supported the idea, that they represent the content domain of fatigue.
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Table 5.5. Patient characteristics IV: Antineoplastic treatment
within the last 2 months (n= 499)
154
T reatm ent percentages percentages
(combinations (combinations
not included) included)
Chem otherapy 30.7 37.3
H orm onotherapy 11.8 13.6
Im m unotherapy 2.0 4.2
Radiotherapy 2.0 3.8
Combination therapy 7.8 ------
Surgery 4.0 6.8
No treatm ent 41.7 41.7
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Table 5.6. Patient characteristics V: Regular use of other medications
___________(non-antineoplastic) (n = 499)________________________
Type of medication percentages 
(of users)
Non- Users 48%
Users 52%
Pain medication 14.8
Psychoactive drugs 5.8
Sleep medication 7.6
Others 37.9
Corticosteroids 3.0
Multiple nominations possible
Table 5.7. Occurrence of fatigue in the whole patient population, measured
with the items of the Fatigue Assessment Questionnaire FAQ (n 499)
Ranking Binary items percentage
(Item num ber in FAQ) of occurrence
1 experiencing pleasant tiredness (14) 62%
2 decreased physical performance (16) 59 %
3 loss of energy (20) 53 %
4 weakness (19) 49 %
5 fight overcoming inactivity (21) 45%
6 unusual need for rest (2) 44%
7 feeling sleepy during the day (23) 42%
8 wish to switch off thoughts (15) 41 %
9 feeling unusually tired (6) 39 %
10 becoming slower (1) 37%
10 sleeping problems at night (3) 37%
11 feeling tense (11) 36 %
12 having heavy limbs (13) 35%
13 wish to withdraw (4) 34%
14 decreased attentiveness (17) 33 %
15 feeling impatient (18) 32%
16 increased forgetfulness (9) 28%
16 difficulties in concentrating (4) 28%
17 experiencing malaise (12) 25 %
18 sadness (22) 24%
19 feeling exhausted (7) 23%
20 loss of interest (19) 19 %
21 anxiety (8) 18 %
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Criterion related validity was difficult to assess, as no comparable instrum ent was 
available in German and convergent validity therefore could not be tested 
directly. The different stages of cancer, which were hypothesised to correlate with 
fatigue, however, can be used as an external criterion. As the instrum ent was able 
to assess differences between the different stages of cancer (see later, Table 5.15. 
and 5.16.), this can be seen as support for criterion-related validity, it could be seen 
as a type of know n group validation. Validity concerning feasibility and 
acceptability w as estab lished  by the h igh  rate  of correctly  com pleted 
questionnaires (97%). The response rate of 86% also supported the im portant 
aspect of face validity.
Construct validity was examined using factor analytic techniques (promax 
rotation). Factor loadings are presented in Table 5.9.. Three factors could be 
established, supporting an earlier hypothesised theoretical framework of fatigue 
as a m ultidim ensional construct, w ith expression at physical, affective and 
cognitive levels (chapter 2 and 4). Factor analysis showed, that the items "wish to 
withdraw , feeling exhausted, loss of interest and pleasant tiredness "were not 
related to any factor and therefore were deleted from the instrum ent before data 
analyses began. The instrument now comprised 19 binary items and a physical (11 
items), an affective (5 items) and a cognitive (3 items) sub scale, including a forth 
one-single-item scale w ith "sleeping problems" and LASA scales to m easure 
quantity and distress of fatigue. The item "sleeping problems at night" (identified 
in the qualitative interviews), showing no relation to the three identified factors, 
was used as a one single item scale because it was hypothesised that it was a 
separate concept w ith an influence on a possible activ ity / inactivity imbalance 
(chapter 2).
To support reliability of the FAQ, internal consistency was examined (Table 5.10.). 
A special version of the Coefficient alpha, (the Kuder-Richardson formula 20, for 
dichotomous items), was calculated after the identification of sub scales by factor 
analyses and after deleting redundant items. The reliability coefficient was 0.90 for 
the overall scale, 0.90 for the physical sub scale, 0.65 for the affective sub scale and 
0.68 for the cognitive sub scale. The correlation coefficients (Pearson) of the items 
within the sub scales supported the 3 factor solution (Table 5.11.).
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Table 5.10. Reliability of the scale after factor analysis (varimax rotation)
___________of the Fatigue Assessment Questionnaire (FAQ)___________
Factor 1 (physical scale): 0.90 
Factor 2 (affective scale): 0.65 
Factor 3 (cognitive scale: 0.68
Overall reliability of the scale: 0.90
Correlation alpha, Kudar Richardson formula 20
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It was difficult to establish stability (one element of reliability), as a test-retest was 
not appropriate for m easuring a fluctuating construct like fatigue. Stability, 
however could be supported by reproducibility of consistent results w ith the FAQ 
sub scales and the FAQ LAS A scales in different stages of cancer (see later, Tables 
5.15. and 5.16.).
The correlation of fatigue w ith different types of cancer
Table 5.12. shows a statistical difference in physical fatigue betw een all cancer 
types together (P= 0.005). A less significant difference in affective fatigue was also 
established between all cancer types (P= 0.03), but no difference was found for 
cognitive fatigue (P= 0.13). Patients w ith lung-, prostate-, ovarian cancer, and the 
groups w ith melanoma and mixed cancer types showed the m ost prom inent 
difference between physical and affective fatigue.
Table 5.13. shows the results of quantitative levels of fatigue in the different types 
of cancer, as measured with the LASA (Linear Analogue Scale Assessment) scales 
of FAQ. Even though a difference in fatigue levels between the different types of 
cancer can be observed, these differences are not statistically significant, apart 
from a trend for significance for the measurement period of last m onth (P= 0.06) 
and for the period of the last six m onths (P= 0.08). Levels of fatigue were, 
however, highest ranked in patients with lung and ovarian cancer for the period 
of last week. Patients w ith breast- and gastrointestinal cancer show ed stable 
fatigue levels over the three measurement periods, whereas patients w ith lung 
cancer showed an increase from the last six m onths towards last week. Fatigue 
distress, as measured with the LASA scale of FAQ, is also presented in Table 5.13.. 
Again, no statistically significant difference was found between all types of cancer 
(P= 0.18). However, the fatigue distress levels were ranked highest in lung- and 
ovarian cancer, followed by prostate cancer, m elanom a and gastrointestinal 
cancer. To better illustrate these differences, fatigue levels for last week, last 
m onth and fatigue distress (measured with LASA scales of FAQ) in the groups 
w ith different cancer types are presented as box plots in the Figures 5.1- 5.2.. 
Physical, affective and cognitive fatigue (m easured w ith the sub scales w ith 
dichotomous items of FAQ) in the groups w ith different types of cancer are 
presented as box plots in the Figures 5.2. and 5.3..
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Table 5.12. Type of cancer and fatigue, measured with the FAQ sub scales
___________(Fatigue Assessment Questionnaire) (n=499)_________________
Type of cancer fatigue
FAQ sub scales 
last week
physical affective cognitive sleeping
problem s %
mean SD mean SD mean SD
Lung cancer (28) 7.0 (3.1) 1.9 (1.4) 1.3 (1.0) 68%
Breast cancer (149) 3.8 (3.6) 1.4 (1.4) 0.8 (1.0) 36%
Malignant lymphoma (115) 4.5 (3.6) 1.4 (1.5) 0.8 (1.1) 31%
Gastrointestinal cancers (64) 4.4 (3.7) 1.1 (1.1) 0.6 (0.9) 37%
Prostate cancer (11) 4.9 (3.8) 1.2 (1.2) 1.1 (1.1) 27%
Cancer of the testis (32) 3.6 (4.1) 2.0 (1.5) 0.8 (1.0) 41%
Ovarian cancer (26) 5.4 (3.6) 1.1 (1.2) 0.8 (0.9) 31%
Gynaecological cancer (24) 
(endometrium, cervix, vagina)
2.5 (4.1) 1.6 (1.4) 0.9 (1.0) 46%
Melanoma (17) 5.5 (3.9) 1.8 (1.3) 1.2 (1.1) 29%
Others (33) 5.5 (3.7) 2.0 (1.7) 1.1 (1.2) 45%
P* 0.005 0.03 0.13
*Kruskal-Wallis Test
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Figure 5.1. Fatigue levels in different types of cancer, last w eek
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL GYN.
Figure 5.1. Fatigue levels in different types of cancer, last m onth
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL. GYN.
Figure 5.2. Levels of fatigue-distress in different types of cancer
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL GYN.
Figure 5.2. Physical fatigue in different types of cancer
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL. GYN.
Figure 5.3. Affective fatigue in different types of cancer
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL. GYN.
Figure 5.3. Cognitive fatigue in different types of cancer
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL. GYN.
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Analysing fatigue in  the different stages of breast cancer, m alignant lym phom a 
and gastrointestinal cancers
The three largest patient groups with breast cancer, m alignant lym phom a and 
gastrointestinal cancer were further analysed (Table 5.14.).
In patients w ith breast cancer, a significant difference in physical fatigue (FAQ 
physical sub scale) was found w ith highest physical fatigue levels in localised 
disease, followed by metastatic disease, followed by disease in rem ission (P= 
0.001). This was not the case for affective fatigue (FAQ affective sub scale) (P= 
0.38) and cognitive fatigue (FAQ cognitive sub scale) (P= 0.15). No significant 
difference was found either for the quantity of fatigue (LASA) for the three time 
periods of measurement, nor for its distress. A trend was found for all measures 
to be higher in breast cancer patients w ith localised disease than in metastatic 
disease. Looking at anxiety, mean results varied between 4.5 an 6.9, not reaching 
any significant difference. Depression, however, was significantly different 
between the three stages (P= 0.005) with higher levels in breast cancer patients 
with localised diseased, followed by metastatic disease.
In patients w ith malignant lymphoma, a significant difference was again found 
in physical fatigue w ith highest levels in patients w ith m etastatic disease, 
followed by localised disease and disease in remission (P= 0.001). This was not the 
case for affective fatigue (P= 0.07) and cognitive fatigue (P= 0.22). A significant 
difference was found for the quantity of fatigue (LASA) for last week (P= 0.01) and 
even stronger for the period of last month (P= 0.0002) and for the last six m onths 
(P= 0.0003). Sleeping problems, although not significantly different, w ere more 
prominent again in those lymphoma patients with localised disease than in those 
with metastatic disease. Looking at anxiety, a significant difference was found 
between the stages of lymphom a w ith highest levels in m etastatic disease, 
followed by localised disease and disease in remission (P= 0.005). The same was 
the case for depression (P= 0.0004).
In patients w ith gastrointestinal cancer, no statistical difference was detected 
between disease in remission and localised plus metastatic disease (as one group), 
apart from the levels of depression (0.03), which were higher in metastatic disease 
than in localised disease or disease in remission.
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When the three groups of patients w ith breast cancer, malignant lymphoma and 
gastrointestinal cancer were compared, using two way ANOVA, w ith stage as 
second factor, no statistical difference was found between the three diagnoses.
The other types of cancer were not further analysed due to the relatively small 
number of patients in the group.
The correlation of fatigue with different stages of cancer
The association of fatigue with different stages of all cancer types was found to be 
statistically significant (Table 5.15.). Physical fatigue, as m easured w ith  the 
physical sub scale of the FAQ, was highly significant w ith highest levels in 
metastatic disease, followed by localised disease and disease in remission (0.0001). 
Affective fatigue remained significant (0.02), although less different than physical 
fatigue, and the same was the case for cognitive fatigue (0.03). No difference was 
found between stages in cancer and sleeping problems (P= 0.76). The association 
of fatigue with stages of cancer was statistically significant w hen m easured w ith 
the LASA scale of FAQ (Table 5.16.) for the periods of last week (P= 0.0001), last 
m onth (P= 0.0001) and last six months (P= 0.0002). W hereas m ean levels of 
fatigue remained stable from last six months to last week in patients w ith disease 
in remission, fatigue levels showed a tendency to increase in patients w ith  
metastatic disease and localised disease from the last six m onths tow ards the last 
week period. Fatigue distress was also found to be significantly different between 
the stages (P= 0.0002), as measured with the LASA scale of FAQ, w ith highest 
levels in m etastatic disease, followed by localised disease and disease in 
rem ission. The m ean levels for fatigue and for fatigue d istress w ere 
approximately the same which emphazises its relevance.
, The influence of anti-cancer treatment on fatigue
Table 5.17. presents the mean fatigue levels, m easured w ith the LASA scale of 
FAQ, for last week and last m onth in relation to the different treatm ent 
modalities (in mm). Im m unotherapy (only 10 patients) was associated w ith  the 
highest levels of fatigue (51), followed by chem otherapy (42), and then  by 
radiotherapy (40) (only 6 patients). Mean levels of fatigue were lower for the 
patients receiving hormonetherapy (29) and after surgery within the last 6 weeks 
(34) than w ith the other treatm ent regimens. The mean levels of fatigue in
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Table 5.17. Differences of fatigue intensity in relation to different types of
treatment, measured with the LASA scales of FAQ
(Fatigue Assessment Questionnaire) (n=499)
last week 
FAQ-LASA 
fatigue 
mm
last month 
FAQ-LASA 
fatigue 
mm
mean SD mean SD
Chemotherapy, all (n=153) 42.0 28.5 43.3 26.5
without non-cancer medications (55) 37.2 26.4 42.4 26.7
with non-cancer medications (98) 46.2 29.3 43.9 26.6
Hormonetherapy, all (n=59) 29.0 25.5 30.5 26.0
without non-cancer medications (22) 25.2 25.1 28.4 25.4
with non-cancer medications (37) 31.3 25.8 31.8 26.7
Immunotherapy, all (n=10) 51.2 32.5 58.7 27.8
without non-cancer medications (3) 56.6 17.2 54.6 21.0
with non-cancer medications (7) 48.8 38.3 60.4 31.6
Radiotherapy, all (n=6)
without non-cancer medications
40.2 34.0 43.2 36.9
with non-cancer medication (6) 45.8 33.6 49.3 36.4
Combinationtherapy (n=39) 34.8 25.2 35.5 24.6
without non-cancer medications (12) 33.3 25.6 39.2 24.5
with non-cancer medications (27) 35.5 26.1 33.9 24.9
Surgery, all (n=29) 34.7 25.5 30.9 31.1
without non-cancer medications (12) 32.7 25.9 19.5 25.3
with non-cancer medications (8) 37.6 26.3 48.0 32.6
No cancer treatment, all (n=207) 31.8 27.7 32.0 26.9
without non-cancer medications 29.0 27.7 30.3 27.6
with non-cancer medications 36.8 27.2 34.9 25.4
All cancer treatment (n=291) 38.6 28.0 39.3 27.4
without non-cancer medication 31. 27. 27. 33.
with non-cancer medication 40. 28.4 39.2 27.4
P* 0.0004 0.003
* Kruskal Wallis Test
patients with any kind of anti-cancer treatm ent was 38, the m ean levels of those 
with no cancer treatment at all was 31.
When examining fatigue levels in all patients receiving anti-cancer treatm ent 
and comparing them with those patients who did not (Table 5.18.), statistically 
significant differences were found for mean fatigue (LASA scale of FAQ) for last 
week (0.005), last m onth (0.003) and fatigue distress (0.002). Physical fatigue was 
statistically significantly different between patients with and w ithout anti-cancer 
treatm ent (0.0001), whereas no significant difference was found for affective 
fatigue (0.62) and cognitive fatigue (0.56). Sleeping problem s did not differ 
between the two groups (P= 0.58).
The influence of other medications on fatigue (other than anti-cancer treatment)
Fatigue levels of the patients who received other medications than anti-cancer 
treatment (defined in Table 5.6.), were different from those of patients who did 
not need such medications. Table 5.18. shows the difference in fatigue between all 
patients receiving additional non-cancer m edication and those w ho did not 
receive any such drugs. Statistical analysis showed a difference in m ean fatigue 
levels (LASA of FAQ) for last week (P= 0.0004) and last m onth (P= 0.007) and 
fatigue distress (P= 0.001). A difference was also found in physical fatigue (P= 
0.001) and cognitive fatigue (P= 0.0001), whereas affective fatigue did not differ 
between the two groups (P= 0.59). Those patients who did receive non-anti-cancer 
medication, had more sleeping problems than the others (P= 0.0009).
The influence of anti-cancer treatment on fatigue in patients with 
different stages of cancer
In patients with cancer in remission, no difference was found between those with 
and w ithout anti-cancer medication in any of the three stages (Table 5.19.). In 
patients with localised disease, a difference between the groups with and w ithout 
anti-cancer treatm ent in the different stages of cancer was found in physical 
fatigue (physical fatigue sub scale), together w ith a slight, bu t non-significant 
difference in fatigue distress. In metastatic disease, an influence of the anti-cancer 
treatment could not be observed.
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The influence of age and gender on fatigue in patients with cancer
Table 5.20. presents differences in fatigue betw een age and gender. The 
comparison between patients younger than 50 years and patients older than 50 
years showed that younger patients experienced more affective fatigue (affective 
sub scale) than the older group (P= 0.02). A trend could be observed towards more 
physical fatigue (physical sub scale) (P= 0.06) and fatigue distress as measured with 
LASA in the older patient group (P= 0.09). Higher scores of depression were also 
observed in the older patient group ( P= 0.005).
The influence of gender could not be shown to be relevant for fatigue in the 
whole study population (Table 5.20.). Whereas no difference was found between 
age and fatigue, a difference could be observed concerning depression scores 
between males and females: males presented higher scores of depression (P= 0.02).
The investigation of fatigue and gender in different age-groups show ed, that 
there was no difference between females less than 50 years and females more 
than 50 years of age (Table 5.20.). This was not the case in males: the group of 
males over 50 years showed significantly more physical fatigue (P= 0.005) and also 
higher depression scores than those with less than 50 years (P= 0.001).
Differences of anxiety and depression in different stages and types of cancer, 
Kamofsky Index and types of cancer treatment
Table 5.21. presents the results obtained by m easuring anxiety and depression 
with the Hospital Anxiety and Depression Scales (HADS). The overall m ean of 
the anxiety scale showed a significant difference between the groups w ith highest 
anxiety scores in patients w ith localised disease, followed by patien ts w ith  
metastatic disease and then by those w ith disease in rem ission (P= 0.0004). 
Anxiety items w ith highest mean scores were "anxious presentim ents, tension 
and worrying thoughts". All anxiety items showed lower scores in those cancer 
patients in remission.
The overall m ean of the depression scale showed an even m ore significant 
difference between the groups with highest scores of depression in patients w ith 
metastatic disease, followed by patients with localised disease and then by patients
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with disease in remission (P= 0.0001). Depression items w ith the highest mean 
scores were "feeling held back, (not) enjoy future and (not) laughing and seeing 
funny things". All depression items showed lower scores in those cancer patients 
in remission than those with localised or metastatic disease.
Table 5.22. presents the different types of cancer and the related mean scores of 
anxiety and depression. Highest scores for anxiety and depression were observed 
in patients w ith lung cancer. Lowest anxiety scores were found in patients with 
prostate cancer (only 11 patients) and lowest depression scores in patients with 
cancer of the testicles. A significant difference was found for depression when 
comparing all types of cancer (P= 0.003). This was not the case for anxiety (P= 0.53). 
No difference could be observed for anxiety and depression in all types of cancer 
together and the scores on the Karnofsky Index. Figures 5.4. presents the scores of 
anxiety and depression in the different types of cancer, illustrated in box plots.
Cancer treatm ent and its relationship to anxiety and depression scores are 
presented in Table 5.23.. Highest anxiety and depression scores were observed in 
patien ts w ith  chem otherapy. These w ere low est in pa tien ts  receiving 
radiotherapy (only 6 patients). The comparison between patients who received 
any cancer treatm ent w ith the patients who did not, showed no significant 
difference for the anxiety scores (P= 0.08) but a significant difference for the 
depression scores (P= 0.004).
Correlations of fatigue sub scales, fatigue intensity, fatigue distress 
and HADS scores
Table 5.24. presents the correlations of fatigue sub scales w ith fatigue intensity, 
-distress and HAD scores. Physical fatigue correlated m ore h ighly  w ith  
quantitative fatigue of last week and last month (0.71 and 0.61) as m easured with 
the LASA scale. Correlations were less w ith fatigue distress (0.59) and least w ith 
depression (0.53). Affective fatigue correlated highest w ith anxiety (0.61) and 
depression (0.44) as measured with the HAD scales. Cognitive fatigue correlated 
moderately w ith most other variables (0.30 to 0.38). Quantitative fatigue of last 
week (LASA) was more highly correlated with fatigue of last m onth (0.80) than 
w ith fatigue distress (0.68). Quantitative fatigue of the last m onth w as more 
highly correlated with fatigue distress (0.71) and fatigue of the last six m onths 
(0.70). Fatigue distress showed the highest correlation with quantitative fatigue of
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Table 5.22. Differences between type of cancer and means for 
___________ anxiety and depression (HADS) and Karnofsky Index (n = 499)
Type of cancer HAD
Anxiety
HAD
Depression
Karnofsky
Index
mean SD mean SD m edian
Lung cancer (n=28) 6.6 3.8 6.0 3.3 80
Breast cancer (n=149) 5.1 3.3 3.5 3.1 90
Malignant lymphoma (n=115) 5.1 3.6 4.1 3.4 90
Gastrointestinal cancers (n=64) 5.0 3.0 4.3 3.4 90
Prostate cancer (n= ll) 3.6 2.0 4.3 4.7 90
Cancer of the testis (n=32) 5.0 3.3 2.5 2.2 100
Ovarian cancer(n=26) 5.0 5.5 4.3 3.3 90
Gynaecological cancer (24) 
(endometrium, cervix, vagina)
5.0 4.9 3.8 4.2 100
Melanoma (n=17) 5.1 3.0 4.7 2.7 90
Others (n=33) 5.3 3.6 4.6 3.8 90
P* 0.53 0.003
* Kruskal Wallis Test
Figure 5.4. Anxiety and depression in patients w ith different types of cancer
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL. GYN.
Depression (HAD)
LUNG BREAST LYM. Gl. PROST. TESTIS OVAR. OTH. MEL. GYN.
183
Table 23. Differences between type of cancer treatment and means for 
________  anxiety and depression (HADS) ( n= 499)__________________
HAD
Anxiety
HAD
Depression
Treatm ent
mean SD mean SD
chemotherapy (30%) 5.8 3.4 5.0 3.6
horm onotherapy (11%) 4.4 3.5 3.1 2.8
im m unotherapy (2%) 5.3 4.5 4.3 3.9
radiotherapy (2%) 3.8 3.3 2.5 2.9
combination therapy (9%) 5.1 3.2 4.4 3.2
surgery (4%) 5.9 3.2
■1
3.5 2.4
Any cancer treatm ent (58%) 5.3 (4.3) 4.3 (3.4)
No cancer treatment (42%) 4.9 (3.5) 3.6 (3.3)
P* 0.08 0.004
* Kruskal Wallis Test
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last m onth (0.70) and physical fatigue (0.59). There was how ever a smaller 
positive relationship with anxiety (0.41) and depression (0.43). Anxiety was more 
highly correlated w ith depression (0.66) and affective fatigue (0.61). D epression 
correlated most with anxiety (0.66) and with physical fatigue of last week (0.53).
Correlation analyses between items of the questionnaire
Correlation analyses between items (Table 5.25.) w ith correlation coefficients 
above 0.50 were found for the items "becoming slower" with weakness (0.61) and 
unusual need for rest (0.56); for "unusual need for rest" w ith unusual tiredness 
(0.75) and weakness (0.59); for "unusual fatigue" with weakness (0.58) and feeling 
exhausted (0.51); for "decreased physical performance" with fighting to overcome 
inactivity (0.59) and loss of energy (0.67); for "loss of energy" w ith fighting to 
overcome inactivity (0.65).
5.7. DISCUSSION
Due to the exploratory research approach, patient characteristics were not equally 
distributed in all aspects. Whereas age was equally distributed in the whole study 
population, 61% of the population were females and 39% were males. The disease 
was active in 36% and inactive in 64% of the patients. Almost half of the patients 
had or had not received anti-cancer treatm ent but the type of treatm ent varied 
greatly. One fifth of the patients were treated in an inpatient setting and four 
fifths of the patients were outpatients. The groups with different types of cancer 
differed considerably in size. As well as these uneven distributions of the 
characteristics, it also has to be kept in mind, that the patients w ith different types 
of cancer were categorised and that some groups, such as breast cancer patients, 
only included females or were associated w ith a uniform  type of treatm ent. 
Control of most of these important variables within the disease groups accounted 
for the differences and testing of the hypothesis was therefore still possible.
Psychometric properties of the Fatigue Assessment Questionnaire (FAQ)
Reliability and validity of the FAQ was tested in a study which com pared the 
experience of cancer patients w ith healthy individuals (chapter 4) and results 
from this epidemiological study show that it is also supported in this w ider group 
of cancer patients. Internal consistency for the FAQ was good for the overall
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scale and for the physical sub scale with a Cronbach coefficient alpha of 0.90. The 
coefficient for the affective sub scale (0.65) and the cognitive sub scale (0.68) can be 
regarded as acceptable, considering that they include only 5 and 3 items and that 
they measure subjective attributes. The overall coefficient of 0.90 supports the 
case for items of all the sub scales measuring the same underlying latent variable 
(De Vellis 1990). It therefore can be questioned w hether this represents a 
contradiction of the division of the scale into three sub scales. However, physical, 
affective and cognitive fatigue was based on factor analysis and it can be argued 
that the validity  of the m ultidim ensional concept had been developed in 
qualitative research, from the patients' perspective, who expressed fatigue at 
these three levels. The correlation coefficients of the items w ithin the sub scales 
further support the sub scales.
The fatigue items of the FAQ sub scales, tested in the earlier study  which 
compared the experience in cancer patients and healthy individuals (chapter 4), 
were all again reported in sim ilar fashion in this study  population, which 
supports their content validity. Redundant items, which did not fit into any sub 
scale, were identified by factor analysis and deleted from subsequent analyses, 
which further im proved the validation process. The use of FAQ in this larger 
patient population led to the (factor analytic) identification of three factors (Table 
5.10.), which were identified earlier, bu t not as clearly as in the m uch smaller 
population in the previous study (Table 4.5.). The ability to m easure differences 
between type and stages of cancer in study 3 supports reliability and validity.
The factors of the FAQ following adjustment are similar to those of sub scales of a 
very recently published multidim ensional fatigue inventory (Smets 1996). This 
inventory comprises scales on general, physical and m ental fatigue and on 
reduced activity and reduced motivation. Future research m ay allow testing of 
convergent validity of the inventory. The Piper Fatigue Scale also reflects a 
multidimensional fatigue concept but, because of its different endpoints, can not 
be compared with FAQ (Piper 1989).
The FAQ was specifically developed in and for a general cancer pa tien t 
population, measuring fatigue on the physical, affective and cognitive dimension 
and also m easuring quantity of fatigue and its distress to include the severity 
dimension. It offers the possibility of identifying fatigue qualitatively at the three 
levels of expression and at the same time allows quantitative m easurem ent by
adding the reported items. With its 19 binary items and 2 LASA scales, w ith a 
m easurem ent period of "one week" it is easy to use (yes/no  answers) and 
prevents vulnerable patients from burdening investigations. Feasibility and 
acceptability have been shown to be very good.
The correlation of fatigue w ith different types of cancer
The investigation of fatigue in the 10 groups of patients with different types of 
cancer did not reveal any significant differences between them w hen measuring 
fatigue with LASA scales of FAQ (Table 5.13.). M easurement of fatigue in the 
same groups w ith the three sub scales of FAQ, however, showed a significant 
difference for the physical sub scale and to a lesser degree for the affective sub 
scale (Table 5.12.). This suggests that there is a more specific, more sensitive 
m easurem ent of fatigue, w ith  qualitative, m ultid im ensional assessm ent 
identifying a major discriminating physical component between types of cancer. 
For all cancer types, physical fatigue was most prom inent, firstly followed by 
affective and secondly by cognitive fatigue. Patients with lung cancer, ovarian 
cancer and melanoma were associated w ith the highest fatigue levels. These 
results are in agreement with a study, in which high occurrence of fatigue in lung 
cancer patients was also confirmed (Hum y 1993). They also conform w ith another 
study, in which 59% of untreated lung cancer patients w ith lim ited disease 
suffered from reduced energy (Sarna 1994). Clinical experience in oncology gives 
the impression, that lung cancer patients suffer more from fatigue than  breast 
cancer patients. This impression has also been described by others (Smets 1996). 
Sleeping problems were far more prominent in patients with lung cancer than in 
other groups. Some of the groups, however, were small and therefore the results 
need to be interpreted cautiously. It has to be added, that the group w ith breast 
cancer patients represented a much more uniform group with one type of cancer, 
in contrast to the group with gastrointestinal cancer, in which a great variety of 
patients w ith different types of cancer, w ith possibly different fatigue base line 
levels, were included.
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The correlation of fatigue with stage of cancer
The hypothesis, that fatigue correlates with stage of cancer, could be supported 
(Table 5.15., 5.16.). Again, the physical fatigue scale showed highest significance 
between the three stages of cancer, which was backed up by the LASA scale 
measurement for last week and last months. The increase of fatigue levels in 
patients w ith localised disease over the last six months confirmed the correlation 
with disease progression. It has to be considered, that the group w ith localised 
disease was smaller than the other groups. The difference in levels of fatigue in 
the different stages may be explained either by the prim ary impact of growing 
cancer bulk on the organ system or by "asthenins", produced by the active 
tumour, causing asthenia (Theologides 1982). Other defence mechanisms of the 
body against the tum our involving cytokines, such as tum our necrosis factors or 
interleukines, might play a role (Morant 1991). Levels of inflammatory mediators 
have been found to be significantly different in various tum our stages (Staal-van 
Brekel 1995) in relation to weight-stable and weight-losing patients. The same 
could be expected in different tum our stages of specific cancer types in relation to 
fatigue. A study involving 1000 patients with advanced cancer, investigating the 
incidence of symptoms, showed that fatigue was consistently among the 10 most 
prevalent symptoms (Donnelly 1995), which supports the correlation of fatigue 
with advanced stages of disease.
The distress from fatigue measured in this study also progressed from cancer in 
rem ission to localised disease to m etastatic disease, w hich underp ins the 
relevance of the experience of fatigue. It also underlines the distressing type of 
fatigue in cancer disease and differentiates itself from usual tiredness which is 
perceived by healthy persons. It supports the content validity of the anchor words 
of the LASA scales of FAQ.
The difference betw een type and stages in breast cancer, m alignant lym phom a, 
gastrointestinal cancer
W hen investigating the different stages in beast cancer, m alignant lym phom a 
and gastrointestinal cancer, a significant difference could be found for physical 
fatigue in lymphoma and breast cancer patients with advanced stages of disease, 
(Table 5.14.). The distress of fatigue, however, remained significant in patients 
w ith m alignant lymphom a only, which could be explained by the fact that
malignant lymphomas are of a systemic nature if they are active. Due to the small 
numbers in the group of patients w ith gastrointestinal cancer, the analysis was 
done w ith patients in remission versus all others. Still, no difference was found 
between stages in this group. As significant differences between stages of cancer in 
all patients had been established before, these results require further thought. It 
could be that some specific types of cancer, such as gastrointestinal cancers, are 
associated with high levels of fatigue, even in non-metastatic states and that these 
type of cancer cells excrete substances which already induce fatigue at very early 
stages. This would still support the hypothesis that fatigue correlates w ith type 
and stage of cancer, but it would include the hypothesis that fatigue can also 
correlate solely with type of cancer. Another explanation would be the presence of 
normal base-line fatigue levels which do not differ at any stage. Fatigue, as 
measured w ith LASA scales for last week in gastrointestinal cancer, however, 
showed fatigue mean levels of 36 mm and mean fatigue distress levels of 38 mm. 
Mean levels of healthy individuals, as measured in chapter 4, were 24 mm for 
fatigue and 28 for its distress (Table 4.9.).
Disentangling confounding treatment variables
The influence of anti-cancer treatm ent versus no anti-cancer treatm ent on levels 
of fatigue could be recognised. Significance was reached for the physical sub scale, 
the LASA scales and for the fatigue distress scale (Table 5.18.). These results raise 
the question of whether the two groups compared represent patients w ith active 
disease (receiving anti-cancer treatment) versus patients w ith inactive disease 
(not receiving anti-cancer treatment). This question, however, could be answered 
by com paring the patients w ith different stages of cancer, receiving or not 
receiving anti-cancer treatm ent (Table 5.19.). The fact, that no significant 
difference was found in fatigue between anti-cancer treatment status in the three 
stages of cancer in the whole population suggests, that the influence of cancer 
stage is more prom inent than the influence of anti-cancer treatment. This does 
not exclude a fatiguing influence of anti-cancer treatm ent in otherw ise not 
fatigued cancer patients, such as in patients w ith breast cancer in an adjuvant 
therapy situation. It therefore does not necessarily contradict the findings of other 
researchers of higher fatigue levels in wom en w ith localised breast cancer, 
receiving a combination of radio- and chemotherapy than in those wom en who 
did not receive treatm ent (Woo 1996).
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However, different levels of fatigue were identified in the different treatm ent 
groups (Table 5.17.). Chemotherapy was clearly associated w ith higher fatigue 
levels than hormonetherapy or than no therapy. It has to be considered, that the 
numbers in the treatm ent regimen in this study varied greatly and conclusions 
need to be treated with caution. A recent investigation indicated similar fatigue 
levels among groups receiving different chem otherapy regim en (Richardson 
1996). It has to be considered, that different therapy regimen are usually given to 
patients with different types of cancer, possibly representing different fatigue base­
line levels. However, the general influence of anti-cancer treatm ent can not be 
underestimated and specific types of therapy need further investigation, such as 
consideration of longitudinal measurement in the course of treatm ent and also 
the type and stage of the disease.
Half of the cancer patients investigated needed some medication other than anti­
cancer treatm ent. Exam ination of fatigue related to these non-anti-cancer 
medications revealed significant differences, indicating higher fatigue levels in 
all measurements, excluding affective fatigue, in those patients who did receive 
such non-anti-cancer medication (Table 5.18.). This raises the question of whether 
the observed difference is caused by the non-anti-cancer medication or whether 
the population examined represents unintended sub groups. For instance it could 
be that some patients were in a curative situation w hilst others w ere in a 
palliative situation, when other medications, such as analgesics, m ight be related 
to symptoms of advanced cancer. The significant occurrence of sleeping problems 
in patients w ith non-anti-cancer medication might support this relationship, as 
sleeping problem s can be associated w ith pain, m ood disturbance or other 
symptoms of active disease. The significant difference between the two groups, 
how ever, needs fu rther atten tion  and it em phasises the im portance of 
controlling such variables when investigating fatigue in cancer patients.
Confounding patient characteristics: age and gender
The smaller significant increase for affective fatigue in younger patients found in 
this study supports findings of an earlier, empirical study, which reported higher 
emotional distress in younger patients than in older patients (Nerenz 1982). 
Results in this study showed significantly higher (physical) fatigue levels in 
males under the age of 50 years than in males over 50 years. This difference needs 
to be treated cautiously, because females outnum bered males in the study
population and the large group of females w ith breast cancer showed generally 
lower fatigue levels than other disease groups. The findings, that fatigue levels 
did not differ between females under and over the age of 50 years and between 
males and females generally, suggests, that these characteristics are of secondary 
importance for the development of fatigue. Type and stage of cancer appear to 
play the primary role in this respect.
Fatigue, anxiety and depression
The co-investigation of anxiety and depression in this study clearly confirmed the 
high correlation of anxiety and depression with stage of cancer. When the disease 
progressed, these emotions also increased (Table 5.21.). The fact that depression 
significantly differed between all groups with different types of cancer, m ight be 
related to the different prognostic outlook (Table 5.22.). Lung cancer patients are 
more likely to be confronted with potentially mortal disease than patients w ith 
cancer of the testis and depression in lung cancer patients m ight present an 
outcome of the coping process. The same significance could be found for 
depression in relation to anti-cancer treatment, where depression was higher in 
patients with anti-cancer treatment (Table 5.23.), which could be related again to 
types and stages of disease, needing specific treatm ent. The significance for 
depression in the group using non-cancer treatment, m ight also be related to the 
fact that for these patients, treatment was no longer available (Table 5.18.). When 
comparing anxiety and depression between breast cancer, m alignant lymphoma 
and gastrointestinal cancer (Table 5.14.), it is interesting to see that patients w ith 
malignant lymphoma showed a significant difference between the stages for both 
anxiety and depression, but patients with gastrointestinal cancer again showed no 
difference for both. In breast cancer, there was a significant difference between 
stages concerning depression, but not for anxiety. However, w hen looking at 
levels of anxiety and depression in relation to age and gender (Table 5.20.), all 
patients over the age of 50 years showed higher levels of depression (but not for 
anxiety) than younger patients, males showed higher levels of depression (but 
not for anxiety) than females, and males over the age of 50 years showed higher 
levels of depression (but not for anxiety) than younger males. W hereas anxiety 
had approximately the same influence on all of the sub groups, depression was 
significantly focused on males over the age of 50 years in this study. As it had 
been shown before that there is an association of anxiety and depression between 
stages of cancer, further research is needed to identify other determ inants.
However, it could be shown that depression differed between types of cancer 
(Table 5.22.), and even though the num bers between disease groups differed 
considerably, it can at least be stated that depression was higher in patients with 
lung cancer than in the other groups.
No systematic studies have yet investigated the relationship between depression 
and anxiety w ith fatigue experienced by cancer patients. Some studies have 
shown fatigue to be related to mood (Blesch 1991, Bruera 1989). The correlation 
between fatigue and depression could, however, also represent two completely 
different concepts. When analysing the fatigue mean levels and the HAD mean 
levels found for the three stages in breast cancer, m alignant lym phom a and 
gastrointestinal cancers (Table 5.14.), it could be said that:
1) significantly different levels of physical fatigue between stages in patients with 
lymphoma were accompanied by significantly different levels of anxiety and 
depression,
2) the significant level of physical fatigue between stages in patients w ith breast 
cancer was accompanied by significant levels of depression (not anxiety) and
3) the non-significance of fatigue in any measurement between stages in patients 
w ith gastrointestinal cancer was accompanied by non- significant levels of 
depression and anxiety either.
The significantly higher physical fatigue levels in males at the age over 50 years 
(Table 5.20.), was accompanied by significant levels of depression (not anxiety). 
These results speak strongly for a very similar concept of fatigue and depression. 
The only contradiction in this sense was the difference in gender. W hereas no 
significant difference in fatigue levels was found betw een m ales (n=195) and 
females (n=304) generally, a significantly higher level of depression was found in 
males (P= 0.02). This difference in depression could suggest that fatigue and 
depression are different constructs. These results need further attention.
The correlation of fatigue with depression and anxiety is of greatest interest, as 
the question of whether fatigue causes depression or whether depression causes 
fatigue, is still subject to debate. The highest correlation could be seen between the 
affective sub scale of FAQ and anxiety of HADS (0.61) (Table 5.24.), w hich 
indicates, that anxiety is partially captured with the affective sub scale in the FAQ 
and, to a lesser degree, also depression (0.44). A positive relationship could,
however, also be observed between the physical sub scale of FAQ and depression 
of HADS (0.53), which indicates, that depression is well captured w ith the 
physical sub scale in the FAQ and, to a lesser degree, also anxiety (0.40). It could be 
argued, that there was a trend for physical fatigue to be positively correlated with 
depression, and for affective fatigue to be positively related to anxiety. This does 
not, however, explain whether they are the same experience or whether they just 
appear together. The relatively positive relationship between fatigue distress and 
depression (0.43) and anxiety (0.41) suggests a similar construct. Cognitive fatigue 
showed positive, bu t less strong, correlation with anxiety and depression of 
HADS. The tentatively proposed framework described in chapter 2, explaining 
fatigue as a multidimensional construct, which is expressed at physical, affective 
and cognitive levels, does therefore receive further support.
Interrelationship between questionnaire-items of the FAQ
The correlation of depression with fatigue emphasised the emotional component 
of fatigue. Further correlation analyses of the questionnaire items supported a 
strong physical fatigue component. The identified descriptors w ith a positive 
relationship between them may represent components of fatigue (Table 5.25.). It 
can be hypothesised, that the interrelationsship betw een these com ponents 
represents the process of fatigue development. Fatigue m ight lead to unusual 
need for rest, which in turn  might lead to inactivity, weakness, to decreased 
physical performance, resulting in a lack of energising metabolic resources. A 
vicious circle phenomenon, involving a rest /  activity imbalance, had  already 
been hypothesised in chapter 2. Further research is needed to study and test the 
interrelationship between these components.
5.8. CONCLUSIONS AND DIRECTION FOR FURTHER RESEARCH
Reliability and validity of the new Fatigue Assessment Questionnaire (FAQ) has 
been supported in a larger cancer patient population. Factor analyses supported 
the earlier hypothesised theoretical framework of fatigue expression at physical, 
affective and cognitive levels.
There was also a correlation of stages of cancer with fatigue levels. Patients w ith 
metastatic disease generally experienced more fatigue than those in remission,
although there might be types of cancer which produce high fatigue levels, even 
in localised disease. Correlation of specific types of cancer w ith levels of fatigue 
could partially be confirmed. The limitation of this study is the uneven num ber 
of disease groups, induced by its exploratory approach. Further research is needed 
to study groups of patients with different cancer types in comparable group-size in 
order to identify further risk populations. The role of anti-cancer treatm ent has 
been identified as significant in this study but it is argued that advanced stages of 
cancer are a major determinant factor for the development of fatigue. The same 
role of advanced disease applies to the role of other medications and to age and 
gender. The importance of controlling confounding variables, such as type and 
stage of cancer, treatm ent regimen, co-medication, age and gender in future 
fatigue research has been shown in this study.
Further research is needed to analyse the interrelationship betw een anxiety, 
depression and fatigue and between the identified components of fatigue.
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CHAPTER 6
GENERAL DISCUSSION
This thesis has show n that m any different concepts of fatigue have been 
discussed in the past and in the current century. In patients w ith cancer, the 
discussion around fatigue became very topical in the current decade and today an 
international discussion takes place among nurse researchers. Again, different 
attempts have been made to conceptualise fatigue in cancer patients (Piper 1989, 
Cimprich 1992, Irvine 1994, Winningham 1994). This discussion will focus on the 
most im portant findings of the thesis, nam ely on the difference of fatigue 
concepts between cancer patients and healthy individuals and its importance in 
considering  the use of m easu rem en t in strum en ts. F u rth e rm o re , the 
identification of a new concept of fatigue in cancer patients will be discussed. The 
relationship of a dominant physical and a affective component of fatigue w ith the 
disease will be discussed and implications for nursing practice and research will 
be proposed.
6.1. CRITICAL DESIGN FEATURES
Current international discussion reveals that the complexity of the concept of 
"fatigue" is being emphasised by linguistic and cultural differences throughout 
various countries. Whereas experience shows that English speaking nursing and 
medical experts assume that fatigue is a pathological expression of otherwise 
healthy tiredness, some other groups such as for example German, Italian or 
Swedish populations realise, that there is no such w ord as fatigue in the 
vocabulary of their language. In a German speaking lay population, the word 
fatigue can not be used because it represents a foreign technical term  which is 
only understood by health care professionals. This implies that research not only 
needs to define fatigue as a concept but also its linguistic description and meaning 
in different languages and cultures.
The words which are used to describe fatigue can, apart from the differences in 
languages, change in various health conditions. Evidence for this was given by 
the results of study 1 (chapter 2) which showed the linguistic differences between 
healthy individuals and cancer patients. Neither patients nor healthy individuals 
used the w ord "fatigue" or "malaise" in this German speaking population w hen
they spoke about their experience of fatigue. An im portant characteristic was 
observed in the different mood states w ith which the two groups described 
fatigue. Whereas cancer patients expressed sadness and suffering w hen speaking 
about their fatigue experience, the interviews did not put an emotional strain on 
healthy persons. These observations support the notion of different grounds 
upon which fatigue feelings might be rooted in ill and healthy individuals. 
Unmistakably sadness was present with the fatigued cancer patients, a correlation 
which has been established before (Bruera 1988, Blesch 1991, Smets 1996). In 
contrast, the group of healthy individuals did not appear anxious about their 
feeling tired, they even used words which incorporated some form of hum our. 
This observation is in accordance w ith statem ents from Nixon (1976), who 
described tiredness in healthy persons as a non- anxiety-"inducing state. It 
becomes evident that "normal tiredness" in healthy persons and "abnormal 
tiredness" in cancer patients needs to be differentiated.
The linguistic and cultural differences reveal only the tip of the iceberg. The 
whole concept of fatigue needs to be explored from the perspective of health and 
disease. From the perspective of physiology in health, fatigue is defined as a life 
sustaining state, similar to other physiological needs, such as thirst and hunger 
(Grandjean 1968). Grandjean describes fatigue, together with other authors (Dill 
1967, Barteley 1967), as a defence mechanism, a protective phenom enon and a 
process of adaptation in order to m aintain health. It is, however, difficult to 
define the norm ative tiredness levels of a healthy popu lation  and  data 
considering gender and age are lacking. This makes it difficult to know w hat can 
be labelled as "abnormal tiredness" in diseased persons. Chen (1986) concluded in 
his study, that 20% of healthy adults indicated that they were suffering from 
fatigue, which does not help to identify the level or quantity of w hat is considered 
"abnorm al fatigue". Studies w hich com pare tiredness levels of healthy  
individuals w ith those of diseased persons are lacking or show methodological 
difficulties, especially that of measurement, sample size or confounding variables 
(Pickard 1991, Glaus 1993).
If fatigue is to be measured quantitatively as a continuum, using linear analogue 
scales, it becomes especially im portant that a valid continuum  of the construct 
"fatigue" is defined for the population concerned. Study 1 and 2 (chapter 2 and 3) 
showed that healthy persons experience a different quality of tiredness than 
cancer patients. Whereas tiredness in healthy persons was mainly experienced as
a pleasant consequence of hard work, which was relieved by rest, cancer patients 
spoke about an unusual, extreme, lasting tiredness. The use of anchor words like 
"I do not feel tired" and "I feel very tired", do not capture these two different 
types of tiredness. Symptom distress scales have not respected this difference and 
simply use the anchor words "I do not feel tired" to "I feel very tired" (McCorkle 
1978, Holmes 1991). The newly developed Fatigue Assessment Questionnaire 
(FAQ) took account of that differences in the linear analogue scales: the words 
used by the cancer patients formed the anchor words and the new continuum  
ranked from "I did not feel unusually tired" to "I did feel extremely tired, 
exhausted". This difference in fatigue linear analogue scales has not been 
described in the literature before.
Evidence for the ability of the linear analogue scale of FAQ to distinguish 
between different populations was given in study 2 (chapter 4). The comparison 
of mean fatigue levels betw een healthy individuals and cancer patients, as 
measured with linear analogue scales showed a result of 24 mm of fatigue (for 
last week) in healthy persons and 38 mm for cancer patients w ith various cancer 
diagnoses, which is significantly different (P= 0.004). Distress of fatigue also 
remained significantly different between the two groups. The methodological 
implication of these results is the confirmation of sensitivity to m easure the right 
type of fatigue in cancer patients and the clinical implication is the availability of 
base line data concerning quantitative fatigue from healthy individuals. Even 
though age and gender were equally distributed, the lack of age and gender 
adjusted sub groups could be seen as a limitation of the study. However, no such 
confirmatory study was found in the literature which compared a general cancer 
patient population with healthy individuals.
6.2. DEFINING A CONCEPT OF FATIGUE IN CANCER PATIENTS
Literature shows that fatigue is not a new topic. In the past it has been associated 
with different dimensions, such as w ith muscle fatigue (Kronecker 1891), w ith 
m ental sym ptom s (Cowles 1893), w ith  "over-burdening" and also w ith  
psychological aspects (MacDougall 1899). Muscio stated in 1921, that the term  
fatigue should be banished from scientific discussions and that attem pts to 
develop a fatigue test be abandoned (Muscio 1921). This statem ent reflects, that 
scientists of those times had similar difficulties in defining and measuring fatigue 
as we seem to have today. Only in the sixties did fatigue became a subject for
research again, w hen industrial research attem pted to m easure tiredness in 
airmen (Pearson Byars 1956) and when tiredness in industrial workers became 
interesting in relation to working performance (Grandjean 1961, Yoshitake 1971). 
In the last decade, fatigue was discussed as a disease in its own, as the "Chronic 
Fatigue Syndrome", w ithout clear evidence of its cause (Behan 1985). Today, 
fatigue is recognised as one of the most distressing symptoms of cancer (World 
Health Organisation 1990).
It has become evident that the concept of fatigue is dependent on the nature of 
the population to which it refers. Linguistic and cultural characteristics, health 
status and also the purpose of the research conducted are determ ining factors. 
This thesis aimed at identifying the concept of fatigue as it is experienced by 
cancer patien ts and it therefore was not the aim to identify  causes or 
consequences, but the actual experiences of fatigue. Following the series of studies 
(chapters 2,4,5) a classification system w ith expression of fatigue at physical, 
affective and cognitive levels was identified. This new classification system led to 
the tentative developm ent of a step-like theory, explaining the evolution of 
fatigue/ tiredness, similar to a theoretical framework described by Bruera (1994), 
which explains the production of pain. This theory explains the production of 
fatigue by involving nociception, perception and expression (chapter 2). Studies 1, 
2 and 3 provide the evidence that fatigue can be seen as an "umbrella term" for a 
multitude of components, being expressed at the physical, affective and cognitive 
level. Since it is not yet possible to identify and measure fatigue at a cortical or 
biochemical level, assessment has to be based on patient's subjective expression. 
The basic components of physical, affective and cognitive fatigue appear to be 
relevant for different populations since they were identified in both healthy 
individuals and cancer patients. The causes, however, appear to be different. The 
theoretical models described by Piper (1987), W inningham and Nail (1994) and 
Irvine (1994), offer a m ultitude of theoretical explanations for the causes and 
mechanisms of fatigue in patients with cancer. There is, however, no definition 
of the actual experience of fatigue and no measurement instrum ent provided for 
this framework.
Evidence for the concept of fatigue which has three com ponents w as first 
suggested in the qualitative study 1 (chapter 2), when content analysis of the 
unstructured interviews led to a tentative framework which com prised three 
categories. The concept found partial agreement in the following quantitative
study 2 (chapter 4) and eventually could be confirmed in study 3 which included a 
large cancer patient population (chapter 5). The framework, eventually derived 
from the factor analytic results of study 3, explains the actual experience of fatigue 
in cancer patients which is illustrated in Figure 6.1.. W hilst the expression of 
physical fatigue is dom inant, the affective and cognitive expressions m ight be 
strongly interwoven and feedback mechanisms between the three levels in all 
directions could also be hypothesised. Further research is needed to investigate 
the interrelationship between these different components of fatigue.
The concept with expression of fatigue at physical, affective and cognitive levels 
also fitted for the healthy individuals. The content of the categories, however, has 
shown to be different between them. This evidence was first apparent in study 1 
(chapter 2) where some fatigue experiences were the same in healthy persons as 
in cancer patients while others turned out to be very different, although fitting 
the same classification system. The descriptors used by healthy persons were 
similar to the descriptors found in the frequently used Pearson Byars Fatigue 
Feeling Checklist (Pearson and Byars 1956), which was developed for the 
m easurem ent of tiredness in healthy airmen, representing a continuum  from 
"feeling peppy and refreshed" to "ready to drop". In that scale, the word fatigue is 
not used, which underlines its concept of "healthy tiredness". In study  1, 
circadian or even pleasant tiredness was reported by healthy individuals and 
results of study 2 even showed an inverse correlation in cancer patients. It was 
suggested that a "positive or physiological type of tiredness", resulting from 
physical exercise or hard work, was typical for healthy individuals. However, in 
study 3 w ith a large cancer population it could be shown that the "healthy, 
circadian type of tiredness" was also reported by cancer patients, indicating that 
they can experience more than one type of tiredness. This underlines the 
im portance of m easuring the right type of cancer specific fatigue and the 
importance of using m easurem ent instrum ents which include patien t centred 
items which are developed out of the population concerned. The use of fatigue 
instruments developed for healthy persons (Pearson and Byars 1956, Yoshitake 
1971) or for psychological investigations (McNair 1971) measure different types of 
tiredness than the research in the cancer specific FAQ.
Evidence for a cancer specific type of tiredness was shown in study 1 where cancer 
patients spoke about the distressing type of tiredness. Their experiences had a 
major impact on well-being: expressions, such as decreased physical performance,
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extreme, unusual tiredness; weakness; and unusual need for rest were cancer- 
specific experiences and were not mentioned by healthy persons (chapter 2). One 
of the main differences was the occurrence of weakness in 85% of the group with 
cancer patients, whereas healthy individuals did not describe fatigue as weakness 
at all. Recent literature has recognised the need to investigate whether weakness 
is the same as tiredness (W inningham 1994). Data from this interview -study 
suggest that weakness, as differentiated from weakness caused by neurological 
damage, is an inherent part or component of fatigue in cancer patients.
Evidence for this distressing type of tiredness, possibly better called fatigue, was 
shown in study 2 (chapter 4) which supported the qualitative analyses of fatigue 
with quantitative methods. Univariate analysis of the descriptors, as they were 
identified in study  1 and then  included in the new  Fatigue Assessm ent 
Questionnaire (FAQ), discriminated well between healthy and ill persons. Again, 
decreased physical performance; unusual, extreme tiredness; weakness; unusual 
need for rest; fight overcoming inactivity; and loss of energy were very different 
between healthy persons and cancer patients. At this stage, it was suggested, that 
physical sensations of fatigue might be stronger than affective and cognitive ones, 
as these last two categories did not appear to discriminate between the healthy 
and the diseased group. Nevertheless, the less frequent occurrence of affective 
and cognitive sensations, overall, might also be explained by the fact that they are 
less tangible than the physical sensations and that patients tend to speak more 
openly about physical than about psychological feelings, as has been observed by 
other investigators (Kobashi 1985). The cancer specific fatigue descriptors, with an 
emphasis on the physical impact, were replicated in study 3 (chapter 5).
Throughout all three studies the physical descriptors of fatigue w ere more 
prevalent than the others. The dominant expression of physical fatigue led to a 
tentative hypothesis of an activity /  inactivity vicious circle phenom enon (Figure 
4.1., chapter 4). The hypothesis was supported by the results of study 3 (chapter 5) 
in a large cancer patient population, where the same physical components were 
dom inant w ith the correlation analysis showing a strong correlation betw een 
them. The hypothesis shares one aspect w ith W inningham's theoretical model of 
fatigue in cancer patients, in which fatigue is seen as a sym ptom  caused by 
disease, treatment and other symptoms and as a secondary symptom of decreased 
activity, which leads to decreased functional status and eventually to disability
(W inningham 1994). W inningham  explains her fatigue theory by a lack of 
energising metabolic resources, which leads to further fatigue.
The hypothesised vicious circle phenomenon partially supports this secondary 
fatigue by decreased activity as explained by Winningham. It is, however, argued 
that important causes other than the lack of energising metabolic resources might 
be involved. Fatigue, which in the vicious circle is hypothesised as the "starter" 
of the circle, m ight prim arily be caused by biochemical substances, such as 
inflammatory m ediators or cytokines, produced by different types and stages of 
cancer (M orant 1991, Keller 1993). The biochemical consequences of such 
substances might be also be involved in primary, as well as in secondary fatigue. 
However, fatigue might additionally be caused or at least aggravated by restricted 
affective and cognitive resources. Immobility, isolation and sensory deprivation 
have been thought to induce fatigue mechanisms which involve the inhibition 
of the Reticular Activation System (RAS) in the m id-brain and m edulla, 
responsible for m aintaining wakefulness and of alerting the cortex. Reduced 
cortical activity has also been explained by chronic stim ulation, such as 
depression, anxiety and pain (Astair 1987). These mechanisms m ight well be 
involved in secondary fatigue and m ight influence the activity /  inactivity 
balance. This theory is tentative and further research is needed to substantiate it.
Study 3 (chapter 5) has shed some light on the interrelationship between fatigue 
in patients w ith cancer and the physical and affective fatigue expression: It 
became evident that physical aspects of fatigue are dom inantly linked to the 
biochemical disease process. For example, the results showed some evidence that 
patients with certain types of cancer experience more fatigue than patients w ith 
other types, w ith lung cancer patients showing the highest fatigue levels. But 
these results need to be treated cautiously because the sample sizes were probably 
too small (n= 28). In comparison to them, patients with breast cancer (n= 149) had 
far lower fatigue levels. The difference between types of cancer could only be 
statistically confirmed w ith the physical sub scale of FAQ. This suggests, that the 
more qualitative measurement with the physical sub scale is more sensitive than 
the quantitative m easurement with the linear analogue scale alone. The fact that 
only physical fatigue differed between patients with different types of cancer and 
that affective and cognitive fatigue was commonly lower in patients w ith all 
cancer types, supports the dominance of fatigue as a physical expression.
In study 3 (chapter 5), quantitative fatigue levels, as m easured w ith linear 
analogue scales for the period of last week, were identified in a large general 
cancer patient population with various diagnoses, stages and treatments (n= 499). 
These levels were again higher than those identified earlier in healthy persons. 
Irvine (1994) compared fatigue levels between healthy women and women with 
breast cancer and showed that there was no difference between the two groups. 
This strongly supports the hypothesis that there might be no differences between 
patients with certain types of cancer, such as breast cancer in early stages, and 
healthy persons. It underscores the importance of considering type and stage of 
cancer w hen com paring fatigue levels of cancer pa tien ts w ith  healthy 
individuals. The difference in size of cancer specific sub groups in study 3, 
however, could be responsible for the present lack of a statistically significant 
difference between other groups. Further research is needed to m ore clearly 
analyse fatigue levels in patients with specific cancer types.
The basis of the expectation that fatigue levels between different types of cancer 
are different is the hypothesis, that the impact of cancer on the affected organ may 
play the prim ary role and that the secretion of cancer specific "asthenins" may 
present a secondary cause of fatigue (Theologides 1982, Bruera 1988). A few data 
exist, which indicate high fatigue levels in patients with lung cancer (Blesch 1991, 
Butow 1991, Sarna 1994), a group of tum ours know n to p roduce  m ore 
"paraendocrine" substances than other types of cancer. The influence of 
"asthenins" on energy transform ation processes and on muscle w asting have 
previously been discussed (Keller 1993) bu t it rem ains unclear, w hether the 
immune system or the tum our itself are mainly responsible for their production 
(Morant 1991).
The correlation of fatigue with different stages of cancer was confirmed (chapter 
5). Even the investigation of major influencing factors, such as cancer treatment, 
did not appear to influence the prim ary association of fatigue w ith disease. It 
suggests that the physical expression of fatigue is more likely to be related to the 
disease than to the treatment. Although radiotherapy has been shown to increase 
fatigue towards the end of treatment (Haylock 1979, King 1985) and although it 
has been demonstrated that fatigue is the most prevalent side effect in patients 
receiving chem otherapy and im m unotherapy (Knoff 1986, Rhodes 1988, Piper 
and Rieger 1989, Blesch 1991, Richardson 1996), results of study 3 showed that the 
advanced stage of cancer overruled treatm ent influences. This supports the
theory, that the stage of cancer is the major determ ining factor concerning 
development of fatigue in cancer patients. In this sense, the stage of cancer has 
the highest priority  w hen looking for the causal relationships. It can be 
concluded, therefore, that patients w ith advanced cancer are at higher risk of 
fatigue than patients with localised disease or disease in remission. This result is 
new and has not been investigated and reported so far.
Another im portant finding was that the stage of cancer was not only correlated 
with fatigue but also with depression and anxiety, as m easured w ith the HAD 
scale. The same findings have been described by other researchers (Smets 1996). 
This, however, does not answ er the question of w hether fatigue leads to 
depression or whether depression leads to fatigue. Data from this study indicates 
that fatigue in the advanced stages of cancer is highly correlated w ith anxiety and 
depression. But it was found that depression is more likely to be found in 
advanced stages of most cancer patients than anxiety and that age is an important 
variable. It could be hypothesised that long lasting states of anxiety over the 
course of chronic illness lead to exhaustion as it has been described as forerunner 
of fatigue by Morris (1982). The other im portant message from study 3 is that 
fatigue appears to be linked with depression in advanced cancer disease. This 
strongly suggests that affective fatigue might be linked to psychological coping 
with incurable disease. Results from study 3 also suggest that treatm ent variables 
might play a role in the development of depression in advanced stages, bu t this 
needs to be interpreted very cautiously because of the presence of confounding 
variables, such as stage and type of cancer.
The limitation of study 3 is the numerical imbalance of patients in the various 
sub groups which was the result of the exploratory approach of this investigation, 
aimed at testing consecutive cancer patients in a general oncology population. 
Retrospectively it can be questioned, whether the explorative approach, including 
patients of all major cancer types, should have been replaced by a m ore 
controlled approach from the beginning, aiming at achieving equal num bers in 
defined groups. However, this would have imported considerable selection bias 
and the explorative approach facilitated an interesting insight into the m agnitude 
of the fatigue experience in a general cancer patient population w ith different 
stages of their disease.
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6.3. ISSUES FOR FURTHER RESEARCH 
AND IMPLICATIONS FOR PRACTICE
The three sub scales of the FAQ allow measurement of the physical, affective and 
cognitive elements of fatigue and so enables them to be correlated w ith other 
aspects of the patient and his disease. The inclusion of linear analogue scales for 
the quantitative measurement of fatigue and its distress provides insight into the 
relevance of the fatigue experience. This opens the possibility of identifying more 
cancer-specific fatigue expression which becomes im portant w hen the clinical 
effectiveness of future treatm ent strategies are to be assessed. The validity of the 
FAQ confirms the nature of the fatigue concept. In terms of internal consistency, 
the questionnaire has been shown to be reliable. It can be used in practice and 
used in further research by various professionals who care for cancer patients, 
whether they are physicians, nurses or psychologists. Any further use in research 
could however be helpful to further evaluate the psychometric properties of the 
questionnaire. For the evaluation of therapeutic strategies in the care of cancer 
patients suffering from fatigue, reliable and validated instruments are needed to 
document its effectiveness.
Further research questions raised by this thesis are: 1) Is fatigue a sym ptom  of 
cancer or an expression of coping w ith cancer? 2) Is fatigue independent from 
depression found in patients with advanced stage of cancer? 3) Are biochemical 
substances mainly responsible for physical fatigue and is psychological coping 
with progressive disease mainly associated with affective fatigue? 4) W hat is the 
in terrelationship  betw een the physical com ponents of fatigue, are they 
responsible for a vicious circle and if yes, can it be interrupted?
Further research is also needed to provide definitive answers about w hat types of 
cancer are associated with the highest fatigue levels. These questions have not 
yet received enough attention in the literature, considering their im portance 
concerning the future development of therapeutic strategies. Research will also 
have to deal with separating out the different causes of fatigue in cancer patients 
w ith possible pharm acological, m edical treatm ent and w ith  nu rsing  and 
psychological support measures.
A better understanding of the fatigue mechanisms will facilitate interventions 
strategies. No research exists which deals with the prevention of fatigue in cancer
patients. This could be a focus of future clinical research, for example in patients 
w ith early stages of breast cancer receiving adjuvant treatm ent. Research has 
shown that fatigue levels in these patients correlate w ith the antineoplastic 
treatm ent (Woo 1996). W hat kind of intervention might help these wom en to 
become less fatigued in the course of the treatment? In contrast to that, the 
correlation of fatigue w ith certain types and w ith advanced stage of cancer 
indicate a biological cause which can be seen as an inevitable outcome of the 
disease (Theologides 1982). If progressive cancer cannot be influenced by 
treatment, it will remain difficult to prevent or treat fatigue. It then becomes a 
nursing counselling challenge to help patients to understand  fatigue as a 
symptom of disease and to support them in m anaging the activities of daily 
living w ith a restricted energy account. Study 3 has shown that patients w ith 
advanced cancer suffer from high fatigue levels which are associated w ith 
depression, which guides research and practice towards support of patients in 
coping related to living with incurable disease. For nurses, the hypothesis of the 
activity /  inactivity vicious circle m ight be of considerable in terest, as 
mobilisation, activity and inactivity present an im portant concept in nursing 
care. This thesis has shown that any sound research m ethodology in fatigue 
requires a thorough consideration of the confounding variables, such as type and 
stage of cancer, treatment variables, symptom control measures, emotional status, 
age and gender.
A better knowledge of fatigue in cancer will not only provide the potential to do 
therapeutically oriented research, aiming at relieving fatigue, bu t support nurses' 
understanding  of the patien t's personal fatigue experience. The increased 
knowledge of the caregivers will enable them  to become more aware of this 
distressing, silent companion of m any cancer patients, thus helping patients to 
cope with fatigue. The generation of "general fatigue knowledge" in patients w ith 
cancer should enable caregivers to deal w ith the expression of fatigue in a very 
personal way. Fatigue can also become an important area of judgem ent in clinical 
nursing practice w ith fatigue m easurement becoming a part of the assessm ent 
process.
It is the sincere hope that the outcomes of the thesis will contribute to both, the 
advancem ent of scientific m ethodology of questionnaire design  and  the 
knowledge in the domain of fatigue in cancer, thus improving individual patient
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